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Zusammenfassung
Influenzaviren können Epidemien und Pandemien hervorrufen und sorgen jährlich noch
immer für 300.000 bis 650.000 Todesfälle weltweit. Im Unterschied zu anderen RNA
Viren vervielfältigen sie ihr Genom im Zellkern infizierter Zellen. Für die erfolgreiche Ver-
mehrung müssen neu gebildete Genomsegmente, sogenannte virale Ribonukleoproteine
(vRNPs), allerdings wieder aus dem Zellkern exportiert werden. Dafür nutzt Influenza
einen Exportkomplex, der sich aus den beiden viralen Proteinen Matrixprotein 1 (M1)
und Nukleusexportprotein (NEP) zusammensetzt und vRNPs unter Verwendung des
zellulären Exportproteins CRM1 aus dem Zellkern in das Zytoplasma transportiert. In
den letzten Jahren wurde ein Inhibitor entwickelt, der mit dem viralen Exportkomplex
um die Bindung an CRM1 konkurriert, damit den Export von vRNPs verhindert und
somit die Virusmenge in Lungen von Mäusen und Frettchen deutlich reduziert. Zusätz-
lich konnte weder eine Resistenzbildung seitens des Viruses noch eine Unverträglichkeit
im Menschen in klinische Studien der Phasen I und II nachgewiesen werden (Perwitasari
et al., 2016). Allerdings sind weiterhin zahlreiche Fragen im Zusammenhang mit dem
viralen Exportkomplex unbeantwortet: Wie viele Exportkomplexe werden pro vRNP
gebunden? Wie interagieren die Proteine innerhalb des Komplexes mit vRNPs? Wie
wird die zeitliche und räumliche Präsenz der beteiligten Proteine, insbesondere des
NEPs, im Verlauf der Infektion reguliert?
Die Beantwortung dieser Fragen könnte potenziell zur Weiterenticklung anti-viraler
Therapien beitragen. Um zu einem besseren Verständnis der noch offenen Fragen
beizutragen, wurden in der vorliegenden Arbeit Fluoreszenzfluktuationsspektroskopie
(FFS) und molecular brightness-Analysen genutzt, um die Oligomerisierung von vi-
ralen Proteinen des Exportkomplexes zu quantifizieren. Werden Fluoreszenzproteine
für solche Untersuchungen verwendet, treten häufig nicht-fluoreszente Zustände auf,
die die Bestimmung des Oligomerzustandes stark beeinflussen. Daher wurde in dieser
Arbeit ein einfaches Korrekturmodel vorgestellt, dass die quantifizierte Population an
nicht-fluoreszenten Zuständen berücksichtigt, und somit die genaue Bestimmung des
Oligomerzustandes erlaubt. Dadurch konnte zum ersten Mal gezeigt werden, dass NEP
Homodimere im Zytoplasma ausbildet, wohingegen eine um das 2,5-fach geringere Homo-
dimerpopulation im Zellkern vorhanden war. Durch die Integration von Informationen
über den Lokalisationsphänotyp und den Oligomerzustand von NEP wt, sowie mehrerer
NEP Mutanten, konnte ein Modell abgeleitet werden, dass den Regulationsmechanismus
von NEP beschreibt: Durch vorrübergehendes Maskieren und Demaskieren der beiden
Nukleusexportsignale wird der Transport von NEP reguliert. Die Dimerisierung im
Zytoplasma und Monomerisierung im Zellkern unterstützen diesen Mechanismus.
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Abstract
Influenza viruses are the causative agent of severe epidemics and pandemics, causing
300,000 to 650,000 deaths annually. Unlike other RNA viruses, Influenza viruses replicate
their genome within the nucleus of cells. Hence, progeny genome segments - viral
ribonucleoproteins (vRNPs) - need to be exported from the nucleus to complete the
replication cycle. To fulfil this task, Influenza relies on a viral nuclear export complex
built from matrix protein 1 (M1) and nuclear export protein (NEP), that mediates export
by hijacking the cellular chromosome region maintenance protein 1 (CRM1)-dependent
export machinery. In recent years, a small molecule inhibitor competing with the viral
nuclear export complex for CRM1, was shown to effectively decrease viral load in lungs
of mice and ferrets besides not showing emergence of drug resistance (Perwitasari et al.,
2016). Additionally, this drug has successfully been tested in phase I and II clinical trails,
clearly highlighting the potential of the nuclear export pathway as anti-viral drug target.
However, in this context a number of questions remain unanswered, such as how many
export complexes bind to a single viral ribonucleoprotein (vRNP), what is the exact
interaction pattern of vRNPs with export complex proteins, and how translocation of
nuclear export relevant proteins such as NEP are regulated and optimally timed during
the course of infection?
In the present study, the potential of NEP to form homo-dimers in situ was shown for
the first time by applying fluorescence fluctuation spectroscopy (FFS) and molecular
brightness analysis, that allows determination of protein oligomerization directly in
living cells. However, when using fluorescent proteins in FFS studies non-fluorescent
states are observed, which strongly affect molecular brightness analysis. Therefore, in
this study a simple correction model was described, taking into account quantified
non-fluorescent state fractions, to finally allow accurate and unbiased determination of
oligomerization. This way it was shown, that NEP wt forms homo-dimers within the
cytoplasm of cells, whereas a 2.5-fold lower homo-dimer population was observed in the
nucleus. Combining the subcellular localization dependent oligomeric state of NEP wt
and several NEP mutants with their localization phenotypes, a regulation mechanism
was proposed in which the translocation of NEP is regulated by transient masking and
unmasking of its two nuclear export signals (NESs), which is supported by dimerization
in the cytoplasm and monomerization in the nucleus of cells, respectively.
III

Contents
Zusammenfassung I
Abstract III
1 Introduction 1
1.1 Influenza virus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Influenza A virus molecular structure . . . . . . . . . . . . . . 2
1.1.2 Influenza A virus replication cycle . . . . . . . . . . . . . . . . 6
1.1.2.1 Influenza A virus entry . . . . . . . . . . . . . . . . . 8
1.1.2.2 Influenza A virus transcription and replication . . . . 9
1.1.2.3 Influenza A virus assembly and budding . . . . . . . 11
1.1.3 Influenza A virus nuclear export protein . . . . . . . . . . . . 13
1.1.3.1 NEP structure and post-translational modifications . 14
1.1.3.2 Molecular functions of NEP during viral replication . 17
1.2 Fluorescence fluctuation spectroscopy . . . . . . . . . . . . . . . . . . 22
1.2.1 Fluorescence correlation spectroscopy . . . . . . . . . . . . . . 23
1.2.1.1 Molecular brightness analysis . . . . . . . . . . . . . 28
1.3 Aim of the study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2 Material and Methods 31
2.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.1.1 Biological material . . . . . . . . . . . . . . . . . . . . . . . . 31
2.1.2 Cell culture, infection, and bacteria propagation media . . . . 32
2.1.3 Chemicals and enyzmes . . . . . . . . . . . . . . . . . . . . . . 33
2.1.4 Buffers and solutions . . . . . . . . . . . . . . . . . . . . . . . 35
2.1.5 Antibodies and fluorescent dyes . . . . . . . . . . . . . . . . . 39
2.1.6 Plasmids for transient protein expression . . . . . . . . . . . . 40
2.1.7 Kits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
2.1.8 Consumable material . . . . . . . . . . . . . . . . . . . . . . . 44
2.1.9 Equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.1.10 Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
V
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.2.1 Cell culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.2.2 Cloning of expression plasmids . . . . . . . . . . . . . . . . . . 46
2.2.2.1 Extraction of A/WSN NEP mRNA from infected
MDCK II cells . . . . . . . . . . . . . . . . . . . . . 46
2.2.2.2 Integration of restriction endonuclease recognition sites 47
2.2.2.3 Extension PCR for site-directed mutagenesis . . . . . 48
2.2.2.4 Restriction endonuclease digestion and ligation . . . 49
2.2.2.5 One-step cloning of viral genome segments into pHW2000
plasmid . . . . . . . . . . . . . . . . . . . . . . . . . 49
2.2.2.6 Transformation of E.coli and verification of successful
cloning . . . . . . . . . . . . . . . . . . . . . . . . . 49
2.2.3 Transient transfection of cells . . . . . . . . . . . . . . . . . . 51
2.2.4 Indirect immunofluorescence staining . . . . . . . . . . . . . . 51
2.2.5 Infection of cells, virus propagation and concentration, mutant
virus rescue, and viral infection titer determination . . . . . . 52
2.2.6 Recombinant protein and vRNP extraction . . . . . . . . . . . 54
2.2.6.1 A/WSN M1 expression in E.coli . . . . . . . . . . . 54
2.2.6.2 Purification of recombinant A/WSN M1 protein . . . 55
2.2.6.3 vRNP isolation from concentrated A/WSN virions . 55
2.2.6.4 vRNP and M1 labelling with AlexaFluor™ succin-
imidyl esters . . . . . . . . . . . . . . . . . . . . . . 56
2.2.6.5 Isolation of artificial vRNPs from transfected HEK
293T cells . . . . . . . . . . . . . . . . . . . . . . . . 58
2.2.7 SDS-PAGE and Western Blot analysis . . . . . . . . . . . . . 59
2.2.7.1 Colloidal coomassie staining of SDS-PAGE gels . . . 59
2.2.7.2 Silver staining of SDS-PAGE gels . . . . . . . . . . . 60
2.2.7.3 Western Blot analysis . . . . . . . . . . . . . . . . . 60
2.2.8 Microscopy measurements . . . . . . . . . . . . . . . . . . . . 61
2.2.8.1 Fluorescence (cross-) correlation spectroscopy . . . . 61
2.2.8.2 Molecular brightness analysis and brightness calibration 63
2.2.8.3 Single plane illumination microscopy combined with
FCS . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
2.2.8.4 Fluorescence lifetime imaging microscopy . . . . . . 69
2.2.9 Statistical analyses . . . . . . . . . . . . . . . . . . . . . . . . 70
3 Results 71
VI
3.1 Instrument characterization and optimization for fluorescence cross-
correlation spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . 72
3.1.1 Evaluation of instrument parameters to achieve maximum
brightness and cross-correlation . . . . . . . . . . . . . . . . . 73
3.1.1.1 Coverglass thickness correction . . . . . . . . . . . . 73
3.1.1.2 Determination of the optimal pinhole diameter size . 75
3.1.1.3 Determination of optimal laser power settings . . . . 76
3.1.2 Evaluation of cross-correlation artefacts . . . . . . . . . . . . . 78
3.1.2.1 Evaluation of cross-talk and FRET . . . . . . . . . . 78
3.1.2.2 Evaluation of single-wavelength FCCS . . . . . . . . 79
3.1.3 Performance comparison of mCherry and mCherry2 in FCCS
measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
3.2 Optimization of molecular brightness analysis in one-photon excitation 84
3.2.1 Influence of fluctuation spectroscopy methods, cellular local-
ization, and temperature on molecular brightness . . . . . . . 84
3.2.2 Determination of the oligomeric state of proteins taking into
account apparent fluorescence probabilities . . . . . . . . . . . 86
3.2.3 Performance of different red fluorescent proteins in molecular
brightness analysis . . . . . . . . . . . . . . . . . . . . . . . . 90
3.3 Quantification of the interaction stoichiometry of M1 with vRNPs in
vitro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
3.3.1 Recombinant expression and purification of A/WSN M1 . . . 92
3.3.2 Fluorescence labelling of A/WSN M1 . . . . . . . . . . . . . . 94
3.3.3 Isolation of vRNPs from A/WSN virions or transiently trans-
fected HEK 293T cells . . . . . . . . . . . . . . . . . . . . . . 95
3.3.4 Isolation and labelling of vRNPs from A/WSN virions . . . . 96
3.3.5 Isolation of M1-free, artificial fluorescent vRNPs from tran-
siently transfected HEK 293T cells . . . . . . . . . . . . . . . 98
3.3.6 In vitro fluorescence correlation spectroscopy (FCS) measure-
ments of fluorescent vRNPs . . . . . . . . . . . . . . . . . . . 99
3.4 Investigations on the IAV nuclear export complex interaction network,
and its diffusion dynamics using fluorescence correlation spectroscopy 101
3.4.1 Investigation of the interaction network of nuclear export
complex components using fluorescence cross-correlation spec-
troscopy (FCCS) . . . . . . . . . . . . . . . . . . . . . . . . . 102
3.4.2 Functional relevance of NEP fusion proteins . . . . . . . . . . 104
3.4.3 Localization-dependent dimerization of NEP . . . . . . . . . . 107
VII
3.4.4 Influence of the conserved residue Ser24 on NEP dimerization 111
3.4.5 Role of NES1 and NES2 on NEP dimerization . . . . . . . . . 115
3.4.5.1 Influence of NES mutants on CRM1-dependent nu-
clear export . . . . . . . . . . . . . . . . . . . . . . . 118
3.4.6 Transport dynamics of NEP across the nuclear envelope . . . 120
4 Discussion and Outlook 127
4.1 Characterization of the applied microscopy instrumentation and used
fluorescent proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
4.2 Elucidating the protein interaction pattern of the nuclear export
complex in vitro and in situ . . . . . . . . . . . . . . . . . . . . . . . 137
4.2.1 In vitro quantification of the M1 stoichiometry on isolated
A/WSN vRNPs using FCS and FCCS . . . . . . . . . . . . . 139
4.2.2 In situ studies on the regulation mechanism of Influenza virus
nuclear export protein . . . . . . . . . . . . . . . . . . . . . . 146
List of Abbreviations IX
List of Figures XIII
List of Tables XVII
Bibliography XIX
Appendix XLI
Danksagung LI
Eigenständigkeitserklärung LIII
VIII
1 Introduction
1.1 Influenza virus
Influenza viruses belong to the family of Orthomyxoviridae, which encompasses seven
genera: Influenza virus A, Influenza virus B, Influenza virus C, Influenza virus D,
Isavirus, Thogotovirus and Quaranjavirus.
According to the International Committee on Taxonomy of Virus Classification
(ICTC) and the World Health Organisation (WHO) classification of Influenza viruses
into different genera is determined by the antigenic specificity of their nucleoprotein
(NP) (Assaad et al., 1980). The Influenza genera are further grouped into viral species
containing only a single species each, namely Influenza A virus (IAV), Influenza B
virus (IBV), Influenza C virus (ICV) and Influenza D virus (IDV). According to
a revised system by the WHO, Influenza viruses are designated according to the
following rules (Assaad et al., 1980):
1. description of the antigenic type: A, B, C or D
2. host origin; usually not indicated for strains isolated from human sources
3. geographical origin (country or city)
4. strain/isolate number
5. year of isolation, at least the last two digits
6. for IAV the serotype is further described by the antigenic description of the
two major surface proteins hemagglutinin and neuraminidase, in parentheses
(HxNx)
Thus, IAV A/Panama/2007/1999(H3N2) was isolate number 2007 of a human host
infected in the country of Panama, and possessed a hemagglutinin (HA) of subtype
3 and a neuraminidase (NA) subtype 2.
Influenza viruses are characterized by their segmented single-stranded RNA genome
of negative polarity, which requires a RNA dependent RNA polymerase (RdRP) of
viral origin for successful replication. This particular structure of the genome enables
antigenic shifts, a drastic genome change through segment reassortment of different
strains. Furthermore, the error-prone function of RdRPs enable accumulation of
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minor genome mutations, a process called antigenic drift (reviewed in Shao et al.
(2017)). Eventually, these genome changes result in viral strains able to evade the
adaptive host immune response as the virus is no longer effectively neutralized by
host antibodies in comparison to the parental virus strain. Thus, the host becomes
again susceptible for productive infections by the newly evolved or mutated virus
strains. Among all four Influenza genera IAV possesses the highest genetic diversity
as a result of high mutation rates combined with a broad host spectrum, followed
by IBV (Nobusawa and Sato, 2006). As a result, only IAVs have been reported
to cause rare but severe pandemics (Kilbourne, 2006). Furthermore, IAV and IBV
are mainly responsible for seasonal epidemics of respiratory diseases in humans.
According to the WHO these annual epidemics result in about 3 to 5 million cases
of severe illness and 300,000 to 650,000 deaths (WHO, effective 2018). Whereas
IBVs almost exclusively infect human hosts, IAVs possess a broad host spectrum of
avian and mammalian species: aquatic birds, humans, horses, swine, seals, minks,
and even dogs (Parrish et al., 2015). To date 16 HA and 9 NA genetically distinct
subtypes have been identified in circulating IAVs. All of these subtypes circulate in
aquatic birds, the natural host of IAV. However, only HA subtypes 1 to 3 and NA
subtypes 1 to 2 have caused human epidemics (Watanabe et al., 2014). In recent
years, two new Influenza A-like virus subtypes, derived from bats, were identified by
next generation sequencing: H17N10 and H18N11 (Tong et al., 2012, 2013). ICVs
encompass six genetic and antigenic lineages of which some can lead to infection of
pigs, but mainly infect humans, especially children, causing mild clinical symptoms.
Serological studies not only could show the wide distribution of ICVs, but also the
development of lasting immunity early in life of humans (Salez et al., 2014, Yuanji
et al., 1983). Then, in 2011 an Influenza C-like virus was isolated from pigs, later
classified as new genus Influenza D virus. Studies could show that cattle serve as
natural reservoir for IDVs, even though IDV could be isolated from swine. To date,
no IDV could be isolated from human reservoirs although antibodies specific against
IDV were detected in human sera (Hause et al., 2013, Luo et al., 2017).
1.1.1 Influenza A virus molecular structure
IAVs are pleomorphic with diameters usually ranging from 80 to 120 nm for spherical
particles, whereas for filamentous particles lengths of up to 300 nm have been observed
(see Fig. 1.1a) (Bouvier and Palese, 2008, Chu et al., 1949).
A schematic representation of an IAV virion is shown in Fig. 1.1b. The viral envelope
consists of a lipid bilayer derived from the plasma membrane of the particular infected
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host cell. These lipids are partially derived from lipids present before infection, and
partially from lipids synthesized during infection (Kates et al., 1962). Embedded
into the lipid bilayer are three viral transmembrane proteins, the two glycoproteins
HA and NA, as well as the ion channel matrix protein 2 (M2). The viral envelope is
studded with HA and NA in the order of 300 to 500 HA and 40 to 50 NA molecules
per virion (Harris et al., 2006, Lamb and Krug, 2001). HA forms a homo-trimer and
plays a key role in viral entry by promoting attachment to sialic acids (SAs) and
intracellular fusion of endosomal and viral membranes after internalization (reviewed
in Mair et al. (2014)). The homo-tetrameric NA supports release of progeny virions
by enzymatic cleavage of SAs to prevent rebinding of virions through HA, and thus
virion aggregation (Liu et al., 1995). Additionally, a small number of approximately
14 to 68 M2 molecules is present in the lipid envelope (Zebedee and Lamb, 1988).
M2 forms a homo-tetrameric proton channel and is involved in entry and budding of
IAV (reviewed in Pinto and Lamb (2006), Rossman et al. (2010)).
M1 is a multifunctional protein that plays essential structural and functional roles
during IAV infection. It is the major component of the virion forming an intermediate
layer in between the lipid bilayer and its integral transmembrane proteins, and the
vRNP complexes (Harris et al., 2006, Hutchinson et al., 2014). A direct interaction
of the M1 layer with glycoproteins of the envelope was predicted (Zhang et al., 2000),
and supported by the observation of accompanied lacking of glycoproteins in envelope
regions where also the M1 layer shows gaps (Harris et al., 2006). The core of IAV,
enclosed by M1, encompasses eight vRNPs, 130 - 200 NEPs, and as recently shown
small amounts of non-structural protein 1 (NS1) (Hutchinson et al., 2014, Yasuda
et al., 1993). Furthermore, Hutchinson et al. (2014) provide evidence for the presence
of host-specific proteins not only within the viral core, but also in the viral envelope.
Nevertheless, the putative role of these proteins during IAV infection has not been
investigated yet.
Each IAV virion packages eight genome segments that are numbered in order of
decreasing length with a diameter of approximately 10 nm and lengths ranging
from 30 to 110 nm (Zheng and Tao, 2013). An overview of the eight vRNPs, the
corresponding genome products and their functions is given in Tab. 1.1. Each segment
consists of negative-sense viral ribonucleic acid (vRNA), a hetero-trimeric RdRP and
nucleoproteins (NPs) (see Fig. 1.1d and e). Each vRNA possesses an open reading
frame (ORF) encoding one to four viral proteins via different mechanisms to expand
the coding capacity: alternative reading frames, or alternative splicing (Lamb et al.,
1980, Wise et al., 2011). The ORFs are flanked by short 5’- and 3’-untranslated
regions (UTRs) of varying length. These regions contain 13 (5’-UTR) and 12 (3’-UTR)
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nucleotide (nt) long promoter sequences at their proximal termini (Desselberger
et al., 1980). These sequences are partially base-paired, thus leading to a panhandle
structure within vRNPs which are recognized by the viral RdRP during transcription
and replication, and are essentially identical in all genome segments of IAV subtypes
(Crow et al., 2004, Flick et al., 1996). Furthermore, packaging signals overlap the
UTRs and terminal ORF regions. They are apparently discontinuous, segment-specific
and have been shown to be important for genome packaging into progeny virions
(see Fig. 1.1c) (Fujii et al., 2005, 2003, Liang et al., 2005, Watanabe et al., 2003).
Each vRNA is coated by NP along the negatively charged sugar-phosphate backbone
of vRNAs. In detail, NP forms a right-handed, double-helical structure composed of
two antiparallel NP-strands that is stabilized by intra- and inter-strand interactions
of individual NPs. Per NP, vRNA of approximately 140Å length is included into
the positively charged part present in each NP strand (Arranz et al., 2012). This
is in agreement with previous reports showing that 20 to 24 RNA-nts are bound
per NP (Jennings et al., 1983, Ortega et al., 2000). Thus, interaction between NP
and vRNA is mainly promoted by unspecific electrostatic interactions rather than
sequence-specific interactions (Baudin et al., 1994). Nevertheless, it was recently
shown that NP does not homogeneously bind to vRNA, and binding is especially
reduced in regions that encompass genome segment packaging signals (Williams et al.,
2018). Finally, one copy of the hetero-trimeric RdRP consisting of three subunits -
polymerase acid (PA), polymerase basic 1 (PB1) and polymerase basic 2 (PB2) - is
bound to the two lose 5’- and 3’-RNA-termini (see Fig. 1.1d and e). It was shown by
scanning transmission electron microscopy that vRNPs of spherical and filamentous
viruses form a multi-segment complex within virions with a 7 + 1 arrangement, i.e.
one central vRNP is surrounded by seven peripheral vRNPs (Harris et al., 2006,
Noda et al., 2006, 2012). In filamentous viruses the majority of the interior is empty,
whereas vRNPs are confined to the distal end (Noda et al., 2006). Additionally,
multiple interactions were found among the surrounding vRNPs and between the
central and spherical vRNPs, even though interactions are limited and unlikely
occur between all eight segments simultaneously (see Fig. 1.1f). The multi-segment
complex is oriented almost perpendicular to the top of the virion. In some virions the
segments seem to unite at the top, in others they appeared isolated from each other.
In summary, the eight vRNPs are well organized in a 7 + 1 pattern within virions
but asymmetrically arranged possessing flexible serpentine-curved structures (Harris
et al., 2006, Noda et al., 2006). There is evidence that vRNPs interact directly with
the matrix layer. In filamentous particles all vRNPs associate with the matrix at the
same end of the virion, whereas in spherical particles contact points were distributed
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around the whole interior surface (Harris et al., 2006). Nevertheless, vRNPs isolated
from purified virions seem to be present in two different forms: M1-associated and
M1-free (Yasuda et al., 1993). Yasuda et al. (1993) could show that NEP within
virions is bound to M1-associated vRNPs. In contrast, NS1 which was recently shown
to be present in virions does not form stable associations with vRNPs (Hutchinson
et al., 2014). The biological relevance of these interactions is still under debate.
a b
c
ORF5’ 3’UTR UTR
e
f
NA
HA
vRNP
M2
M1
NEP
NS1
d
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3’
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RdRP
Figure 1.1: Morphology and molecular structure of IAV virions. a) Cryoelectron
tomography of pleomorphic IAVs. Scale bar: 50 nm (images taken from Harris et al. (2006)).
b) Schematic representation of an IAV virion. The lipid envelope is derived from the host
plasma membrane and studded with three transmembrane proteins: hemagglutinin (HA),
neuraminidase (NA) and matrix protein 2 (M2). Beneath the lipid bilayer matrix protein 1
(M1) encases the viral core consisting of eight negative-sense single-stranded RNA genome
segments (vRNP), nuclear export protein (NEP) and small amounts of non-structural
protein 1 (NS1). c) Schematic illustration of a viral RNA (vRNA). A large open reading
frame (ORF) is flanked by two short terminal untranslated regions (UTRs). At the distal
ends they contain terminal promoter sequences that form the polymerase binding site
during transcription and replication. Specific bundling and packaging signals (red wedges)
overlap the terminal reading frames and UTRs. d) EM image of vRNP segment eight of
IAV A/PR/8/34. Scale bar: 50 nm (image taken from Jennings et al. (1983)). e) Cartoon
of a vRNP. The vRNA is illustrated in form of a black line, coated by nucleoproteins (NPs)
forming an antiparallel double-helical structure. The viral RNA dependent RNA polymerase
(RdRP) is bound to the lose 5’- and 3’-ends. f) A 3-D cross-section was reconstituted from
electron-tomography images taken of IAV A/WSN/1933 virions. Coloured are the eight
distinct vRNPs that assemble within virions with a 7 + 1 arrangement, i.e. one central
vRNP is surrounded by seven peripheral vRNPs. Short structures of ∼2 nm in diameter
were seen inbetween individual vRNPs (arrowheads), indicating direct interactions between
vRNPs (image was taken from Noda et al. (2012)).
5
Introduction
Table 1.1: List of the eight viral genome segments of IAV, their gene products
and functions (adapted from Vasin et al. (2014)). Given values are predicted for IAV
A/WSN/1933(H1N1), information about segment lengths, protein primary sequence and
moelcular weight was taken from flu database, NCBI Taxon ID 382835 (access: 2018-08-27).
No.
Length
[nt]
Protein
Size
[aa] (kDa)
Function
1 2341 PB2 759 (85.9) RdRP subunit, mRNA cap binding activity
2 2341
PB1 757 (86.5) catalytic subunit of RdRP
PB1-F2 90 (10.5)
not in all IAV isolates, can be truncated; pro-
apoptotic, regulates innate immune response,
and polymerase activity (binds PB1)
PB1-N40 718 (82)
not essential, maintains balance of PB1 and
PB1-F2 expression
3 2202
PA 716 (82.6)
RdRP subunit, endonuclease activity, cap-
snatching from cellular pre-mRNAs
PA-X 252 (29.4) modulates host gene expression
PA-N155 562 (64.5) unknown
PA-N182 535 (61.3) unknown
4 1775 HA 565 (63.5)
surface glycoprotein, receptor binding and
membrane fusion activity
5 1565 NP 498 (56.4)
encapsidation of vRNA and cRNA, vRNP
import into the nucleus
6 1409 NA 453 (49.6) surface glycoprotein, viral release
7 1027
M1 252 (27.9)
matrix protein, virus assembly, part of the
viral nuclear export complex
M2 97 (11.3)
ion channel, viral uncoating and membrane
scission during budding
M42 99 (11.6)
can functionally replace M2, expression prob-
ably restricted to a minority of IAVs
8 890
NS1 230 (26)
interferon antagonist, regulator of host and
viral gene expression
NEP/NS2 121 (14.4)
regulates activity of RdRP, part of the viral
nuclear export complex
NS3 174 (20) unknown, might play a role in host adaption
1.1.2 Influenza A virus replication cycle
In contrast to many RNA viruses, IAV replicates in the nucleus of an infected
cell (Walker and Ghildyal, 2017). It hijacks a vast amount of host cell factors and
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signalling pathways to accomplish replication. The IAV replication cycle can be
divided into different steps, depicted in Fig. 1.2: (I) attachment to target cells, (II)
internalization, (III) fusion of viral and endosomal membrane, (IV) uncoating and
release of vRNPs to the cytoplasm, (V) import of vRNPs into the nucleus, (VI)
transcription and translation, (VII) vRNP replication, and (VIII) nuclear export,
(IX) genome assembly, (X) virus budding.
mRNA
vRNP (-ss)
cRNP (+ss)
PA
PB1
PB2
NP
M1
NEP
NS1
HA
M2
NA
Figure 1.2: Replication cycle of Influenza A virus. (I) Virions attach to host cells
through binding of HA to SA. (II) After attachment, virions internalize mainly via clathrin-
mediated endocytosis and transit into the endosomal network. (III) During endosomal
maturation the luminal pH decreases, and thus triggers a conformational change in HA
that promotes fusion of viral and endosomal membranes. (IV) Further, M2 is activate
and promotes proton influx into the viral lumen. This leads to a conformational change in
M1, thereby destabilizing of the viral core and interaction between vRNPs and M1, thus
finally promoting uncoating. (V) Then, genome segments are released into the cytoplasm,
and transported and imported into the nucleus through nuclear pore complexs (NPCs)
by hijacking the cellular importin pathway. (VI) In the nucleus, vRNPs are transcribed
into viral mRNAs for protein translation of early proteins (PB1, PB2, PA, NS1, NP, M1,
NEP), that re-translocate into the nucleus to promote transcription and replication, but
also assembly of progeny vRNPs and their nuclear export. Later, structural and budding
relevant components are translated and undergo apical transport to the plasma membrane.
(VII) vRNP replication is mediated through a genome intermediate: complementary viral
RNPs (cRNPs). (VIII) Finally, newly assembled vRNPs associate to NEP and M1 to form
nuclear export complexes, and are exported by a CRM1-dependent pathway. (IX) Next,
vRNPs translocate to the apical plasma membrane via Rab11-positive vesicles that may
function as platform for bundling of vRNPs to multi-segment complexes, which are in turn
packaged into budding virions. (X) Eventually, bud formation is mediated by HA, NA,
and M1, followed by M2-mediated membrane scission and NA-mediated virion release from
host cell membranes.
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1.1.2.1 Influenza A virus entry
The first step of the IAV entry process is the attachment of virions to the surface
of host cells, mediated by the viral transmembrane protein HA. The primary at-
tachment factor is SA, a distal residue of oligo-saccharide chains of glycoproteins
and lipids. The two major linkages of SAs and galactose are α-2,3 or α-2,6 linkages.
The resulting structural conformation influences attachment of IAV as different HA
subtypes display differences in recognition of these SA linkages. Whereas human HA
preferentially binds to α-2,6-linked SA, HA of avian origin displays a preference for
α-2,3-linked SA (Rogers et al., 1983). These differences match the linkage-occurrence
on epithelial cells of the respective hosts, and thus host and cell tropism (Zeng et al.,
2013). The respiratory and intestinal tract of birds mainly possess α-2,3 linked SAs.
In contrast, the upper respiratory tract of humans mainly contains α-2,6 linked SAs.
Hence, human IAVs attach more abundantly to the upper respiratory tract. Certainly,
the lower respiratory tract of humans possesses mainly α-2,3 linked SAs, and is thus
readily infected by IAVs of avian origin (van Riel et al., 2010). IAV is internalized
primarily through clathrin-mediated endocytosis, although clathrin-independent en-
docytosis and macropinocytosis were described as alternative entry routes (de Vries
et al., 2011, Matlin et al., 1981, Sieczkarski and Whittaker, 2002). However, SA itself
possess no signalling capacity to induce internalization of IAVs, thus the requirement
of specific receptors was hypothesized early. To date, some members of receptor
tyrosin kinases (RTKs), such as the group of epidermal growth factor receptors
(EGFRs) and c-Met kinase (receptor of hepatocyte growth factor) were shown to
induce internalization of IAV. It was hypothesized that multivalent binding of IAV
through HA is able to cluster EGFR and other RTKs to form signalling platforms
leading to receptor-mediated activation of the PI3K/Akt pathway finally inducing
internalization of IAV (Eierhoff et al., 2010). Nevertheless, very recent data of Fratini
et al. (2018) showed that recruitment of clathrin and formation of clathrin-coated
pits by reovirus T3D strain and nanoparticles can be independent from receptor
signalling. Although this effect is highly particle size dependent (i.e. when particle
size exceeds 300 to 500 nm uptake is mostly clathrin-independent), these observations
might be one plausible explain why downregulation of EGFR does not completely
block IAV infection even though predicted to be necessary for endocytosis (Eierhoff
et al., 2010, Fratini et al., 2018).
Independently of the endocytic pathway IAVs transit into the endosomal network.
Upon internalization the primary endocytic vesicles and their cargos undergo homo-
typic fusion to form early endosomes. Early endosomes maturate to late endosomes,
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thereby decreasing luminal pH from 6.5 to 4.5 by activation of v-type vacuolar H+
ATPase, altering phosphatidylinositol lipids and differential recruitment of Rab-
family GTPases (reviewed in Elkin et al. (2016)). Decrease of luminal pH of late
endosomes (pH <5.5) triggers a conformational change in HA that leads to exposure
of a fusion peptide which is able to insert into the endosomal membrane, thereby
mediating fusion of viral and endosomal membrane. Meanwhile, the ion channel M2 is
activated by low pH and promotes proton influx from endosomes into the viral lumen,
thus decreasing its pH which leads to a conformational change in M1 (Pinto et al.,
1992, Wharton et al., 1994). Through the conformational change of M1, first the
viral core is destabilised, and second interaction between vRNPs and M1 is weakened
or even lost (Fontana and Steven, 2013, Martin and Helenius, 1991). After uncoating
of virions the genome segments are released into the cytoplasm through disassembly
of the viral core. Next, vRNPs are transported to the nucleus independently of
M1. Import into the nucleus is mediated through NPCs by hijacking the classical
cellular importin pathway (Martin and Helenius, 1991). First, importin-α (IMPα)
proteins recognize nuclear localization signals (NLSs) and are in turn recognized by
importin-β1 (IMPβ1) transporters, that mediate nuclear import. Although all vRNP
components possess NLSs, only one unconventional NLS out of three described NLS
of NP is critical for vRNP import (Cros et al., 2005). Whether vRNPs are imported
individually or in bundles is not known yet.
1.1.2.2 Influenza A virus transcription and replication
Once in the nucleus, each vRNP acts as an autonomous unit for transcription
and replication. vRNPs are transcribed into viral mRNAs (vmRNAs) for protein
translation and replicated through a complementary viral RNP (cRNP) intermediate
to generate progeny vRNPs. Both processes are accomplished by the viral RdRP, a
270 kDa hetero-trimeric complex composed of subunits PB1, PB2, and PA. These
three subunits are linked in a head-to-tail order, where the C-terminal domain of
PA interacts with the N-terminal domain of PB1 which in turn interacts with its
C-terminal extremity with the N-terminal part of PB2 (He et al., 2008, Sugiyama
et al., 2009).
Transcription of vmRNA is a primer- and promoter-dependent process leading to
transcripts possessing 5’-caps and 3’-poly(A)-tails. The RdRP itself is not able
to synthesize cap-structures. Hence, Influenza relies on host cell mRNAs. In a
process called ’cap-snatching’ 5’-cap structures of host cell mRNAs are transferred
to vmRNA. First, the central region of PB2 binds nascent-capped cellular mRNAs,
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second the N-terminal endonuclease activity of PA promotes cleavage of cellular
mRNAs 10 to 14 nts downstream of the 5’-cap (Dias et al., 2009). These short
RNA fragments then serve as primers for vmRNA synthesis catalysed by PB1.
Consequently, vmRNA is a chimeric RNA comprising viral coding sequences and
variable sequences of the hijacked host mRNA, respectively. However, it is speculated
that primers complementary to the 3’-end of vRNAs are preferentially selected
for transcription (Geerts-Dimitriadou et al., 2011). Eventually, poly(A)-tails are
synthesized by reiterative copying of the oligo-U stretch located at the 5’-end of
vRNAs (Poon et al., 1999). Finally, the mature transcripts are released and either
further processed through splicing or bound to cellular cap-binding proteins to form
vmRNP complexes that are immediately exported from the nucleus by the host cell
machinery and translated (Bier et al., 2011, Pritlove et al., 1998).
All encoded proteins and their functions are listed in Tab. 1.1. During infection
early, intermediate, and late proteins are distinguished according to their temporal
expression pattern (Yamanaka et al., 1991). Early proteins comprise PB1, PB2,
PA, NP that re-enter the nucleus to promote further transcription and replication
of progeny vRNPs (Shapiro et al., 1987). Furthermore, NS1 is an early protein of
multiple functions: a major virulence factor counteracting induction of the host
interferon system (reviewed in Klemm et al. (2018)), an inducer of host shut-off
(Khaperskyy and McCormick, 2015). Intermediate proteins are M1 and NEP which
translocate into the nucleus to regulate RdRP activity, and facilitate nuclear export
of progeny vRNPs. Late proteins, including the structural proteins HA, NA, and M2,
that are translated at the rough endoplasmic reticulum and subsequently enter the
secretory pathway to the plasma membrane to prepare budding of progeny virions
(Doms et al., 1993).
Transcription of vmRNA peaks about 2 to 5 h post infection. Then, vmRNA levels
decrease, although protein translation further continuous. In contrast, vRNA synthesis
already starts early in infection but continues to late stages of infection, although
synthesis of different vRNA and vmRNA species are apparently differently regulated
(Hatada et al., 1989, Shapiro et al., 1987). However, vRNP synthesis takes place in two
steps via a full-length positive-sense complementary RNA, namely complementary
viral RNA (cRNA). First, vRNA is transcribed into cRNA that assembles into cRNP
complexes and serves in a second step as template for the synthesis of progeny vRNPs.
Both processes are probably primer-independent as cRNA and vRNA contain a
5’-triphosphate, but depend on a promoter-like structure at their terminal ends
to promote de novo synthesis of the first nts, and thus further synthesis through
RdRP (Crow et al., 2004). Furthermore, termination of polymerisation at vRNA
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poly-U-sites needs to be prevented, a mechanism assured by NP (Beaton and Krug,
1986).
Nevertheless, how the viral RdRP switches between transcription and replication
activity is not yet fully understood. Whereas transcription is accomplished by a
cis-acting RdRP, replication is likely carried out by a trans-acting RdRP (reviewed
in Fodor (2013)). Moreover, Perez et al. (2010) showed evidence, that small viral
RNAs (svRNAs) exist, an RNA species of 22 to 27 nts in length and unique to each
of the 5’-ends of vRNP segments. They are likely transcribed from 3’-ends of cRNAs,
which might be promoted by NEP. These svRNAs interact directly with the RdRP
and are proposed to allosterically modify PA endonuclease activity, finally enabling
full-length synthesis of cRNA (Perez et al., 2010). After replication progeny vRNPs
are exported out of the nucleus by a CRM1-dependent pathway. Whether cRNPs
remain in the nucleus due to their different promoter structure compared to vRNPs
(Tchatalbachev et al., 2001), or are exported via a CRM1-independent pathway is
still under debate (Chaimayo et al., 2017). Similar to vRNP import, it is not yet
known whether vRNPs are exported individually or in bundles. Nevertheless, two-
and four-colour FISH experiments suggest that vRNPs may be exported in form
of subcomplexes that are not fully assembled (Chou et al., 2013, Lakdawala et al.,
2014).
1.1.2.3 Influenza A virus assembly and budding
Assembly and budding of IAV mainly provide stable virions containing a full set of
all eight vRNPs (Nakatsu et al., 2016). However, the exact molecular basis of both
processes, assembly and budding, is barely understood. Nuclear export of vRNPs is
promoted by RAF-MEK-ERKMAPK signalling activated by HA bound to the plasma
membrane late in infection. Hence, HA-induced kinase signalling and phosphorylation
of a yet unknown target in the nucleus could activate vRNP export once the budding
site is established (Marjuki et al., 2006, 2007). Following nuclear export, vRNPs
are transported to the apical plasma membrane for packaging into progeny virions.
Currently, two models exist describing the transport mechanism of vRNPs through
the cytoplasm of infected cells. In the first model, vRNPs are actively transported via
Rab11a-positive recycling endosomes and microtuble-dependent vesicular transport
across the cytoplasm (Amorim et al., 2011). Herein, the host protein Y-box-binding
protein 1 (YB-1) mediates interaction of vRNPs with microtubules around the
microtubule organizing centre (MTOC) where vRNPs are likely packed into Rab11a-
positive recycling endosomes for apical transport (Kawaguchi et al., 2012). In contrast,
11
Introduction
in a more recently described model by de Castro Martin et al. (2017) it was shown,
that IAV infection induces a strong rearrangement, swelling, and tubulation of the
endoplasmic reticulum (ER) that is not observed in uninfected cells. These ER
tubules extend from the nuclear envelope to the plasma membrane and both, Rab11
and vRNPs were shown to be recruited to these tubules. Additionally, the modified
ER forms irregularly coated vesicles that have been observed exclusively in infected
cells, carry and transport Rab11 and vRNPs, and finally release and transfer vRNPs
to the apical plasma membrane in a process described as ’touch-and-go’ (de Castro
Martin et al., 2017). Of note, both models highlight the presence of PB2 in the
observed vesicles, and additionally there is already evidence that PB2 of vRNPs
interact with Rab11 to target vRNPs to Rab11-positive vesicles (Amorim et al.,
2011). However, in both models Rab11-positive vesicles are involved in apical vRNP-
transport. Hence, these vesicles may function as a platform for bundling of vRNPs
to multi-segment complexes, which are in turn packaged into budding virions. It
is currently believed that vRNP bundling and packaging is a selective process and
may be hierarchical rather than random for two reasons: (I) only 0.24% of progeny
virions would exhibit a full set of all eight vRNPs assuming equal incorporation
probability for each segment, and (II) several studies showed that a vast amount
of viruses contain exactly one copy of each segment (Fournier et al., 2012, Gavazzi
et al., 2013, Inagaki et al., 2012, McGeoch et al., 1976). In recent years, bundling and
packaging signals were identified in all of the eight IAV segments, again emphasizing
a selective packaging mechanism for IAV. Herein, bundling signals that are important
for specific interactions of several vRNPs with one another are segment specific and
located at the terminal coding region. In contrast, packaging signals important for
incorporation of the full set of vRNPs are encoded in the 3’- and 5’-UTRs of each
segment (Goto et al., 2013). However, where single vRNPs bundle, whether there
is a hierarchical order, or strain dependency, as well as the mechanism for final
incorporation in budding virions still need to be investigated. Eventually, it is not
known how vRNPs dissociate from Rab11-positive recycling endosomes and move
into the budding zone on the apical plasma membrane. Of note, Rab11 has not been
detected in progeny virions (Hutchinson et al., 2014).
Simultaneously, the structural proteins HA, NA and M2 are synthesized in the rough
endoplasmic reticulum and post-translationally modified in the trans-Golgi network
(TGN). In this context, glycosylation of HA and NA was reported (Deom and Schulze,
1985). M2 possesses a critical role within the TGN during infection as it ensures
conformational stability of HA. During virus entry HA changes its conformation pH-
dependently. Late in infection M2 prevents this pH-induced conformational change
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through balancing the pH between the cytoplasm and TGN (Ciampor et al., 1992,
Grambas and Hay, 1992). It was reported that the coat protein I (COPI) complex,
important for cargo-transport within the TGN, is involved in apical targeting of HA,
NA and M2, although only HA and NA contain apical sorting signals within the
transmembrane domains (Barman and Nayak, 2000, Lin et al., 1998, Sun et al., 2013).
In the apical plasma membrane, HA and NA locate to shingolipid- and cholesterol-
rich patches whereas M2 is excluded from these domains (Leser and Lamb, 2005).
Furthermore, M1 oligomerizes at the plasma membrane providing structure and
stability of budding viral particles (Calder et al., 2010, Hilsch et al., 2014). Thereby,
M1 likely interacts with the cytoplasmic tails of HA and NA, and additionally
interacts with M2 (Chen et al., 2008, Kerviel et al., 2016, Zhang et al., 2000).
Eventually, incorporation of vRNPs into budding virions may be promoted through
interaction with M1 although the molecular basis is currently poorly understood
(Chaimayo et al., 2017). However, M2 primarily localizes to the neck of budding
virions, thus promotes membrane scission and release of virions (Rossman et al.,
2010). Eventually, NA of progeny virions cleaves SAs on the host cell surface, ensuring
release of emerging virions (Calder et al., 2010).
1.1.3 Influenza A virus nuclear export protein
The NEP of IAV was first described by Skehel (1972) as a viral protein expressed
in cells only after infection (virus strain: A/FPV), and thus termed non-structural
protein 2 (NS2). The newly identified viral protein was reported to be expressed late
in infection in small quantity compared to other viral proteins (Lamb et al., 1978).
It was then demonstrated to be encoded from genome segment 8 by alternative
splicing of NS1 mRNA (Lamb et al., 1980). While the continuous product of segment
8 translates into NS1, a weak splice site gives rise to the second, less abundant
construct encoding for NEP (Lamb and Lai, 1980). It was shown that the latter
accounts for ∼15% of segment 8 derived vmRNAs (Robb et al., 2010). Utilizing this
mechanism IAV ensures slow accumulation of NEP during the course of infection to
properly regulate timing of its functions during IAV replication (Chua et al., 2013).
Subsequently, few groups were able to show that NEP is already present in purified
virions of IAV (Lamb et al., 1978, Yasuda et al., 1993). The average number of NEP
molecules in a single virus particle was estimated to be around 130 to 200 molecules
(Yasuda et al., 1993). O’Neill et al. (1998) later proposed to rename the protein
from NS2 to NEP after elucidating its main function during IAV infection - the
nucleocytoplasmic export of newly assembled viral genome segments.
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1.1.3.1 NEP structure and post-translational modifications
All four Influenza virus genera encode NEP through alternative splicing, either of
genome segment 8 (IAV and IBV) or 7 (ICV and IDV). Whereas two NESs were
found in IAV and ICV, so far only a single NES was found in IBV (Huang et al.,
2013, Paragas et al., 2001). In IDV evidence for a functional NES is still missing
(compare Fig. 1.3, and Figs. 4.1 and 4.2 in Appendix). Interestingly, NES1 of IAV-
NEP differs from the canonical NES motif in the sense that two to three of the five
hydrophobic amino acids (AAs) are Met (’M’) instead of Leu (’L’). Although all
identified NEPs share nuclear export activity based on NES-interaction with CRM1
(Paragas et al., 2001), the primary structure of all four proteins is distinct from each
other in sequence length, AA composition, and NES motif position. The NEP of
IAV and IBV consist of 121AAs and 122AAs, respectively. Although both sequences
share limited sequence identity of only 25 - 27%, the chemical nature of residues
is conserved at various positions, suggesting a common secondary structure (see
Fig. 1.3) (Akarsu et al., 2003, Paragas et al., 2001). In contrast, the NEP of ICV
and IDV consist of 183AAs and 184AAs, respectively.
NEP of IAV is the only variant that has been extensively studied. Among IAVs the
primary structure is highly conserved (∼93.4%) (Paterson and Fodor, 2012). It can
be subdivided into two domains, an N-terminal protease-sensitive (AAs 1 to 53), and
a C-terminal protease-insensitive domain (AAs 54 to 121) (see Fig. 1.3). Structural
information is limited to the C-terminal region as the N-terminal part has failed to
be crystallized due to its high conformational flexibility (Lommer and Luo, 2002).
Additionally, structural features of these region are highly conserved; especially the
α-helix C2 of the C-terminal domain shows high structural conservation among IAVs
(∼96.3%) (Paterson and Fodor, 2012). Akarsu et al. (2003) successfully crystallized
the C-terminal region of NEP, encompassing AAs 59 to 116, with a resolution
of 2.6Å. The C-terminus forms a helical hairpin consisting of two antiparallel α-
helices C1 (AAs 64 to 85) and C2 (AAs 94 to 115) with six helical turns each, and
an inter-helical turn in between residues 86 and 93. Overall, both helices interact
extensively with each other through a total of 12 hydrophobic and four polar AA
residues (see Fig. 1.4a). The almost perfect antiparallel structure causes an overall
amphipathic character of the C-terminal domain with predominantly hydrophilic
(helix C1) and hydrophobic (helix C2) opposing external faces. Further, Akarsu et al.
(2003) identified Trp at position 78 as the major M1 binding epitope and speculated
that interaction between NEP and the basic NLS of M1 has a significant electrostatic
component since Trp78 is surround by several Glu residues. Interestingly, they not
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only observed a significant fraction of dimers for the truncated C-terminal NEP, but
also a small dimer fraction for full-length NEP, even though this observation was not
further discussed (see Fig. 1.4b). However, recently Golovko et al. (2017) reported
that NEP is prone to dimerize over a wide range of expression conditions.
Figure 1.3: Consensus sequences of the primary structures and predicted sec-
ondary structures of IAV and IBV NEP. Consensus sequences of the primary struc-
tures of IAV and IBV NEP were generated using WebLogo3 (access: 2018-07-11). Sequence
information was extracted from Influenza research database (https://www.fludb.org, access:
2018-07-11). For IAV sequence information (n=26,966 sequences) was restricted to human
and avian virus isolates encompassing subtypes H1N1, H3N2, H5N9 and H7N1 only. For
IBV sequence information of n=7,245 isolates were taken into account. Predicted and
determined helical secondary structures are labelled H, according to Akarsu et al. (2003).
The identified NES motifs are framed in red, according to Huang et al. (2013), Paragas
et al. (2001), Richardson and Akkina (1991). IAV: Influenza A virus. IBV: Influenza B
virus. Colour code of AAs according to chemical properties: polar AAs G,S,T,Y,C are
green, neutral AAs Q,N are purple, basic AAs K,R,H are blue, acidic AAs D,E are red,
hydrophobic AAs A,V,L,I,P,W,F,M are black.
Darapaneni et al. (2009) predicted a possible structure model for the N-terminal
domain consisting of residues 1 to 62. Since the N-terminus was shown to exist in a
highly flexible conformation (Lommer and Luo, 2002) this model might describe one
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out of several possible structural models. In this model, the N-terminus is composed
of two antiparallel α-helices N1 and N2 that are connected by an inter-helical turn. A
short bend α-helix followed by a loop connects helix two (N2) with helix three (C1)
of NEP (see Fig. 1.4c) (Darapaneni et al., 2009). In this model the most conserved
part of IAV NEP is the C-terminal helix encompassing residues 93 to 114. The rest
of the structure predicted by Darapaneni et al. (2009) contains highly conserved
residues especially within the turns and loops joining the α-helices, namely Ser at
position 24, as well as Trp and Arg at positions 65 and 66, respectively. Assuming
correctness of the predicted model, the two identified NES motifs would be located
within α-helix N1 (NES1) and N2 (NES2) for IAV and IBV (NES in N1), though not
in ICV, since the location of the NES is different (see Fig. 1.3) (Paragas et al., 2001).
In line with this observation the same arrangement of three consecutive Ser or Thr
with respect to the predicted α-helices, and thus NES motifs is found in NEP of IAV
and IBV, respectively. Of these highly conserved three AAs, Ser24 is surface-exposed
(Darapaneni et al., 2009).
Additionally, post-translational modifications were observed for NEP. First, N-
terminal modifications were found for both, IAV and IBV. Whereas IBV NEP shows
methionine excision and N-terminal acetylation at the same time, both modifications
could also be found in IAV NEP, but occurred only separately from each other
(Hutchinson et al., 2012). Whether these modifications influence or regulate NEP’s
function has not been investigated yet. Second, NEP was identified as a possible
target for sumoylation (Domingues et al., 2015), although yet no molecular function
has been attributed to this modification. Third, phosphorylation of NEP was found
in IAV, but not IBV or ICV (Hutchinson et al., 2012). Richardson and Akkina
(1991) showed that a certain population of NEPs of several IAVs is phosphorylated
in cells during infection. Moreover, phosphorylation was shown to be unambiguously
located at Ser24, although phosphorylation of Ser23 and Ser25 was also observed to
a lesser extent (Hutchinson et al., 2012, Reuther et al., 2014b). However, Reuther
et al. (2014b) showed, that substitution of all three Ser either with Ala (i.e. constant
neutral charge), or Asp (i.e. constant negative charge), does not affect viral growth in
A549 cells. Based on the sequence of A/WSN, casein kinase 2 (CK2) was predicted
to be a potential kinase candidate. Thus far, the role of Ser phosphorylation in NEP
has not been elucidated. Nevertheless, due to the conserved spacing of the NESs
and the phosphorylation site, a role in masking and unmasking of the NESs was
speculated (Hutchinson et al., 2012).
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Figure 1.4: Structure of IAV truncated C-terminal NEP and predicted model
of full-length NEP (Akarsu et al., 2003, Darapaneni et al., 2009). a) A ribbon
diagram of the crystallized truncated C-terminal domain of influenza A/WSN NEP. Both
antiparallel helices C1 and C2 as well as the six layers of hydrophobic residues involved
in inter-helical contacts are illustrated (Akarsu et al., 2003). b) Ribbon diagram of the
truncated C-terminal NEP homo-dimer. The hydrophobic core of the dimer is built up
by six layers of interacting side chains. Each of the two helices contributes at least one
side chain per layer, with symmetry-related residues in the same layer. The hydrophobic
residues in the dimer interface are emphasized in the legend to the right (Akarsu et al.,
2003). Furthermore, Trp78 (W78), which is important in M1 binding, is highlighted in
yellow. c) Ribbon model with indicated N- and C-termini of the predicted full-length
model of Darapaneni et al. (2009). The ribbons are coloured with a conservation score
as indicated. In the inset to the bottom right, the structural parts that are known from
experiments are indicated in grey as well as the predicted part in green (Darapaneni et al.,
2009).
1.1.3.2 Molecular functions of NEP during viral replication
NEP is a multifunctional protein: it was found in small amounts in IAV virions
(Yasuda et al., 1993), participates in regulating the transcription and replication
activity of the viral polymerase (Robb et al., 2009), supports export of newly
assembled vRNPs from the nucleus (Watanabe et al., 2001), and possibly participates
in viral budding through binding to F1F0-ATPase (Gorai et al., 2012), a host protein
shown to be involved in membrane softening (Almendro-Vedia et al., 2017). An
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overview highlighting the different roles of NEP in IAV replication is depicted in
Fig. 1.5.
F1F0-ATPase
Figure 1.5: Overview of the molecular functions of NEP during IAV replication.
Adapted from Paterson and Fodor (2012). Although NEP was found in IAV virions
bound to M1-associated vRNPs, the molecular mechanism resulting in its incooperation
into virions is not known. However, it accumulates slowly during infection and regulates
the transcription and replication activity of the viral RdRP late in infection. It can directly
interact with PB1 and PB2 and regulates the vmRNA:cRNA ratio. Together with svRNAs
it drives accumulation of cRNAs and thereby promotes replication activity of RdRP. NEP
possesses an additional role in nuclear export of progeny vRNPs. It participates in building
up the nuclear export complex, in which it interacts with vRNP-associated M1 and the
main cellular export factor CRM1 to promote translocation of vRNPs into the cytoplasm.
Whether NEP remains bound to M1 and/or vRNPs after nuclear export is not known
yet. However, it interacts with F1F0-ATPase at the plasma membrane, a cellular ATPase
providing ATP, and softening membranes.
In IAV virions 130 to 200 NEPs have been found that are bound to M1-associated
vRNPs (Hutchinson et al., 2014, Yasuda et al., 1993). However, how and why NEP
is packaged into virions is not clear yet. It was shown, that NEP interacts with
F1F0-ATPase and that this host factor might be involved in IAV budding as will
be explained later in this section (Gorai et al., 2012). As a consequence of this
interaction, NEP might be delivered into virions. Alternatively, or concurrently with
this, NEP could piggy-back on vRNPs after nuclear export (Pohl et al., 2016). While
it was suggested that M1 remains attached to newly replicated vRNPs after nuclear
export (Martin and Heleniust, 1991), it is not clear yet whether NEP also remains
bound to vRNPs. Nevertheless, a role of NEP early in infection, which could also
explain its appearance in virions, has not been demonstrated up to now.
NEP is only ∼14 kDa in size and does not possess a NLS. Hence, NEP very likely
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translocates into the nucleus by passive diffusion (Gao et al., 2014). Then, during
transcription and replication newly translated NEP translocates back into the nucleus,
where it participates in regulating the activity of the viral RdRP, as well as nuclear
export of progeny vRNPs. IAV replicates its genome via a replication intermediate,
cRNP. How the relative amounts of the three viral RNA products, vmRNA, cRNP,
and vRNP, are regulated is still not completely understood. However, several studies
hint towards a regulation mechanism in which the viral RdRP switches its activity
from transcription to replication late in infection in a NEP and svRNAs dependent
manner (Perez et al., 2010, Robb et al., 2009). Virus-derived svRNAs very likely
regulate the switch of RdRP activity, since (I) their accumulation correlates with
accumulation of vRNAs, and (II) they physically interact with the RdRP (Perez et al.,
2010). It was further shown, that their synthesis is not only dependent on RdRP and
NP, but also NEP. However, the exact role of NEP in this process remains unclear
(Perez et al., 2010). Robb et al. (2009) reported, that NEP promotes accumulation
of cRNAs and vRNAs, while reducing the accumulation of vmRNAs. This function
is proposed to be independent of its nuclear export function, since deletion of NES1
did not influence its ability to regulate vRNA levels. However, NES2 was not yet
identified during that time, and the tested construct resulting in the described
RNA-level alterations possessed both, α-helix N2 in which NES2 is located, and a
complete C-terminus. In contrast, a mutant lacking the complete N-terminus showed
a moderate influence on cRNA levels, but not on vRNAs, and thus an effect of NES2
can not be excluded completely (Robb et al., 2009). Moreover, it was concluded, that
NEP drives a specific alteration of the RdRP activity, since its regulating effects
are sub-type specific, but conserved among IAV and IBVs (Robb et al., 2009). This
hypothesis was later promoted by the observation, that NEP drives adaptation of
highly pathogenic avian influenza virus to mammalian cells by increasing replication
efficiency of RdRP (Mänz et al., 2012). The reduced replication efficiency of avian
RdRPs in mammalian cells was attributed to synthesis of defective and less stable
cRNPs, and thus impaired vRNP replication (Nilsson et al., 2017). Interestingly, the
authors either observed an adaptive mutation in PB2 (PB2-E627K) to overcome
limitations in replication efficiency, or a compensating adaptive mutation in NEP
(NEP-M16I) that stimulated RdRP activity concentration dependently, but not both
adaptive mutations simultaneously. Eventually, they hypothesized that NEP might
increase cRNP stability, and thus vRNA synthesis through direct binding of NEP to
PB1 and PB2 (Mänz et al., 2012). Taken together, these studies indicate a significant
role of NEP during replication by regulating the vmRNA:cRNA ratio, and thus
replication of progeny vRNPs. A remaining open question is, how Influenza viruses
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are able to distinguish between progeny vRNPs that should be exported out of the
nucleus, and transcription/replication-relevant vRNPs templates. Chase et al. (2011)
hypothesized that progeny vRNPs gain access to the CRM1-dependent pathway,
hijacked by IAVs for vRNP export (Watanabe et al., 2001), through targeting with
high affinity to chromatin close to the nuclear envelope. It was observed, that vRNPs
but not cRNPs, as well as viral nuclear export complex components such as M1 and
NEP localize in these regions. Finally, it was demonstrated, that CRM1 relocalizes
to chromatin regions where vRNPs accumulate and further colocalized with NEP,
that was not observed before (Chase et al., 2011). It is very well established, that
vRNPs are then exported out of the nucleus via a viral nuclear export complex. The
nuclear export complex assembles on progeny vRNPs following a ’daisy-chain’-model.
In this model M1 first binds to NP through its C-terminal domain. Thereby, the
NLSs on NP are masked to prevent immediate reimport of vRNPs (Noton et al.,
2007). In turn, NEP binds with its C-terminal region to the N-terminal domain of
M1. According to this model, the NLS in M1 is masked by the interaction with NEP,
whereas both NESs on NEP remain free to interact with the cellular export factor
CRM1 to finally induce translocation of progeny vRNPs into the cytoplasm (Akarsu
et al., 2003, Gao et al., 2014, Huang et al., 2013). Although some studies suggest
an NEP-independent vRNP export, Neumann et al. (2000) could demonstrate, that
mutant rescue of viruses lacking NEP was impossible, since vRNPs retained within
the nucleus, clearly demonstrating the importance of NEP in vRNP export. However,
in a more sophisticated model of the viral nuclear export complex, the ability of NEP
to bind PB1 and PB2 to regulate transcription and replication activity is considered
(Brunotte et al., 2014). It was shown, that M1 and NEP cooperatively regulate
RdRP activity independently of their CRM1-dependent export activity. Further,
polymerase-associated NEP supported interaction of M1 with vRNPs, by providing
an additional binding site on NEP for M1 that is located in a region between AA55
and the first C-terminal α-helix. Hence, in this model, NEP does not only bind to M1
with its C-terminal region, but also to PB1 and PB2, and additionally strengthens
interaction of M1 with vRNPs (Brunotte et al., 2014). However, it is still not known
whether vRNPs are completely covered with viral nuclear export complexes or only
bound by a small fraction. Based on previous observations, showing that M1 is
extracted together with export-ready vRNPs in high abundance, and possibly binds
unspecifically to vRNPs, it is standing to reason that progeny vRNPs are completely
covered by M1 (Chase et al., 2011, Noton et al., 2007). In contrast, only low amounts
of NEP were isolated together with chromatin-targeted vRNPs (Chase et al., 2011).
Assuming that NEP binds additionally to PB2 and PB1 within the nuclear export
20
Introduction
complex (Brunotte et al., 2014), it would be possible that vRNPs are not completely
encapsidated by NEP to promote nuclear export. Untill today, it is not known
whether NEP remains bound to exported vRNPs and is thus involved in apical
transport, or dissociates again from vRNPs. However, in an interactome study mostly
proteins of the cytoskeleton or intracellular transport pathway were identified to be
targets of NEP (de Chassey et al., 2013), although the biological function of these
interactions still needs to be investigated.
a b
Figure 1.6: Comparison of viral nuclear export complex models. (Brunotte
et al., 2014). a) Cartoon of the currently proposed ’daisy-chain’-model. First, M1 binds
with its C-terminus (’C’) to vRNPs. Second, NEP bridges the interaction between M1-
associated vRNPs and the cellular export factor CRM1. Thereby, the NLS of M1 is
masked, while both NESs in the N-terminal domain (’N’) of NEP are recognized by CRM1.
b) Cartoon of the refined nuclear export complex model. In this model, NEP again binds
with its two NESs to CRM1. However, it does not only bind to M1, but also to the RdRP
via interaction with PB1 and PB2. Thereby, NEP and M1 regulate the RdRP activity and
additionally the binding of M1 to vRNPs is strengthened.
Eventually, a role of NEP in the viral budding process was reported by Gorai et al.
(2012). In this study, F1F0-ATPase was identified to be an interaction partner of NEP.
F1F0-ATPase mainly localizes in the membrane of mitochondria and is important
for ATP production in cells. Additionally, F1F0-ATPase localizes in small quantity
in plasma membranes and promotes a decrease in surface tension of membranes
in GUVs, very likely through its rotational activity (Almendro-Vedia et al., 2017).
NEP was found to colocalize only with the plasma membrane, but not mitochondrial
membrane bound F1F0-ATPase fraction (Gorai et al., 2012). RNA interference
studies showed, that F1F0-ATPase is not involved in genome replication, protein
expression, or transport of viral membrane proteins, but promotes virion release
and together with NEP enhances production of virus-like particles (Gorai et al.,
2012). Thus, the host factor F1F0-ATPase might play a role in the budding process
of IAV. However, the exact role of NEP in this process is still unknown, although
F1F0-ATPase was initially identified as an interaction partner of NEP.
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1.2 Fluorescence fluctuation spectroscopy
Magde et al. (1972) were the first to combine correlation methods of signal fluctuations
with fluorescence. In the seminal work a filter fluorimeter was used to provide informa-
tion about diffusion and interaction kinetics of DNA with ethidium bromide (Magde
et al., 1974). Subsequently, correlation spectroscopy was successfully applied on pla-
nar lipid bilayers to measure diffusion coefficients of 3,3’-dioctadecylindocarbocyanine
iodide (DiI) or rhodamine-labelled dipalmitoylphosphatidylethanolamine (DPPE)
(Fahey et al., 1977), and on the plasma membrane of rat myoblasts to measure
the lateral mobility of the fluorescently labelled lectin concanavalin A bound to its
receptor (Elson et al., 1976). However, the cuvette-based fluctuation spectroscopy was
later replaced by microscope setups. Only the advances in microscopy technologies,
such as lasers with high temporal stability, high numerical aperture objectives, fast
single-photon detectors and cameras, and implementation of the confocal illumination
scheme made fluorescence fluctuation spectroscopy a versatile toolbox for minimally
invasive studies on spatio-temporal dynamics in living systems. In single-colour spec-
troscopy, fluctuations in fluorescence intensity are recorded and correlated to obtain
information on molecule mobility, i.e. diffusion times and coefficients, or diffusion
type, local concentrations, hydrodynamic radii, or even photophysical properties
like excited state transitions or bleaching. Applying dual-colour cross-correlation
spectroscopy allows for the analysis of highly specific interactions such as association-
dissociation rates in enzymatic or chemical reactions.
Originally used in single-spot mode, FCS and dual-colour FCCS provide high tem-
poral resolution of fast dynamics, but possess limits in spatial resolution and on
recording rather slow dynamics. To date, different fluorescence fluctuation modalities
exist to overcome these temporal and spatial limitations. Petersen (1986) introduced
the principle of scanning fluorescence correlation spectroscopy (sFCS) in which a
laser beam is scanned over a sample, usually at speeds faster than the dynamics of
the molecule to be investigated. Hence, the particle is detected in different locations,
allowing for spatio-temporal correlation analysis. The spatio-temporal correlation
depends on the distance and time a particle needs to move from one location to
another. To date, different scanning and analysis modalities of sFCS exist to address
different problems. For example, line-sFCS performed perpendicular to the plasma
membrane of cells allows for the analysis of dynamics slower than the actual scan
rate, since the line is scanned over the same region several times, thereby increasing
measurement time, and thus allowing for detection of a significant number of inde-
pendent events. Additionally, artefacts of membrane movements during scanning can
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easily be corrected as the membrane will appear at least once in each scanned line;
thus this additional fluctuation can be filtered out from the actual data. Finally, it
is less phototoxic since the beam stays at a certain location only for a very short
time (reviewed in Chiantia et al. (2009)). In recent years, this scanning mode was
combined with pair-correlation function (pCF) analysis to measure fluorescent protein
translocation through nuclear pore complexes (Cardarelli and Gratton, 2010). In
pCF the time-dependent probability to observe an intensity signal from one specific
particle in a pair of spatially separated observation volumes is calculated. Amplitude
and lag time of this temporal cross-correlation analysis depend on the distances of
the observation volumes and particle mobility. If there is a structural feature like
the nuclear envelope that hinders free movement of the particles, a shift of the pCF
peak to longer lag times will be observed (Digman and Gratton, 2009).
Nevertheless, all applications described so far are especially limited in space. There-
fore, several strategies have been specifically adapted to further extend FCS by
multiplexing. In confocal microscopy, this was either done by measuring several
observations volumes in parallel using laser scanning microscopy combined with
multiple individual single-photon sensitive detectors (Blom et al., 2002), or using
spinning disc microscopy to place thousands of spatially widely separated observation
volumes into the sample (Sisan et al., 2006). However, this multiplexed FCS scheme
comes to the cost of signal-to-noise ratio (SNR), since each pixel is illuminated only
a fraction of time. Furthermore, confocal FCS is rather limited to thin samples since
out-off focus light in thick samples further decreases the SNR. To overcome these
limitations, different illumination schemes as in single plane illumination microscopy
(SPIM) were applied. Here, any plane within a 3-D sample can be illuminated, and
thus be used for measurements of thick samples (Huisken et al., 2004). By combining
SPIM with fast and sensitive cameras, this imaging-based mode can be combined
with FCS, potentially allowing to collect diffusion maps, concentration maps, or
interaction maps with high spatial-temporal resolution (Wohland et al., 2010).
1.2.1 Fluorescence correlation spectroscopy
In confocal FCS only a small fraction of the sample is illuminated by focusing a laser
beam through a high numerical aperture objective into a sample. In a confocal setup
with one-photon excitation, a pinhole further confines the observation volume, thereby
restricting out-of-focus light. In two-photon excitation, an axially confined detection
volume is present. Herein, excitation requires two photons and the excitation rate
depends on the square of the laser intensity. Hence, only a small sample volume is
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excited with no need for an emission pinhole. In contrast to one-photon excitation,
the excitation profile in two-photon excitation results in a smaller observation volume
with improved z-sectioning (Berland et al., 1995). However, in both cases, the resulting
observation volumes are assumed to be approximately Gaussian-shaped in 3-D as
illustrated in Fig. 1.7a (Bacia and Schwille, 2007).
When performing FCS measurements, first, fluctuations of the fluorescence intensity
within the observation volume are recorded. These fluctuating intensity traces result
from the dynamic exchange of fluorescent objects between the illuminated observation
volume and its non-illuminated environment, i.e. the magnitude of the fluorescence
intensity will either increase or decrease with changing fluorophore number (see
Fig. 1.7b).
One-photon 
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photon 
excitation
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yz
a b
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Figure 1.7: Illustration of the observation volume and fluorescence intensity
traces in one-colour single-spot FCS measurements. a) Schematic representation
of the approximately Gaussian-shaped observation volume in one-photon and two-photon
excitation. The structural parameters defining the observation volume are shown in one-
photon excitation exemplarily. The lateral extension w0 (red), and axial extension z0 (blue)
are shown. The ratio z0/w0 gives the structural parameter S. b) Left panel: Representation
of an observation volume (blue) and different fluorescent molecules; from top to bottom:
fast and low concentration (green), slow (red), fast and high concentration (light green).
Right panel: Fluorescence fluctuation time traces caused by the movement of the respective
molecules through the observation volume (image taken from González Bardeci et al.
(2017)).
The spatio-temporal information provided by these fluctuations can be accessed by
calculating auto-correlation and cross-correlation curves (for dual-colour applications)
from the obtained intensity traces as depicted in Fig. 1.8a and b on page 27, respec-
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tively (reviewed in Bacia and Schwille (2003)). Furthermore, an appropriate model
describing the dynamics underlying the fluctuations is fitted to the experimentally
obtained auto-correlation and cross-correlation curves. Thus, information about local
concentrations, diffusion dynamics and interaction kinetics can be extracted.
Assuming an equilibrium state, fluorescence fluctuations over time δ F(t) are defined
as the difference from the average fluorescence signal:
δF(t) = F(t) – 〈F(t)〉. (1.1)
The normalized auto-correlation function (ACF) G(τ) is defined as:
G(τ) = 〈δF(t) · δF(t + τ)〉〈F(t)〉2 . (1.2)
The right panel of Fig. 1.8a visualizes the auto-correlation analysis for free diffusion
of a fluorophore in 3-D space with a simplified fluorescence trace. The fluorescence
trace is analysed for its self-similarity, i.e. the signal at time t is compared to the
signal at time t + τ. This procedure is performed multiple times with different lag
times τ, and the products are averaged over all time points. For very short lag times
the observed fluorophores have not moved far in the observation volume, thus the
fluorescence signal only changes slightly. Hence, for very short lag times, the shifted
fluorescence trace is still self-similar to the original data, resulting in a large sum, i.e.
high amplitude for G(τ). Opposed to this, the longer the lag time, the more likely
it is that fluorophores have diffused out of the observation volume. Thus, the sum
becomes smaller and eventually decays to zero. Therefore, the decay time, extracted
from the inflection point of the ACF, is referred to as diffusion time τd. Assuming
that (I) the intensity is proportional to the number of molecules N in the observation
volume and, (II) the number N follows a Poisson distribution, G(0) is:
G(0) = 〈δF(t)
2〉
〈F(t)〉2 =
〈δN2〉
〈N〉2 =
1
〈N〉 , (1.3)
and thus the amplitude of the ACF is inversely proportional to the number of
molecules N. Both, diffusion time τd and number of molecules N are relative numbers.
Only when the spatial dimensions of the observation volume are known, diffusion
coefficient D, and local concentration C can be calculated. The effective volume Veff
is given as:
Veff = pi
3
2 · w30 · S = pi
3
2 · w30 ·
z0
w0
= pi
3
2 · w20 · z0, (1.4)
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where w0 denotes as lateral, and z0 denotes as axial extension as depicted in Fig. 1.7a.
The effective volume Veff can be determined through calibration by measuring a
fluorophore with known diffusion coefficient D (Magde et al., 1972). Then, curve
fitting with an appropriate model yields τd and S, from which Veff can be calculated
and vice versa an unknown diffusion coefficient D of a molecule of interest can be
calculated after calibration. The diffusion coefficient D in a 3-D volume is given as:
w20 = 4 ·D · τd ⇐⇒ D =
w20
4 · τd
. (1.5)
Using Eqn. 1.4 and 1.5 the effective volume Veff can finally be obtained from
calibration measurements:
Veff = pi
3
2 · S · (4 ·D · τd)
3
2 (1.6)
Eventually, the concentration C can be calculated with:
C = NVeff
. (1.7)
In dual-colour measurements, ACFs for each individual colour can be calculated,
but also co-movement of both fluorophore species can be evaluated by analysing
the cross-correlation function (CCF). Thus, interaction kinetics for protein-protein
or enzyme-ligand interactions can be quantified. In cross-correlation analysis, the
similarity of two independent signals FR and FG is analysed instead of the self-
similarity of the signal fluctuations in one channel (see Fig. 1.8b). The normalized
cross-correlation function (CCF) GCC(τ) provides a direct measure of the interacting
fraction, i.e. the amplitude is directly proportional to the fraction of interacting
objects:
GCC(τ) =
〈δFR(t) · δFG(t + τ)〉
〈FR(t) · FG(t)〉
. (1.8)
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Figure 1.8: Scheme of fluorescence correlation and cross-correlation curves,
and their analysis (adapted from Fitzpatrick and Lillemeier (2011)). a) Left
panel: Auto-correlation curves G(τ) for several transport types plotted over the lag time τ
in ms. The amplitude encodes the inverse of the observed average particle number N. The
inflection point encodes the diffusion time τd. Red: free diffusion of a fluorescent object
within 3-D space, such as the cytoplasm of a cell. Green: free diffusion of a fluorescent
object within a 2-D plane, such as the plasma membrane of a cell. Blue: active transport
of a fluorescent object, for example along the cytoskeleton e.g. microtubules. Yellow:
anomalous sub-diffusion of a fluorescent object within a highly constrained 3-D space, such
as the nucleus of a cell. Right panel: Visualisation of the auto-correlation analysis for free
diffusion in 3-D space (red auto-correlation curve). The herein simplified fluorescence trace
is analysed for its self-similarity, i.e. signals at time t is compared to the signal at time t +
τ for different lag times τ, and the products are averaged. For short lag times shifted data
are still self-similar to the original data, resulting in a large sum. The longer the lag time,
the smaller becomes the sum. b) Left panel: Auto-correlation and cross-correlation curves
of a green and red fluorescent object partially interacting with each other. Red and green
depict auto-correlation curves for a green and a red object, respectively. Auto-correlation
curves are calculated as described in a). Orange illustrates the cross-correlation curve with
an interacting fraction of 50%. Right panel: Visualisation of the cross-correlation analysis.
Principally, the analysis is performed similar to an auto-correlation analysis described in
a). However, instead of the signal self-similarity in one channel, the similarity between two
signals is analysed.
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1.2.1.1 Molecular brightness analysis
In fluorescence fluctuation spectroscopy, the temporal evolution of fluctuations
provides information about dynamics of the investigated system, while the magnitude
provides information about concentration or interactions. Furthermore, the detected
fluorescence intensity trace provides information about the average fluorescence
intensity. Through division of the average fluorescence intensity by the number of
molecules, the molecular brightness can be determined. The molecular brightness ε
is a measure for the average fluorescence signal originating from a single diffusing
object per second (Digman et al., 2008):
ε = 〈F(t)〉N . (1.9)
The concept of molecular brightness analysis, and how fluorescence fluctuations
encode information about oligomerization is visualized in Fig. 1.9. In this example,
results for three homogeneous solutions with equal concentrations of fluorescent
proteins, that form either monomers, dimers or trimers are illustrated. Thus, the
obtained average fluorescence intensity for each of the three solutions is identical.
Nevertheless, the strength of fluorescence intensity fluctuations differs for each sample.
For a monomeric solution, the intensity fluctuates slightly around the average intensity,
since only individual molecules contribute to changes in signal intensity while diffusing
through the observation volume. For higher oligomers like dimers or trimers, more
than one fluorescent molecule simultaneously diffuse through the observation volume,
thus contributing to stronger fluctuations in signal intensity relative to the average
intensity. Hence, the strength or variance of the fluctuations encode information
about the number of fluorescent units in an oligomer (Mieruszynski et al., 2015).
Therefore, to analyse the oligomerization of a protein of interest, it is genetically fused
to a fluorescent protein, and then fluorescence correlation spectroscopy is performed
directly in living cells. Eventually, information about the molecular brightness ε is
extracted from these measurements. By comparing the obtained molecular brightness
ε of an unknown sample to a monomeric reference, the number of fluorescent subunits
within a protein complex can be quantified. In theory, ε will increase proportionally
to the number of fluorescent units in an oligomer, i.e. a dimer would be twice as
bright as a monomer, a trimer three-times brighter (Digman et al., 2008).
Molecular brightness analysis can be performed with different experimental methods,
e.g. FCS, and number and brightness (N&B) analysis, as used in this work, or photon
counting histogram analysis (Chen et al., 1999) and subunit counting (Arant and
Ulbrich, 2014). Differently from other fluorescence based approaches, such as Förster
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resonance energy transfer (FRET) or bimolecular fluorescence complementation
(BiFC), fluorescence fluctuation spectroscopy provides the size of the complex, and
is less dependent on the exact labelling position.
<F
>
<F
>
<F
>
Observation
volume
Figure 1.9: Principle of molecular brightness analysis to gain information about
protein oligomerization (adapted from Mieruszynski et al. (2015)) From top to
bottom: observation volumes, corresponding intensity traces, and intensity distributions
of signals for freely diffusing monomers, dimers, and trimers, respectively. For all three
illustrated oligomer solutions the same total number of molecules is present in the obser-
vation volume, thus give rise to the same average fluorescence intensity over time. For a
monomeric solution, the intensity signal fluctuates slightly around the average intensity,
since only single molecules contribute to changes in signal intensity while diffusing in and
out of the observation volume. For higher oligomers like dimers or trimers, more than
one molecule simultaneously diffuse through the observation volume, thus contributing to
stronger fluctuations of the signal intensity compared to the average intensity. Hence, the
strength or variance of the fluctuations encode information about the number of fluorescent
units in an oligomer.
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1.3 Aim of the study
Influenza viruses replicate their genome in the nucleus of infected host cells, and
thus require successful transport of newly synthesized vRNPs from the nucleus to
the budding site at the apical plasma membrane. Hence, nuclear export of vRNPs
is a critical step in virus replication. NEP together with M1 are the major viral
components involved in facilitating translocation of vRNPs into the cytoplasm. Viral
mutants lacking NEP can not be rescued since their vRNPs retain in the nucleus, as
emphasized by Neumann et al. (2000). A considerable number of studies demonstrated,
that Influenza viruses hijack the cellular CRM1-pathway to export progeny vRNPs.
Moreover, in recent years, a reversible CRM1 inhibitor, Verdinexor, was shown
to specifically inhibit virus replication by competing with NEP-binding to CRM1
(Perwitasari et al., 2016). Altogether, these findings highlight the importance of NEP-
mediated nuclear export for successful virus replication. However, regardless of the
importance, several question remain unanswered. Essentially, the exact interaction
pattern and composition of nuclear export complexes bound to vRNPs is still not
fully understood. Hence, the following questions should be addressed in this study:
1. Are progeny vRNPs completely covered with M1?
2. How many NEPs bind to these vRNPs, i.e. how many export complexes are
bound to progeny vRNPs to support their export?
3. How is the translocation activity of NEP itself regulated in cells?
To address these questions, different fluorescence fluctuation spectroscopy methods
and molecular brightness analysis were used to (I) quantify the stoichiometry of M1
proteins on isolated vRNPs in vitro, and (II) investigate the regulation mechanism of
NEP in situ as preparatory work for future studies on the protein interaction pattern
of nuclear export complexes with vRNPs. For the precise quantification of interac-
tion stoichiometries, oligomerization, and protein dynamics optimal measurement
conditions need to be determined. In this context, the following questions should be
addressed in this study:
1. What are the limitations of the used microscope instrumentation in FCCS?
2. What are the optimal FCCS measurement conditions for the fluorescent protein
pair mEGFP, mCherry2?
3. Which fluorescent protein tags possess high apparent fluorescence probabilities
in combination with high photostability to allow precise quantification of
protein oligomerization by applying molecular brightness analysis?
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2.1 Materials
2.1.1 Biological material
Table 2.1: Overview of cell lines used in this study. All cell lines were purchased
from ATCC, Manassas, Virginia, USA.
Cell line Origin Morphology Order no.
A549 human alveolar lung cells epithelial CCL™ - 185
HEK 293T human embryonic kidney cells epithelial CRL™ - 11268
MDCK II madin-darby canine kidney cells epithelial CCL™ - 34
Table 2.2: Overview of bacteria strains used in this study. For cloning and plasmid
amplification the bacterial strain E.coli DH5α was used. For heterologous protein expression
E.coli Rosetta™ (DE3) was used, a BL21 derivate optimized to enhance expression of
eukaryotic proteins. It contains codons rarely used in E.coli by supplying certain tRNAs
on a compatible chloramphenicol-resistant plasmid. Additionally, this strain carries one
copy of the T7 RNA polymerase gene under control of a lacUV5 promoter, thus, suitable
for IPTG induced expression of target genes cloned into pET-15b vector. Both bacteria
strains are chemically competent.
Name Organism Genotype
DH5α E.coli
F- endAl recAl hsdR17 (rk-mk+) supE44λ- thi-l
gyrA(Nal) relAl Φ80 lacZΔM15Δ (lacZY A-argF)
Rosetta™ (DE3) E.coli
F- ompT hsdSB(rB- mB-) gal dcm (DE3)
pRARE (CamR)
Table 2.3: Virus subtype information of the used IAV strain. In the following
study, A/WSN/1933 will be abbreviate with A/WSN.
Virus Serotype Host Isolation country Year of isolation
A/WSN/1933 H1N1 human United Kingdom 1933
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2.1.2 Cell culture, infection, and bacteria propagation media
Table 2.4: Overview of culture media used for cell cultivation, virus infection,
and bacteria propagation. Unless otherwise indicated, all components were purchased
from PAN-Biotech GmbH, Aidenbach, Germany.
Description Composition
Cell culture
medium
Dulbecco’s Modified Eagle’s Medium (DMEM) without
phenol red
10% fetal bovine serum (FBS) (v/v)
2mM L-glutamine
1% penicillin/streptomycin (v/v)
Cell culture
freezing medium
70% DMEM (v/v)
20% FBS (v/v)
10% DMSO (v/v)
Infection medium
DMEM
0.1 or 1% FBS (v/v) for MDCK II or A549 cells
0.2% BSA (v/v) (Merck KGaA, Darmstadt, Germany)
2mM L-glutamine
1% penicillin/streptomycin (v/v)
Transfection
medium
RPMI-1640
2mM L-glutamine
1% penicillin/streptomycin (v/v)
LB medium for
E.coli propagation
10 g/L Bacto™ tryptone (BD Biosciences GmbH, Heidel-
berg, Germany)
5 g/L Bacto™ yeast extract (BD Biosciences GmbH, Hei-
delberg, Germany)
5 g/L NaCl
50 μg/mL kanamycin or 100 μg/mL ampicillin
LB agar for E.coli
propagation
LB medium with 15 g/L agar
50 μg/mL kanamycin or 100 μg/mL ampicillin
32
Material and Methods
2.1.3 Chemicals and enyzmes
Experiments were done using standard laboratory chemicals, purchased from Merck
KGaA, Darmstadt, Germany (former: Sigma-Aldrich) and Carl Roth, Karlsruhe,
Germany; all other chemicals and enzymes and their suppliers are listed below:
• Acrylamide/bis-acrylamide (37.5:1; 30% stock solution Rotiphorese®) (Carl
Roth, Karlsruhe, Germany)
• Alkaline Phosphatase from calf intestinal (Thermo Fisher Scientific Inc.,
Waltham, Massachusetts, USA)
• Ammonium persulfate (APS) (Merck KGaA, Darmstadt, Germany)
• Ampicillin (Merck KGaA)
• Anchored Oligo(dT)20 Primer (Thermo Fisher Scientific Inc.)
• β-mercaptoethanol (Merck KGaA)
• Bromophenol blue (Merck KGaA)
• BSA (Molecular probes Inc., Eugene, Oregon, USA)
• Chloramphenicol (Merck KGaA)
• Coomassie Brilliant Blue G-250 (Carl Roth)
• Deoxyribonucleotide triphosphates Mix dNTPs (10 mM) (Thermo Fisher Sci-
entific Inc.)
• Dimethylsulfoxid (DMSO) (Merck KGaA)
• Dithiothreitol (DTT) (Merck KGaA)
• DNA Loading Dye, Orange (6x) (Thermo Fisher Scientific Inc.)
• DNase I (Thermo Fisher Scientific Inc.)
• DPBS with Mg2+ and Ca2+ (PBS +/+) (PAN-Biotech GmbH, Aidenbach,
Germany)
• DPBS without Mg2+ and Ca2+ (PBS -/-) (PAN-Biotech GmbH)
• Ethylenediaminetetraacetic acid (EDTA) (Serva Electrophoresis GmbH, Hei-
delberg, Germany)
• Fish gelatin (Merck KGaA)
• Formalin 10% (Merck KGaA)
• GeneRuler™ 1kb DNA Ladder (Thermo Fisher Scientific Inc.)
• H7 (Abcam, Cambridge, UK)
• Imidazole (Merck KGaA)
• Isopropyl β-D-1-thiogalactopyranoside (IPTG) (Thermo Fisher Scientific Inc.)
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• Kanamycin (Merck KGaA)
• Leptomycin B (LMB) (Merck KGaA)
• Lipofectamine™ 3000 reagent (Thermo Fisher Scientific Inc.)
• Lysophosphatidylcholine from egg yolk (Merck KGaA)
• Lysozyme (Merck KGaA)
• Octyl β-D-glucopyranoside (Merck KGaA)
• peqGOLD Taq-DNA-Polymerase (PEQLAB Biotechnology GmbH, Erlangen,
Germany)
• Phenylmethanesulfonylfluorid (PMSF) (Merck KGaA)
• Phusion™ High-Fidelity DNA Polymerase (Thermo Fisher Scientific Inc.)
• Precision Plus Protein All Blue Standards (Bio-Rad Laboratories GmbH,
Hercules, California)
• Restriction enzymes: AgeI, BamHI, EcoRI, Esp3I, KpnI, NdeI, NheI, NotI,
SmaI, XbaI, XhoI (Thermo Fisher Scientific Inc.)
• RNase H (Thermo Fisher Scientific Inc.)
• Rnasin® (40U/μL) (Promega GmbH, Mannheim, Germany)
• Roti®-GelStain (Carl Roth)
• Rotiphorese® 10x TBE buffer for agarose gel electrophoresis (Carl Roth)
• Sucrose (AppliChem GmbH, Darmstadt, Germany)
• SuperScript™ IV Reverse Transcriptase (Thermo Fisher Scientific Inc.)
• T4-DNA-Ligase (Thermo Fisher Scientific Inc.)
• TALON® Metal Affinity Resin (Takara Bio Inc., Kyoto, Japan)
• N,N,N’,N’-Tetramethyl-ethane-1,2-diamine (TEMED) (Merck KGaA)
• TPCK-Trypsin (Merck KGaA)
• TurboFect transfection reagent (Thermo Fisher Scientific Inc.)
• U0126 (Promega GmbH)
• UltraPure™ Agarose (Thermo Fisher Scientific Inc.)
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2.1.4 Buffers and solutions
Table 2.5: Immunofluorescence (IF) staining buffers.
Buffer type Composition
IF fixation 10% formalin
IF permeabilization 0.5% Triton X-100 (v/v) in DPBS
IF blocking 3% BSA (w/v) + 100mM glycine in DPBS
IF antibody dilution 1% BSA (w/v) in DPBS
Table 2.6: Buffers used for heterologous protein expression in E.coli, and pro-
tein purification.
Buffer type Composition
Growth medium
LB medium
0.4% glucose (w/v)
50 μg/mL chloramphenicol
100 μg/mL ampicillin
Lysis buffer
2x PBS -/-
113mM NacCl
100 μg/mL DNAse I
300 μg/mL lysozyme
1 tablet/L "complete" mini w/o EDTA (Roche,
Rotkreuz, Swiss)
5mM β-mercaptoethanol
1mM PMSF
Binding buffer
pH 7.4
1x PBS -/-
363mM NaCl
5mM β-mercaptoethanol
Pre-wash buffer, pH 7.4 binding buffer + 60mM imidazole
Elution buffer, pH 7.4 binding buffer + 250mM imidazole
Table 2.7: Buffers used for purification and concentration of A/WSN.
Buffer type Composition
TNE buffer, pH 7.4
10mM Tris-HCl
100mM NaCl
1mM EDTA
TNE sucrose gradient
linear gradient from 20% to 60% sucrose (w/v) in
TNE buffer
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Table 2.8: Overview of buffers used for isolation of vRNPs from A/WSN virions
or transiently transfected HEK 293T cells. All buffers were prepared with ultra pure
DNAse- and RNAse-free water (Thermo Fisher Scientific Inc.). For isolation from transiently
transfected HEK 293T cells, transfection was performed with plasmids encoding for proteins
PA, PB1, PB2-mCherry2-His, and NP mRNA and vRNA.
Buffer type Composition
Lysis buffer
(virions)
100mM KPO4 (pH 8.1) or 100mM MES (pH 5.5)
100mM KCl
5mM MgCl2
5% glycerol (w/v)
1.5mM DTT
50mM octyl β-D-glucopyranoside
10mg/mL lysophosphatidylcholine from egg yolk
Gradient buffer
(virions)
30mM MES, pH 5.8
10mM NaCl
120mM KCl
with 33%, 40%, 50% or 70% glycerol (w/v)
Resuspension buffer
(virions)
10mM KPO4
120mM KCl, pH 8.0
RIPA - lysis buffer
(cells)
25mM Tris HCl, pH 7.6
150mM NaCl
1% nonident P-40 (w/v)
1% sodium deoxycholate (w/v) /
0.1% SDS (w/v)
1mM PMSF
Wash buffer
(cells)
50mM Tris-HCl, pH 8.0
100mM KCl
5mM MgCl2
0.5% nonident P-40 (w/v)
20mM imidazole
1 μL/mL RNAsin
Elution buffer
(cells)
50mM Tris-HCl, pH 8.0
100mM KCl
0.5% nonident P-40 (w/v)
175mM imidazole
1 μL/mL RNAsin
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Table 2.9: Overview of SDS-PAGE buffers.
Buffer type Composition
Stacking gel (5%)
5% acrylamide/bis-acrylamide (v/v) (37.5:1; 30%
stock solution Rotiphorese®)
125mM Tris-HCl, pH 6.8
0.1% SDS (w/v)
0.1% APS (w/v)
0.1% TEMED (v/v)
Resolving gel (10%)
10% acrylamide/bis-acrylamide (v/v) (37.5:1; 30%
stock solution Rotiphorese®)
375mM Tris-HCl, pH 8.8
0.1% SDS (w/v)
0.1% APS (w/v)
0.04% TEMED (v/v)
Resolving gel (12%)
12% acrylamide/bis-acrylamide (v/v) (37.5:1; 30%
stock solution Rotiphorese®)
375mM Tris-HCl, pH 8.8
0.1% SDS (w/v)
0.1% APS (w/v)
0.04% TEMED (v/v)
SDS sample buffer,
reducing (4x)
5% SDS (w/v)
0.5 g/L bromophenol blue
25% β-mercaptoethanol (v/v)
25% glycerol (v/v)
500mM Tris-HCl pH, 6.8
SDS sample buffer,
non-reducing (4x)
5% SDS (w/v)
0.5 g/L bromophenol blue
25% glycerol (v/v)
500mM Tris-HCl, pH 6.8
Running buffer (pH 8.3)
3 g/L Tris-HCl
1 g/L SDS
14.4 g/L glycerine
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Table 2.10: Overview of buffers used for SDS-PAGE gel staining: Colloidal
coomassie and silver staining.
Buffer type Composition
Coomassie staining
0.02% Coomassie Brilliant Blue G-250 (w/v)
5% aluminum sulfate-(14-18)-hydrate (w/v)
10% ethanol (v/v)
2% orthophosphoric acid (v/v)
Coomassie destaining
10% ethanol (v/v)
2% orthophosphoric acid (v/v)
Silver staining
- fixative
30% ethanol (v/v)
10% acetic acid (v/v)
Silver staining
- sensitizer
30% ethanol (v/v)
0.5% glutaraldehyde (v/v)
0.5M sodium acetate
0.2% sodium thiosulfate (w/v)
Silver staining
- staining solution
0.1% silver nitrate (w/v)
0.02% formaldehyde (w/v)
Silver staining
- developer
2.5% sodium carbonate (w/v)
0.01% formaldehyde (w/v)
Silver staining
- stop
0.05M EDTA
Table 2.11: Buffers used for Western Blot (WB) analysis using Odyssey® In-
frared imaging system.
Buffer type Composition
WB blocking
10mM Tris-HCl, pH 7.6
150mM NaCl
2% fish gelatin (w/v)
1% ovalbumin (w/v)
WB antibody dilution
50mM Tris-HCl, pH 7.6
150mM NaCl
1:2 diluted in WB blocking buffer
WB wash buffer
50mM Tris-HCl, pH 7.6
150mM NaCl
0.05% Tween20 (v/v)
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2.1.5 Antibodies and fluorescent dyes
Table 2.12: Overview of used primary antibodies. Application (App.): Immunoflu-
orescence staining (IF), Western Blot (WB)
Antigen Species App. Dilution Supplier (Order no.)
Influenza A M1 mouse IF 1:500 Bio-Rad (MCA401)
Influenza A NEP rabbit IF 1:200 Thermo Fisher (PA5-32235)
Influenza A NP mouse IF 1:1000 Merck KGaA (MAB8257)
Influenza A PA rabbit WB 1:500 Thermo Fisher (PA5-32223)
Influenza A PB1 rabbit WB 1:500 Thermo Fisher (PA5-34914)
Influenza A PB2 rabbit WB 1:500 Thermo Fisher (PA5-32221)
Table 2.13: Overview of used secondary antibodies. Application (App.): Immunoflu-
orescence staining (IF), Western Blot (WB). All secondary antibodies used for IF were
purchased from Thermo Fisher Scientific Inc., all secondary antibodies used for WB were
purchased from LI-COR Biosciences GmbH (Bad Homburg, Germany).
Antigen Conjugate Species App. Dilution
mouse IgG (H+L) AlexaFluor™ 488 goat IF 1:1000
rabbit IgG (H+L) AlexaFluor™ 488 goat IF 1:1000
rabbit IgG (H+L) AlexaFluor™ 594 goat IF 1:1000
mouse IgG (H+L) AlexaFluor™ 647 goat IF 1:1000
rabbit IgG (H+L) AlexaFluor™ 647 goat IF 1:1000
mouse IgG (H+L) IR Dye 680 goat WB 1:10,000
rabbit IgG (H+L) IR Dye 800 CW goat WB 1:10,000
Table 2.14: Overview of used fluorescent dyes. Both succinimidyl esters were used to
label M1 or vRNPs. AlexaFluor™ 488 succinimidyl ester was additionally used to calibrate
the confocal volume when performing FCS measurements. DAPI was used to stain nuclei
of fixed cells, whereas Hoechst was used to stain nuclei of cells used for live cell imaging.
Fluorescent dyes
Excitation/
Emission [nm]
Supplier
AlexaFluor™ 488 Succinimidyl Ester 494/517 Thermo Fisher
AlexaFluor™ 647 Succinimidyl Ester 651/672 Thermo Fisher
4’,6-Diamidino-2-Phenylindole (DAPI) 345/455 Thermo Fisher
Hoechst 33341 343/478 Molecular Probes
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2.1.6 Plasmids for transient protein expression
An overview of all oligonucleotides used for cloning of the following plasmids, as well
as the used coding sequence of A/WSN/1933 NEP and the corresponding amino
acid sequence is given in the Appendix, Tab. 4.1.
Table 2.15: Overview of all plasmids used or generated in this work. Used
abbreviations for antibiotics based selection markers: amp - ampicillin, kana - kanamycin,
ClAm - chloramphenicol. Unless otherwise indicated, all IAV expression plasmids were
generated from Influenza A/WSN sequences.
# Name Backbone Insert Marker Origin
01 pET-15b pET-15b amp
Merck,
#69661-3
02 pcDNA 3.1+
pcDNA
3.1+
amp
Thermo Fisher,
#V79020
03 Flag-hCRM1
p3xFLAG
CMV-10
hCRM1 amp
Addgene,
#17647
04
hCRM1-
mCherry2-C1
No. L03 hCRM1 kana this work
L01 mCherry-C1 pBR322 mCherry kana this work
L02 mCherry-N1 pBR322 mCherry kana this work
L03 mCherry2-C1 pBR322 mCherry2 kana
Addgene,
#54563
L04 mCherry2-N1 pBR322 mCherry2 kana
Addgene,
#54517
L05 mEGFP-C1 mEGFP kana
Addgene,
#54759
L06 mEGFP-N1 mEGFP kana
Addgene,
#54767
L07 mEGFP-mCherry No. 02
mEGFP,
mCherry
amp this work
L08
mEGFP-
mCherry2
No. 02
mEGFP,
mCherry2
amp this work
L09 2xmEGFP No. L05 mEGFP kana this work
L10 3xmEGFP No. L09 mEGFP kana this work
L11 4xmEGFP No. L10 mEGFP kana this work
Continued on next page...
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# Name Backbone Insert Marker Origin
L12 2xmCherry No. L01 mCherry kana this work
L13 2xmCherry2 No. L03 mCherry2 kana this work
L14 mCardinal-C1 mCardinal kana
M.Sc.
R. Petazzi
L15 2xmCardinal No. L14 mCardinal kana
M.Sc.
R. Petazzi
L16 pmScarlet-C1 pC1 mScarlet kana
Addgene,
#85042
L17 2xmScarlet No. L16 mScarlet kana
M.Sc.
V. Dunsing
L18 pmScarlet-I-C1 pC1 mScarlet-I kana
Addgene,
#85044
L19 2xmScarlet-I No. L18 mScarlet-I kana
M.Sc.
V. Dunsing
L20
cMyc-NLS-
mEGFP
No. 02 NLS, mEGFP amp this work
L21
ADAR1-NES-
mEGFP
No. 02 NES, mEGFP amp this work
I01 pHW2000 pHW2000 amp PD Dr. T. Wolff
I02 WSN-181 pHW2000 PB2 amp PD Dr. M. Veit
I03 WSN-182 pHW2000 PB1 amp PD Dr. M. Veit
I04 WSN-183 pHW2000 PA amp PD Dr. M. Veit
I05 WSN-184 pHW2000 HA amp PD Dr. M. Veit
I06 WSN-185 pHW2000 NP amp PD Dr. M. Veit
I07 WSN-186 pHW2000 NA amp PD Dr. M. Veit
I08 WSN-187 pHW2000 M1/M2 amp PD Dr. M. Veit
I09 WSN-188 pHW2000 NS1/NEP amp PD Dr. M. Veit
I10 NEP_pET15b No. 01 NEP
amp +
ClAm
this work
I11 NEP_pCMV3 pCMV3 NEP amp this work
I12 NEP-mEGFP-N1 No. L06 NEP kana this work
I12a NEP-mEGFP-C1 No. L05 NEP kana this work
Continued on next page...
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# Name Backbone Insert Marker Origin
I13
NEP-mCherry2-
N1
No. L04 NEP kana this work
I14
NEP-S24E-
mEGFP
No. L06 NEP-S24E kana this work
I15
NEP-S24A-
mEGFP
No. L06 NEP-S24A kana this work
I16
NEP-mNES1-
mEGFP
No. L06 NEP-mNES1 kana this work
I17
NEP-mNES2-
mEGFP
No. L06 NEP-mNES2 kana this work
I18
NEP-mNES1+2-
mEGFP
No. L06
NEP-
mNES1+2
kana this work
I19
NEP-ΔNES1-
mEGFP
No. L06 NEP-ΔNES1 kana this work
I20
NEP-ΔNES2-
mEGFP
No. L06 NEP-ΔNES2 kana this work
I21
NEP-2xNES1-
mEGFP
No. L06 NEP-2xNES1 kana this work
I22
NEP-2xNES2-
mEGFP
No. L06 NEP-2xNES1 kana this work
I23
NEP-NES2-1-
mEGFP
No. L06 NEP-NES2-1 kana this work
I23
NS1(SAM)-2A-
NEP
No. I01 NS1/NEP amp this work
I24
NS1(SAM)-2A-
NEP-S24E
No. I01
NS1/NEP-
S24E
amp this work
I25
NS1(SAM)-2A-
NEP-S24A
No. I01
NS1/NEP-
S24A
amp this work
I26
NS1(SAM)-2A-
NEP-ΔNES1
No. I01
NS1/NEP-
ΔNES1
amp this work
I27
NS1(SAM)-2A-
NEP-ΔNES2
No. I01
NS1/NEP-
ΔNES2
amp this work
I28
NS1(SAM)-2A-
NEP-2xNES1
No. I01
NS1/NEP-
2xNES1
amp this work
Continued on next page...
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# Name Backbone Insert Marker Origin
I29
NS1(SAM)-2A-
NEP-2xNES2
No. I01
NS1/NEP-
2xNES2
amp this work
I30
NS1(SAM)-2A-
NEP-NES2-1
No. I01
NS1/NEP-
NES2-1
amp this work
I31 M1_pET15b No. 01 M1
amp +
ClAm
this work
I32 M1_pCMV3 pCMV3 M1 amp this work
I33 M1-mCherry2-N1 No. L04 M1 kana this work
I34 M1-mCherry2-C1 No. L03 M1 kana this work
I35 NP_pCMV3 pCMV3 NP amp this work
I36 NP-mCherry2-N1 No. L04 NP kana this work
I37 NP-mEGFP-N1 No. L06 NP kana this work
I38 PA_pCMV3 pCMV3 PA amp this work
I39 PA-mCherry2-N1 No. L04 PA kana this work
I40 PA-mEGFP-N1 No. L06 PA kana this work
I41 PB1_pCMV3 pCMV3 PB1 amp this work
I42 PB1-mCherry2-N1 No. L04 PB1 kana this work
I43 PB1-mEGFP-N1 No. L06 PB1 kana this work
I44 PB2_pCMV3 pCMV3 PB2 amp this work
I45 PB2-mCherry2-C1 No. L03 PB2 kana this work
I46 PB2-mEGFP-C1 No. L05 PB2 kana this work
I47
His-PB2-
mCherry2-C1
No. I44 PB2 kana this work
2.1.7 Kits
• BCA Protein Assay Kit Pierce (Thermo Fisher Scientific Inc.)
• CloneJET PCR Cloning Kit (Thermo Fisher Scientific Inc.)
• Pierce 660 Protein Assay Kit (Thermo Fisher Scientific Inc.)
• QIAGEN Plasmid Maxi Kit (Qiagen, Hilden, Germany)
• QIAprep Spin Miniprep Kit (Qiagen)
• QIAquick Gel Extraction Kit (Qiagen)
• RNeasy Mini Kit (Qiagen)
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• Trans-Blot® Turbo™ Ready-to-assemble Midi PVDF Transfer Kit (Bio-Rad
Laboratories GmbH, Hercules, California)
2.1.8 Consumable material
Conducted experiments were done using standard laboratory consumable material;
all other material is listed below:
• Disposable Polypropylene Columns, 5 mL (Qiagen)
• MatTek glass bottom dish, 35 mm microwell diameter, 14 mm coverslip diame-
ter, No. 1.5 glass thickness, poly-d-lysine coated (MatTek corporation, Ashland,
USA)
• Vivaspin® 20, molecular weight (MW) cut-off 50 kDa (Sartorius, Goettingen,
Germany)
2.1.9 Equipment
Conducted experiments were done using standard laboratory equipment; all other
equipment is listed below:
• Dark Hood DH-40 (Biostep GmbH, Burkhardtsdorf, Germany)
• Density gradient fractionater ’Auto Densi-Flow’ (Labcono, Kansas City, USA)
• Gradient master ip (Biocomp Instruments, Fredericton, Canada)
• Intas Gel iX Imager (Intas Science Imaging Instruments GmbH, Goettingen,
Germany)
• Mini-PROTEAN 3 electrophoresis system with accessories (Bio-Rad Laborato-
ries GmbH)
• Odyssey® Infrared imaging system (LI-COR Bioscience, Bad Homburg, Ger-
many)
• Olympus Fluoview FV-1000 inverted laser scanning microscope (LSM) (based
on Olympus IX-81, Olympus, Tokyo, Japan), upgraded with a PicoQuant
Fluorescence Lifetime setup (PicoQuant, Berlin, Germany): 60x/1.2 NA water
UPlanSApo objective, 488 nm argon laser, 561 nm diode laser, 470 nm pulsed
diode laser, 405/488/559/635 dichroic filter for LSM, 570 nm dichroic mir-
ror, 520/35 nm bandpass filter (mEGFP channel) or 635 nm long-pass filter
(mCherry or mCherry2 channel) for SPAD detection
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• Olympus Fluoview FV-1000MPE inverted laser scanning microscope (based on
Olympus IX-81, Olympus, Tokyo, Japan): 40x/1.35 NA and 60x/1.2 NA water
UPlanSApo objective, 488 and 515 nm argon laser, 405, 561 and 635 nm diode
laser, 405/488/559/635 dichroic filter
• Trans-Blot® Turbo™ Transfer System for Western Blot (Bio-Rad Laboratories
GmbH)
2.1.10 Software
• FIJI is just ImageJ, Version 2.00.-rc-65/1.51u (Wayne Rasband, NIH)
• FV 10-ASW FluoView1000, Version 4.0b (Olympus, Tokyo, Japan)
• GraphPad Prism, Version 7.0d for Mac OS X (GraphPad Software Inc., San
Diego, California, USA)
• Intas GDS Software Version 4.0 (Intas Science Imaging Instruments GmbH,
Goettingen, Germany)
• MATLAB®, Version R2015a (8.5.0.197613) (Math Works Inc., Natick, USA)
• RStudio, Version 1.0.153 (RStudio Inc., Boston, USA)
• Serial Cloner, Version 2.6.1 (SerialBasics)
• SymPhoTime 64, Version 2.4 (PicoQuant, Berlin, Germany)
2.2 Methods
2.2.1 Cell culture
Cell propagation. All cell lines used in this study were propagated in cell culture
medium and kept at 37 ◦C and 5% CO2. Cells were passaged every two to three
days in dependence of experiments, but always before reaching full confluency. For
this purpose, cells were rinsed once or twice with PBS -/- to facilitate detachment
by removing all traces of FBS that might inhibit trypsin activity, and to remove
dead cells. Next, cells were detached by incubation with a suitable amount of a
trypsin-EDTA solution at 37 ◦C and 5% CO2 for 5 to 15min. Finally, detachment
was stopped by adding an excess of fresh cell growth medium to inactivate trypsin.
Through gentle pipetting, cells were aspirated and subsequently seeded into new 75
or 175 cm2 cell culture flasks, or seeded for further experiments. Additionally, cells
were analysed for mycoplasma contamination within the laboratory by PCR. Cells
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were used for about 15 to 20 passages; afterwards new cells were thawed.
Cell thawing. Cells were long-term stored in liquid nitrogen in freezing medium
containing high DMSO concentration. Hence, cells need to be thawed quickly to
avoid any toxic effects of DMSO. Therefore, cells were briefly thawed at 37 ◦C and im-
mediately transferred to a 15mL falcon containing 10mL cold growth medium, thus
directly decreasing DMSO concentration from initially 10 % to 1% (v/v). Then cells
were pelleted (1,300 rpm, 5min, 4 ◦C), resuspended in 10mL of fresh, pre-warmed
growth medium, and finally transferred into new 75 cm2 cell culture flasks.
Cell freezing. Approximately 1,000,000 cells were frozen in 1mL of cell culture
freezing medium containing 10% DMSO (v/v). DMSO is used as penetrating cyro-
protectant to avoid freezing damage of cells (mainly membrane rupture) due to ice
crystal formation during cryopreservation. Cells were frozen slowly to allow water
to move out of cells, and thus further prevent cells from freezing damage. In order
to achieve slow freezing, cells were frozen for several hours at -20 ◦C, then at -80 ◦C
over night (oN), and finally transferred into a liquid nitrogen tank for long-term
storage.
2.2.2 Cloning of expression plasmids
All plasmids generated in this work are listed in Tab. 2.15. For all plasmids, cloning
was performed according to the following descriptions. Sequence specific primers
for polymerase chain reaction (PCR) and restriction endonucleases (REases) for
digestion steps are not further indicated within these sections, but separately listed
in Tab. 4.1 in the Appendix.
Visualization and purification of DNA was usually performed by separating DNA
according to size in agarose gel electrophoresis followed by extraction using QIAGEN
gel extraction kit. For standard DNA fragments with sizes ranging from 500 to
3,000 nts, 1% agarose (w/v) in TBE buffer was used and DNA visualized using
Roti®-GelStain. For DNA fragments smaller than 500 or larger than 3,000 nts, 2.0 or
0.5% agarose (w/v) was used, respectively.
2.2.2.1 Extraction of A/WSN NEP mRNA from infected MDCK II cells
A/WSN NEP mRNA is produced through alternative splicing of segment 8 mRNA
during infection, thus corresponding cDNA can only be acquired from infected cells
for further cloning steps. Therefore, MDCK II cells were first infected with A/WSN as
described in Section 2.2.5 followed by mRNA extraction 24 hours post infection (hpI)
46
Material and Methods
using RNeasy Mini Kit. Then, whole mRNA was reverse transcribed into cDNA using
anchored oligo(dT)20 primer, which binds to 5’-ends of mRNA’s poly-A-tails, and
SuperScript™ IV reverse transcriptase according to the manufacturer’s instructions.
Prior to synthesis and amplification of second strand cDNA by PCR, RNA of the
previously originated DNA-RNA-hybrid was digested with RNase H according to
the manufacturer’s instruction. Finally, NEP cDNA was specifically amplified and
provided with restriction sites for cloning into plasmids according to a standard
PCR-protocol described in the following section.
2.2.2.2 Integration of restriction endonuclease recognition sites
For successful integration of a certain sequence into a target plasmid this sequence
needs to be provided with suitable REase recognition sites by standard PCR using
Phusion™ High-Fidelity DNA polymerase that possesses proof-reading activity and
thus allows mutation-free DNA amplification. The applied PCR protocol (Tab. 2.16)
is separated into two main cycles with different annealing temperatures.
Table 2.16: PCR protocol to integrate restriction endonuclease recognition
sites to a sequence of interest. Phusion™ High-Fidelity DNA polymerase possesses
extension times of 15 to 30 s/kb, and thus elongation time was adjusted in dependence of
the DNA-length to be amplified. Amplification was usually performed with high fidelity 5x
buffer, or 5x GC buffer for templates that are difficult to amplify.
PCR reagents PCR reaction
Step Temp. [◦C] Time [s] Cycles
Template 100 ng Denaturation 95 300
Phusion 0.5 μL Denaturation 95 30
10 μM Primer fw 2.5 μL Annealing 58 25 10
10 μM Primer rev 2.5 μL Elongation 72 x
5x Buffer 10 μL Denaturation 95 30
10mM dNTPs 1.0 μL Annealing 68 25 20
ddH2O add to Elongation 72 x
50 μL Elongation 72 300
Cooling 12 ∞
A sequence, hereafter referred to as ’insert’, does not carry specific REase recognition
sites, thus used primers initially do not bind completely to their targets and therefore
low annealing temperatures are applied. Since restriction sites are introduced during
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the first amplification cycles, a complete complementary sequence compared to
the respective primer will be present within the insert. Thus a higher annealing
temperature is needed for specific primer binding for later amplification cycles.
2.2.2.3 Extension PCR for site-directed mutagenesis
A 2-step PCR protocol, first introduced by Ho et al. (1989), was applied for site-
directed mutagenesis to introduce single point mutations, deletions or insertions at
certain gene regions.
In step one, two fragments A and B of a single insert are separately amplified
in two different PCR reactions following the protocol in Tab. 2.16. Herein, the
reverse primer of A and forward primer of B do not only carry the desired mutation
flanked by several nts complementary to the target sequence, but also possess distinct
sequence overlap with each other, resulting in long sequence overlaps at the 3’- and
5’- ends of fragments A and B, respectively. In step two, both reaction mixtures were
combined, and A and B allowed to anneal through their terminal overlaps, followed
by an extension reaction giving rise to a single mutated gene construct. This second
extension PCR protocol is described in detail in Tab. 2.17.
Table 2.17: Protocol part two of the extension PCR approach for site-directed
mutagenesis. Phusion™ High-Fidelity DNA polymerase possesses extension times of 15
to 30 s/kb, and thus elongation time was adjusted in dependence of the DNA-length to
be amplified. Amplification was usually performed with high fidelity 5x buffer, or 5x GC
buffer for templates that are difficult to amplify.
PCR reagents PCR reaction
Step Temp. [◦C] Time [s] Cycles
Phusion 0.5 μL Denaturation 95 300
Fragment A 10 μL Denaturation 95 30
Fragment B 10 μL Annealing 58 25 30
5x Buffer 10 μL Elongation 72 x
10mM dNTPs 1.0 μL Annealing 58 60
ddH2O add to Elongation 72 300
50 μL Cooling 12 ∞
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2.2.2.4 Restriction endonuclease digestion and ligation
An insert, amplified or mutated by PCR and terminally flanked with REase recogni-
tion sites, was digested with REases for 1 h at 37 ◦C according to the manufacturer’s
instructions. Likewise, target plasmids were digested with corresponding REases.
Digested products were first analysed and purified by agarose gel electrophoresis,
and subsequently ligated through the generated overlapping sequences. Ligation was
performed for 1 h at room temperature (RT) using T4-DNA-Ligase according to the
manufacturer’s instructions. For efficient ligation of plasmid and insert molar ratios
of either 1:3 or 1:5 were used, respectively.
2.2.2.5 One-step cloning of viral genome segments into pHW2000 plasmid
Cloning of IAV segments into pHW2000 plasmid was performed by combining REase
cleavage and ligation in a single step. Esp3I is a type II REase which cleaves DNA
outside of its recognition site. Inserts and pHW2000 contain Esp3I recognition
sites distal to the cleavage site. Hence, after ligation recognition sites are removed
from the assembled plasmids. This way, digestion and ligation can be carried out
simultaneously; 30 repeating cycles of 10min digestion at 37 ◦C followed by 10min
ligation at 23 ◦C were performed to obtain pHW2000 plasmids encoding mutated
variants of A/WSN segment 8 (Tab. 2.15, No. I23 - No. I30). Furthermore, type II
REase do not introduce any additional scar sequences. This is especially important for
pHW2000 viral rescue systems since pHW2000 expresses viral mRNA, and virus-like
RNA bidirectional using human RNA polymerase I and II promoter and respective
terminator sequences (Hoffmann et al., 2000). While RNA polymerase II starts
synthesising viral mRNA after the first encoded start codon, RNA polymerase I
immediately starts polymerisation one nt downstream to its promoter sequence. To
ensure successful packaging of viral segments into progeny virions it is important
to prevent insertion of any additional nt by cloning, which is only guaranteed using
type II REases.
2.2.2.6 Transformation of E.coli and verification of successful cloning
Plasmids containing a certain insert were amplified by transformation into chemically
competent bacteria, E.coli DH5α. Therefore, 100 μL bacteria suspension was thawed
on ice, afterwards mixed with the obtained ligation reaction, and further incubated
for 20min on ice. Uptake of plasmid DNA was forced by a short heat-shock at 42 ◦C
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for 90 s. Then, bacteria were cooled on ice for another 5min. To allow generation
of antibiotic resistance 400 μL LB medium without antibiotics was added, and
suspensions incubated for 1 h at 37 ◦C under constant shaking at 200 rpm. Finally,
bacteria were pelleted (5min, 10,000 rpm), resuspended in 50 μL LB medium, and
plated on LB agar plates containing appropriate antibiotics, thus allowing for selection
of successfully transformed bacteria. Agar plates were incubated oN at 37 ◦C.
Colony PCR. Successful cloning was verified by colony PCR. Therefore, single
bacteria colonies were picked, added to the PCR reaction mixture instead of a
DNA template, and additionally spotted onto a new LB agar plate (’master plate’)
containing appropriate antibiotics for selection. This plate was again incubated oN
at 37 ◦C. In parallel, colony PCR was performed as described in Tab. 2.18 using
insert-specific primers to determine the presence or absence of a certain insert within
colonies.
Table 2.18: Colony PCR protocol for verification of successful cloning. PeqGOLD
Taq-DNA-Polymerase possesses extension times of approximately 30 to 60 s/kb, thus
elongation time was adjusted in dependence of the DNA-length to be amplified.
PCR reagents PCR reaction
Step Temp. [◦C] Time [s] Cycles
Template clone Denaturation 95 300
Taq Polymerase 0.125 μL Denaturation 95 30
10 μM Primer fw 1 μL Annealing 58 25 30
10 μM Primer rev 1 μL Elongation 72 x
10x Buffer 2.5 μL Elongation 72 300
10mM dNTPs 1.0 μL Cooling 12 ∞
ddH2O add to
25 μL
After verification of successful cloning by colony PCR, plasmids were amplified. To
this aim, single bacteria from master plates were transferred into LB medium contain-
ing antibiotics for selection, and grown oN at 37 ◦C under constant shaking (200 rpm).
The next day, bacteria were pelleted by centrifugation (10min, 5,000 rpm), and
plasmids extracted using QIAprep spin miniprep kit according to the manufacturer’s
instructions. Eventually, plasmid sequences were verified through sequencing by
Eurofins Genomics GmbH (Ebersberg, Germany) or LGC Genomics GmbH (Berlin,
Germany).
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2.2.3 Transient transfection of cells
Transfection of A549 cells. Approximately 800,000 cells were transfected with
250 to 500 ng of indicated plasmids using Lipofectamine™ 3000 transfection reagent
according to the manufacturer’s instruction. In case of simultaneous transfection of
multiple plasmids, plasmids were pre-mixed in a single droplet to promote combined
uptake into cells. In brief, plasmids were incubated with 2 μL P3000 reagent per
500 ng plasmid DNA. In parallel, 2 μL Lipofectamine™ 3000 was pre-diluted in 98 μL
serum-free transfection medium and incubated for 5min at RT. The pre-formed
Lipofectamine™ 3000-complexes were then added to the plasmid-P3000-mixture,
carefully mixed, and further incubated for 15min at RT to allow transfection reagent
binding to plasmid DNA. Finally, the mixture was added drop-wise to cells, and
transfection was carried out for 16 - 24 h prior to experiments.
Transfection of HEK 293T cells. 1,000,000 cells were transfected with 250 to
1,000 ng plasmid DNA using TurboFect transfection reagent according to the manu-
facturer’s instruction. For this amount of plasmid DNA 2 to 4 μL transfection reagent
was pre-diluted in 100 μL serum-free transfection medium and added to the plasmid
DNA. Mixtures were incubated for 20min at RT and then added drop-wise to cells.
Transfection prolonged for 16 - 24 h. In case of transfection with multiple plasmids,
plasmids were again pre-mixed in a single droplet to promote simultaneous uptake.
2.2.4 Indirect immunofluorescence staining
Approximately 400,000 A549 cells were seeded into poly-d-lysine coated 35mm
MatTek dishes containing 14mm diameter coverslips one day prior to experiments.
All solutions, antibodies, and fluorescence dyes used for immunofluorescence (IF)
staining are listed in Tab. 2.5, Tab. 2.12, Tab. 2.13, and Tab. 2.14, respectively.
First, growth medium was aspirated, and cells fixed for 20min at RT using 10%
formalin which conserves the cellular morphology. Then, cells were washed three
times with DPBS, and afterwards permeabilized for 15min at RT to allow subsequent
antibody penetration through cell membranes. Next, blocking with IF blocking
buffer was performed at RT for 1 h under continuous agitation to prevent non-
specific binding of secondary antibodies later during staining. Furthermore, glycine
was added to the buffer to quench background fluorescence caused by non-reacted
aldehydes of fixatives. After rinsing cells again with DPBS, antigens were detected
using indicated primary antibodies diluted in antibody dilution buffer. Antigen
recognition was performed either at 4 ◦C oN, or at RT for few hours. Cells were
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then washed several times with DPBS to remove any unbound primary antibodies.
Primary antibodies were finally detected using conjugated secondary antibodies
reactive against immunoglobulins of the source species of the primary antibody as
described before. Eventually, nuclei were stained using DAPI.
2.2.5 Infection of cells, virus propagation and concentration,
mutant virus rescue, and viral infection titer
determination
Infection of cells. A549 cells were either infected with A/WSN obtained from
MDCK II supernatant at low multiplicity of infection (MOI), or viral concentrates
as indicated. Viruses were diluted in infection medium either without addition
of TPCK-trypsin for single-round infections, or with 2.5 μg/μL TPCK-trypsin to
promote multiple-round infections. N-tosyl-L-phenylalanine chloromethyl ketone
(TPCK) inactivates extraneous chymotryptic activity in trypsin extracts allowing
for specific trypsin activity only, which is important for HA activation of IAV, and
thus infectivity. Viruses were allowed to bind to cells and become internalized for 1 h
at 37 ◦C. Afterwards, virus containing medium was exchanged with fresh infection
medium, and cells further maintained under normal growth conditions according to
the experimental procedure.
Virus propagation on MDCK II cells. A/WSN virus was propagated on MDCK
II cells. For this purpose, MDCK II cells were infected with A/WSN at an MOI of
0.01 as described above. Infection medium was supplemented with 2.5 μg/μL TPCK-
trypsin to allow multiple-round infection to increase virus yield. Approximately 1 -
3 days post infection cytopathic effect (CPE), in case of IOnfluenza infection cell
lysis, was observed and supernatant containing virus harvested and cleared from
cell debris by centrifugation (30min, 5,000 rpm). Virus containing supernatant was
immediately used for infection or further concentrated to obtain viral concentrates.
Concentration of A/WSN. Virus obtained from MDCK II supernatant was pel-
leted by ultra-centrifugation at 100,000 x g for 2 h at 4 ◦C. Then, supernatant was
removed, and pellets dried before resuspension in 500 μL TNE buffer. The obtained
virus concentrate was either used immediately for infections or further cleared by
ultra-centrifugation through a linear 20 - 60 % sucrose (w/v) gradient (100,000 x
g, 4 h, 4 ◦C). After collecting virus from the gradient, viruses were pelleted again
by ultra-centrifugation (100,000 x g, 1.5 h, 4 ◦C), and finally resuspended in 500 μL
TNE buffer. Protein concentration was determined using Pierce BCA protein assay
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kit according to the manufacturer’s instructions.
Rescue and growth kinetics of mutant A/WSN virus. Viruses carrying dif-
ferent mutations of vRNP segment 8 were generated as described in Hoffmann et al.
(2002). In brief, 1,000,000 HEK 293T cells were seeded in 6-well plates one day prior
to transfection. Then, cells were co-transfected with eight plasmids (500 ng each)
encoding for all viral RNAs and viral-like mRNAs (Tab. 2.15, No. I02 - I09) to
generate viruses from transfected cells. To generate mutant viruses plasmid No. I09
was exchanged against a mutated version (Tab. 2.15, No. I23 - I30). Transfection was
performed as described in Section 2.2.3. Transfection medium was exchanged against
infection medium supplemented with 2.5 μg/mL TPCK-trypsin and replication effi-
cient 500,000 MDCK II cells, 6 h post transfection. Virus titer of the supernatant of
transfected cells was determined 72 h post transfection. Growth kinetics of mutant
viruses were analysed by monitoring infection of MDCK II cells over a time period
of 3 days. 3.2x106 MDCK II cells were infected with a MOI of 0.0003. Then, 12, 24,
48, and 72 hpI supernatant samples were taken and infectious titers determined as
follows.
Determination of infection titer. Viral infection titers were routinely obtained
by determination of 50 % Tissue Culture Infectious Dose (TCID50). TCID50 is an
endpoint dilution assay, that allows to quantify the amount of virus that is required
to infect 50% of inoculated tissue culture cells. First, MDCK II cells were seeded in
U-shaped 96-well plates and inoculated with viruses (in infection medium supple-
mented with 2.5 μg/μL TPCK-trypsin) in 1 log10-steps to a final dilution of 10-10 in
eight technical replicates. In this study a modified version of an hemagglutination
assay was performed to asses the TCID50. Thereby, the ability of HA to agglutinate
red blood cells (RBCs) carrying SAs on their surface is utilized. Human RBCs were
washed several times with PBS -/-, then diluted in PBS -/- (1% v/v), and added to
the virus containing supernatant of MDCK II cells directly. Samples were incubated
at RT for up to 1 h to allow the formation of a lattice-like structure in presence of
viruses due to agglutination of RBCs by HA. In the absence of virus, RBCs will
form a pellet at the bottom of the well. Thus, non-infected and infected wells can be
distinguished. Eventually, the TCID50 was calculated using the Reed-Muench method
(Reed and Muench, 1938). From TCID50 values plaque forming unit (PFU) and MOI
can be calculated. To transform TCID50 values into PFUs Poisson distribution is
applied:
P(k) = e–mm
k
k! , (2.1)
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where k is the number of positive wells, and m the average number of infectious viral
particles per volume. P(0), the proportion of negative wells, gives:
P(0) = e–mm
0
0! = e
–m · 1. (2.2)
For any positive titer P(0)=0.5 since the TCID50 determines the infectious dose
which will infect 50 % of the cell monolayer. Thus, P(0) can be expressed as:
e–m · 1 = 0.5, (2.3)
which gives the factor that is multiplied with the determined TCID50 to transform
this value into PFU given as PFU/mL:
m = –ln(0.5) = 0.69, (2.4)
MOI is the average number of viral particles infecting one single cell, and related to
PFU as follows:
MOI = PFUCellnumber. (2.5)
2.2.6 Recombinant protein and vRNP extraction
2.2.6.1 A/WSN M1 expression in E.coli
The viral protein M1 of A/WSN was expressed in E.coli strain Rosetta™ (DE3)
using pET-15b expression system. As a consequence the protein carries an N-terminal
His-tag, followed by a thrombin recognition site. Protein expression is facilitated by
T7 RNA polymerase under control of a lac operator, thus allowing protein expression
induced through IPTG.
First, 100mL growth medium containing 50 μL/mL chloramphenicol and 100 μL/mL
ampicillin was inoculated with transformed bacteria, and bacteria suspension grown
oN at 37 ◦C under continuous shaking (200 rpm). Second, 20mL of this oN culture was
used to inoculate another 1,000mL of growth medium. Bacteria were grown at 37 ◦C
under continuous shaking until reaching OD600 nm=0.5. Third, protein expression
was induced by adding 0.1mM IPTG. For optimization of protein expression, bacteria
cultures were grown at several temperatures as well as time periods (indicated in
Fig. 3.14) under continuous shaking. Later, A/WSN M1 was exclusively grown for
3 h at 37 ◦C after induction of protein expression. Finally, after successful protein
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expression, bacteria cultures were harvested by centrifugation (10min, 5,000 rpm,
4 ◦C), and either stored at -80 ◦C or immediately lysed and further processed.
2.2.6.2 Purification of recombinant A/WSN M1 protein
All buffers used for purification of M1 were always adjusted for the indicated pH values
prior to use. For protein purification pelleted bacteria were resuspended in 10mL of
chilled lysis buffer, frozen at -80 ◦C for 15min, and subsequently thawed slowly at
4 ◦C under continuous shaking to promote lysis. Next, samples were ultra-sonicated
on ice using a tip sonicator with the following settings: 5 cycles, 20 s sonication, 30 s
pause, 80% duty cycle, output control 4. Afterwards, lysed bacteria were centrifuged
for 20min, at 23,000 rpm and 4 ◦C to separate soluble proteins in the supernatant
from in-soluble proteins in the pellet fraction. M1 was expected to be present in
the soluble protein fraction, thus supernatant was used for affinity chromatography
purification using TALON® metal affinity resin which binds His-tagged proteins
through its charged Co2+ surface with higher affinity than Ni2+. Resin was first
washed with 20mL binding buffer to remove storage buffer, and then transferred
to bacteria supernatant together with 1mL of fresh binding buffer. Binding of His-
tagged proteins was proceeded for 30 to 60min, at 4 ◦C under constant rotation
to avoid resin aggregation. Afterwards, resin and bound proteins were transferred
to a polypropylene column and incubated with another 15mL binding buffer for
additional 10min at 4 ◦C under constant shaking. Then, resin was allowed to seal
within the column by buffer draining. Resin was carefully washed with another
15mL of binding buffer followed by a washing step with 10mL of pre-wash buffer
containing 60mM imidazole to remove non-specifically bound proteins from resin.
Elution of His-tagged proteins was finally carried out by adding 10mL of elution
buffer containing high concentrations of imidazole to promote release of His-tagged
proteins through competitive binding to Co2+-ions on the TALON surface. Fractions
of ∼500 μL were collected, and analysed for protein concentration and purity.
2.2.6.3 vRNP isolation from concentrated A/WSN virions
First, 5mg virus concentrate was diluted in TNE buffer and pelleted by centrifu-
gation for 40min and 41,100 rpm at 4 ◦C. To remove the viral envelope 10mg/mL
lysophophatidylcholine was added to the lysis buffer immediately before use, and
pellets thoroughly resuspended in 1mL pre-warmed buffer for 35min at 31 ◦C. Viral
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vRNPs were separated from viral coats by ultra-centrifugation through a discon-
tinuous glycerol gradient for 4 h at 39,000 rpm and 4 ◦C. Glycerol was diluted in
gradient buffer and layered from bottom to top as follows: 5mL 70%, 0.75mL 50%,
0.375mL 40% and 1.8mL 33% (w/v) glycerol gradient buffer. A density gradient
fractionater was used to collect fractions of 500 μL after centrifugation. Fractions
were then analysed for the presence of NP as main vRNP component, as well as
polymerase complexes by SDS-PAGE analysis followed by either silver or colloidal
coomassie staining (see Section 2.2.7). Fractions containing NP and polymerase
complexes but low amounts of M1 were pooled and diluted in 20mL gradient buffer
lacking glycerol. Finally, vRNPs were concentrated, and unbound M1 further released
by centrifugation at 4,800 rpm and RT for 30min using Vivaspin 20 columns with
MW cut-off of 50 kDa, thus retaining vRNPs of MDa size, but let pass M1 (∼28 kDa).
Centrifugation was performed three times, whereby resuspension buffer was added at
centrifugation steps two and three to retain vRNPs under physiological conditions,
and allow labelling with AlexaFluor™ succinimidyl esters (NHSs).
2.2.6.4 vRNP and M1 labelling with AlexaFluor™ succinimidyl esters
Amine-reactive fluorescent dyes, AlexaFluor™ NHSs 488 and 647 were used to
label non-protonated aliphatic amine groups of proteins which are present on the N-
terminus of proteins as well as lysine. After reaction NHSs produce stable carboxamide
bonds with their targets, thus deterioration over time is marginal. Nevertheless,
AlexaFluor™ can hydrolyse from NHSs and thereby decrease labelling efficiency. In
particular, AlexaFluor™ 488 reactivity was reported to be as low as 30 to 40%, and
therefore M1 and vRNPs were preferably labelled using AlexaFluor™ 647 NHS for
FCS analysis. For cross-correlation approaches M1 was labelled using AlexaFluor™
488 despite reduced reactivity, and vRNPs were labelled using AlexaFluor™ 647 to
ensure spectral separation.
M1 and vRNPs were directly labelled in the respective storage buffers with pH
values close to neutral pH. A five-fold molar excess of dye was added to the sample
while vortexting the protein solution, and reaction was proceeded oN at 10 ◦C and
constant agitation at 300 rpm. Free, unbound dye was removed either through size
exclusion chromatography using Sephadex G-25 (fractionation range: 1 to 5 kDa)
for separation of dye-labelled M1 (∼29.2 kDa), which will immediately elute from
free dye (1.16 kDa) that will be retained, or by using Vivaspin 20 columns with MW
cut-off of 50 kDa (centrifugation: 4,800 rpm, RT, 30min) to remove unbound dye
from labelled vRNPs. Eventually, protein concentration and labelling efficiency was
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determined by measuring absorption of obtained fractions at 280 nm, and either 488
or 647 nm, respectively. Labelling ratio R was determined as follows:
R =
CDye
CSample
. (2.6)
For precise concentration C calculation absorption A, extinction coefficient ε, and
the path length l (l=0.1 cm nanodrop, l=1 cm spectrometer) of the measured sample
was taken into account. Thus, dye concentration C can be calculated as follows:
CDye =
ADye
εDye · l
. (2.7)
Furthermore, to precisely determine the labelling ratio R of M1, a correction factor
CF for the respective dye was necessary, since the dyes contribute themselves to the
absorption A at 280 nm. All important parameters necessary for the quantification
of labelling ratios are listed in Tab. 2.19. Finally, concentration of M1 was calculated
as follows:
CM1 =
A280 – ADye · CF280nm
εM1 · l
. (2.8)
Using Eqn. 2.6, and results of Eqn. 2.7 and Eqn. 2.8, the labelling ratio of M1 labelled
either with AlexaFluor™ 488 or 647 was determined.
To calculate the labelling ratio R of vRNPs according to Eqn. 2.6, the concen-
tration of vRNPs needed to be determined. vRNPs were extracted from virions,
and thus are present as mixture corresponding to segment 1 to 8. As all vRNPs
differ in size and thereby protein proportion, sample concentration could only be
approximated according to the following assumptions by comparing the absorption
measured at 280 nm to a BSA standard:
1. all eight segments are present in equal amounts
2. only vRNP protein components NP, PA, PB1 and PB2 are present in the
sample
3. each vRNP is bound by one single polymerase complex, and NP molecules
every 24th nt (Jennings et al., 1983, Ortega et al., 2000)
For segment 1 the MW is approximately 5.75MDa, for segment 8 ∼2.35MDa. The
average MW for one undefined single vRNP in a mixture of all eight vRNPs is
4.25MDa, corresponding to 4.25 · 106 g/mol. Hence, the concentration of vRNPs
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could be determined with the following equation where C is the measured protein
concentration:
CvRNP =
C
MWvRNP
, (2.9)
In a mixture of vRNPs the exact composition of the sample is unknown. Therefore,
the concentration for an average MW as well as the concentrations for both edge
cases, i.e. only the smallest or the largest vRNP were present in the sample, was
used to calculate a concentration interval. Thus, the possible lower and upper limit
of the labelling ratio R can be determined using Eqn. 2.6.
Table 2.19: Overview of parameters important for calculating the labelling
ratios of M1 and vRNPs with AlexaFluor™ dyes. Parameters in part A are used to
precisely calculate M1 and AlexaFluor™ dye concentrations. AlexaFluor™ dye parameters
are taken from the supplier (Thermo Fisher Scientific Inc.). ε: extinction coefficient, CF:
correction factor for dye absorption at 280 nm. In part B the approximated MW for each
of the eight IAV segments is given in MDa. MWs were calculated based on the assumption
that each vRNP possesses a single copy of the viral RdRP and binds NP every 24th nt.
Segment lengths are given in Tab. 1.1 in the Introduction.
Part A Part B
Parameter Value Segment No.
Molecular
weight [MDa]
εM1 14,502.5 cm-1 M-1 1 5.75
εAlexa488 71,000 cm-1 M-1 2 5.75
CF280nm,Alexa488 0.11 3 5.5
εAlexa647 239,000 cm-1 M-1 4 4.43
CF280nm,Alexa647 0.03 5 3.9
6 3.67
7 2.64
8 2.35
2.2.6.5 Isolation of artificial vRNPs from transfected HEK 293T cells
HEK 293T cells were transfected for 24 h with four plasmids, together encoding
for an artificial vRNP corresponding to segment 5 of A/WSN (Tab. 2.15, No. I06,
I38, I41, I47). Plasmid No. I46 encodes PB2 N-terminally fused to a His-tag used
for purification through affinity chromatography, as well as mCherry2. To facilitate
detachment, cells were washed once with PBS -/- before being scraped off from cell
culture plates, and then pelleted by centrifugation for 5min and 1,500 rpm at 4 ◦C.
Cell pellets were then resuspended and lysed in 1mL RIPA lysis buffer, and further
58
Material and Methods
incubated for 30min at 4 ◦C under continuous shaking. Afterwards, cell debris was
separated from supernatant containing vRNPs by centrifugation (15min, 14,000 x
g, 4 ◦C). Affinity chromatography for vRNP isolation was adapted from Jorba et al.
(2009). In brief, 1mL vRNP containing supernatant was incubated oN at 4 ◦C with
2mL wash buffer and 500 μL TALON® metal affinity resin which binds His-tagged
proteins through its charged Co2+ surface. Next, resin was washed with, in total 100
volumes of wash buffer to remove unbound protein contaminations. Finally, vRNPs
were eluted from resin with 2mL elution buffer in 250 μL fractions.
2.2.7 SDS-PAGE and Western Blot analysis
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) allows separation of proteins
according to their electrophoretic mobility. Due to the stoichiometric binding of
the negatively charged surfactant sodium dodecyl sulfate (SDS) to proteins, their
intrinsic charge is covered. About one SDS molecule binds two AAs, thus leading to
similar charge-to-mass ratios of proteins. As a result, upon application of an electric
field, all proteins migrate towards the anode according to their MW.
Discontinuous SDS-PAGE was used, allowing for separation of proteins with sizes
ranging from 5 to 250 kDa. Resolving gels of 10% or 12% acrylamide/bis-acrylamide
were used for analysis of vRNP-isolates or purified M1, respectively. First, resolving
gels were casted using Mini-PROTEAN 3 electrophoresis system. Second, after poly-
merisation, the resolving gel was overlaid with a stacking gel of 5% acrylamide/bis-
acrylamide concentration. Hence, in discontinuous systems proteins migrate quickly
through the stacking gel with large pore size, and are slowed down as they reach the
border of the small-pore resolving gel. As proteins slow down at gel borders, they
stack on top of one another forming a tight band, which improves resolution while
migrating through the resolving gel.
Samples were denatured with SDS sample buffer either under reducing or non-
reducing conditions by incubation at 95 ◦C or 70 ◦C for 10min, respectively. After
sample loading, gels were run at constant voltage of first 120V, and then increased
to 160V when reaching the resolving gel. After electrophoresis proteins were either
visualized by coomassie or silver staining, or specifically detected by Western Blot.
2.2.7.1 Colloidal coomassie staining of SDS-PAGE gels
Staining was performed according to Dyballa and Metzger (2009), allowing detection
of protein concentrations as low as 10 ng. In brief, SDS-PAGE gels were washed
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three times with deionized ultra-pure water to remove excess of SDS which interferes
with coomassie binding to proteins. Then, gels were stained with colloidal coomassie
staining solution oN at RT under continuous shaking. The next day, gels were
first washed with deionized ultra-pure water following destaining using coomassie
destaining solution until sufficient removal of background. Finally, gels were imaged
using either Dark Hood DH-40 or Odyssey® infrared imaging system.
2.2.7.2 Silver staining of SDS-PAGE gels
Staining was performed according to Chevallet et al. (2006), allowing detection of
protein concentrations in the low ng range. All solutions were freshly prepared with
deionized ultra-pure water of very low resistivity, and all steps were performed at
23 ◦C under constant agitation. After electrophoresis gels were fixed for at least
30min using fixative solution. Next, gels were washed twice with 20% ethanol (v/v),
followed by two washing steps with deionized ultra-pure water, at least 10min for each
step. Before staining, gels were sensitized with sensitizer solution for 30min, and then
washed three times with deionized ultra-pure water for exact 10min. Subsequently,
gels were stained for 30min using staining solution containing excess of Ag+ ions that
form complexes with proteins. Afterwards, gels were briefly washed with deionized
ultra-pure water, and subsequently developed using developer solution. Thereby,
Ag+ ions are reduced to elemental silver, and thus protein bands are visualized.
Development was allowed to proceed until expected bands for the protein of interests
became clearly visible, and then stopped by transferring the gels into an EDTA
containing stop solution for 30min. Finally, gels were again washed twice with
deionized ultra-pure water and imaged using Dark Hood DH-40 imaging system.
2.2.7.3 Western Blot analysis
Western Blot (WB) analysis was performed to specifically detect proteins by anti-
bodies after separation through SDS-PAGE. First, proteins were transferred from
SDS-PAGE gel onto a nitrocellulose membrane. Therefore, the gel was placed on top
of the membrane soaked with transfer buffer. Membrane and gel were encased by
bottom and top blotting papers also soaked with transfer buffer. The thus assembled
blotting sandwich was placed into a transfer cassette, and trapped air was removed
using a blot roller. Next, protein transfer was performed using a pre-programmed
protocol of the Trans-Blot® Turbo™ transfer system for 30min and 25V constant.
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Efficiency of protein transfer was monitored by verifying successful transfer of pre-
stained MW marker. Second, transferred proteins were specifically identified by
indirect immunofluorescence staining. Initially, the membrane was blocked oN at
4 ◦C using WB blocking buffer to prevent unspecific binding of primary antibodies
since the membrane has a high affinity to bind any protein. The blocked membrane
was then washed with WB wash buffer, followed by antigen detection with suitable
primary antibodies diluted in WB antibody dilution buffer, again oN at 4 ◦C under
constant shaking. Then, unbound primary antibodies were removed by extensive
washing of membranes with WB wash buffer for several times. Primary antibodies
were detected with suitable secondary antibodies by incubation either oN at 4 ◦C or
for few hours at RT under constant shaking. Eventually, membranes were extensively
washed with WB wash buffer, and finally antigens detected using Odyssey® infrared
imaging system.
2.2.8 Microscopy measurements
All microscopy measurements except fluorescence fluctuation spectroscopy and flu-
orescence lifetime imaging microscopy (FLIM) were performed on an Olympus
Fluoview FV-1000MPE inverted laser scanning microscope. Single plane images
or z-stacks were routinely analysed using FIJI software. For the quantification of
intensity distributions in cytoplasm and nuclei of cells, z-stacks were first projected
using median z-projection. Then, region of interests in cytoplasm and nuclei, and a
cell free region of each image (for background correction) were selected and median
intensities determined. Eventually, median intensities were corrected for background
signal and finally, nucleus to cytoplasm (’N/CP’) ratios calculated.
2.2.8.1 Fluorescence (cross-) correlation spectroscopy
FCS and FCCS measurements were performed on an Olympus Fluoview FV-1000
inverted laser scanning microscope, equipped with a time-resolved PicoQuant fluores-
cence lifetime setup. Both, FCS and FCCS measurements, were performed using a
60x/1.2 NA UPlanSApo water immersion objective and a 405/488/559/635 dichroic
mirror. Based on the performed instrument characterization described in Results
section 3.1, measurements were performed using the following settings: mEGFP was
excited with a 488 nm argon laser using a laser power of 3.3 μW (corresponds to a
relative laser power of 0.5%), mCherry and mCherry2 were excited using a 559 nm
diode laser with a laser power of 6 μW (corresponds to a relative laser power of 0.5%).
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Emitted fluorescence was splitted using a 570 nm dichroic mirror and finally detected
after passing through a 520/35 nm bandpass filter (mEGFP), or a 635 nm longpass
filter (mCherry, mCherry2) using two SPAD detectors. Pinhole diameter was kept
at 90 μm, correction collar ring to position 170, correcting for coverglass with a
thickness of 170 μm. In all measurements, MatTek dishes with a coverglass thickness
of 170±5 μm were used. Measurements were performed for 90 s and recorded using
SymPhoTime64 software. After data acquisition, PicoQuant ptu-files, containing the
recorded photon arrival times on SPAD detectors, were converted to an intensity time
series and binned in 5 μs intervals using a custom-written MATLAB code provided
by Dr. Salvatore Chiantia. Subsequently, data were analysed as follows using another
custom-written MATLAB code provided by M.Sc. Valentin Dunsing.
First, signal decrease due to photobleaching was corrected for time series with less
than 50% photobleaching. When stronger photobleaching was observed, data were
discarded. To correct for depletion, the slow intensity decrease has to be modelled.
For a restricted reservoir of fluorescent molecules, the decay is exponential and the
fluorescence time series was thus fitted with a two-component exponential function
f(t) (Ries et al., 2009):
f(t) = f1e
–t
τ1 + f2e
–t
τ2 + offset. (2.10)
With this approximation for the decay, the fluorescence intensity time trace was
corrected, leading to a constant mean value, and constant variance for the corrected
trace Fc(t) (Ries et al., 2009):
Fc(t) =
F(t)√
f(t)
f(0)
+ f(0)
1 –
√√√√ f(t)
f(0)
 . (2.11)
Then, the normalized ACF G(τ) and, CCF GCC(τ) (for dual-colour experiments)
were calculated:
G(τ) = 〈δF(t) · δF(t + τ)〉〈F(t)〉2 , (2.12)
GCC(τ) =
〈δFG(t) · δFR(t + τ)〉
〈FG(t) · FR(t)〉
, (2.13)
as described in Introduction section 1.2.1. To avoid artefacts that can be caused by
long-term instabilities of the system or single bright events, correlation functions
were first calculated segment-wise (10 segments per time trace), and segments with
distortions manually removed (in general no more than two segments) before averaging
the correlation functions. Eventually, a model for anomalous 3-D diffusion and a
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Gaussian-shaped observation volume geometry was fitted to the resulting averaged
correlation-functions (Weiss et al., 2004):
G(τ) = 1N
(
1 + T1 – Te
– ττT
)(
1 +
(
τ
τd
)α)–1 (
1 + 1
S2
(
τ
τd
)α)– 12
, (2.14)
where the particle number N and diffusion time τd were obtained from the fit.
Further, α describes the degree of anomalous sub-diffusion and was constrained to
values between 0.5 and 1 (α<1, sub-diffusion; α=1, free diffusion). The exponential
term accounts for a triplet fraction T with time constant τT which accounts for
photophysical transitions. For mEGFP τT was constrained to values lower than 50 μs
(Haupts et al., 1998), and 200 μs for mCherry or mCherry2 (Hendrix et al., 2008).
The structure parameter S describes the dimensions of the observation volume and
was determined using a 100 nM aqueous AlexaFluor™ 488 NHS solution. S was
typically around 4 to 9.
In dual-colour measurements, all ACFs were calculated using Eqn. 2.12. The CCF
was calculated using Eqn. 2.13 and then the diffusion model of Eqn. 2.14 was fitted
to all correlation curves. Relative cross-correlation, as a measure for the interacting
fraction, was calculated from the amplitudes of ACFs and the CCF as follows:
max
{
GCC(0)
GG(0)
, GCC(0)GR(0)
}
, (2.15)
where GCC(0) is the amplitude of the CCF, and GG(0) and GR(0) are the amplitudes
of the ACFs in the green (G) and red (R) channel, respectively. Further, the SNRs for
both, ACFs and CCFs, were calculated by first determining the standard deviation
of each point of the correlation curve, and then summing up the correlation values
divided by their variance (Wohland et al., 2001).
2.2.8.2 Molecular brightness analysis and brightness calibration
Scanning FCS (sFCS) measurements and N&B analysis shown in this work were per-
formed by M.Sc. Valentin Dunsing on a Zeiss LSM780 system (Carl Zeiss, Oberkochen,
Germany). Exact measurement conditions and data evaluation procedures can be
found in Dunsing et al. (2018). All single-point FCS (pFCS) measurements were
performed on an Olympus Fluoview FV-1000 inverted laser scanning microscope,
equipped with a time-resolved PicoQuant fluorescence lifetime setup as described in
detail above. After fitting a model for anomalous 3-D diffusion and a Gaussian confo-
cal volume geometry to the ACFs, average molecule number and average fluorescence
63
Material and Methods
intensity were extracted from the obtained data. Then, the molecular brightness ε
was calculated by dividing the average intensity by the number of particles (ε =
<F(t)>/N ) to obtain the apparent molecular brightness.
However, the molecular brightness, i.e. photon count rate per molecule, as a measure
for oligomerization is strongly affected by the presence of non-fluorescent fluorescence
proteins as shown in Results section 3.2. Therefore, for precise quantification of the
size of an oligomer based on the number of fluorescent subunits, a brightness correc-
tion was performed to account for non-fluorescent proteins. All parameters that can
lead to non-fluorescent states were considered together in a single parameter, termed
apparent fluorescence probability pf . Thus, the apparent fluorescence probability
pf characterizes the probability of a fluorescent protein to emit a signal. Assuming
that each fluorescent protein subunit of an oligomer contributes a certain molecular
brightness ε with a probability pf , the average fluorescence signal obtained from an
oligomer can be modelled with a binomial distribution. The probability pk to detect
a brightness value kε for a n-mer is given by:
pk =
(
n
k
)
pkf (1 – pf)
n–k , (2.16)
and the ensemble brightness εn detected from a number N of n-mers is given by:
εn =
∑n
k=1(kε)
2Nk∑n
k=1 kεNk
=
∑n
k=1(kε)
2N
(n
k
)
pkf (1 – pf)
n–k∑n
k=1 kεN
(n
k
)
pkf (1 – pf)n–k
= ε
npf(1 – pf) + n2p2f
npf
= ε+ ε(n – 1)pf
(2.17)
In the final analysis, first, ensemble brightness values εn were normalized to the median
brightness value of the corresponding monomeric fluorescent protein, measured under
the same conditions:
εn,norm =
εn
ε
= 1 + (n – 1)pf . (2.18)
Second, the apparent fluorescence probability pf for each experiment was determined,
using the median brightness value of the normalized homo-dimer measurement
performed under the same conditions:
pf = ε2,norm – 1. (2.19)
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Third, the corrected molecular brightness, i.e the brightness value that would be
obtained for an oligomer if all fluorescent subunits were fluorescent, and thus the
true oligomeric state of a protein complex was determined:
n = 1 + εn,norm – 1pf
. (2.20)
Finally, the ratio of n-mers to monomers [n]/[1] was calculated according to:
[n]
[1] =
〈B〉 · ε1 – ε21
ε2n – εn · 〈B〉
, (2.21)
where εn is the theoretically expected molecular brightness of the n-mer, <B> the
measured and then corrected median brightness of the n-mer, and ε1 the theoretically
expected molecular brightness of the monomer.
2.2.8.3 Single plane illumination microscopy combined with FCS
Single plane illumination microscopy - fluorescence correlation spectroscopy (SPIM-
FCS) measurements allow for multiplexed FCS measurements in an imaging mode
using light sheet illumination. Measurements were performed on a custom-built light
sheet microscope. The exact construction of the used setup is described in detail
in the PhD thesis of Dr. Anand Pratap Singh (2014). In SPIM, a combination of a
cylindrical lens and an illumination objective with low NA is used to create a μm
thin light sheet. Thus, only a single plane of defined depth is illuminated within the
sample. Then, detection is performed orthogonal to the illumination by a detection
objective possessing a high NA and fast Andor iXon X3 860 EMCCD camera (Andor
Technology, Belfast, UK).
To extract information about the observation volume and perform precise measure-
ments, careful alignment and evaluation of the light sheet need to be carried out
before conducting experiments. Otherwise, under- or over-estimation of the number
N and diffusion coefficient D can occur as shown in Fig. 2.1a on the following page.
Therefore, illumination and detection objective were first aligned using a mirror
mounted into the sample chamber to obtain maximal overlap for the volume of the
observation plane and light sheet (see Fig. 2.1c). Then, images of the light sheet
cross section, well-focused onto this mirror, were taken every 10 μm to 20 μm along
the whole axis as shown in Fig. 2.1d. For each of these images, line profiles were
plotted and fitted using a Gaussian fit. From these fits, the light sheet thickness
(usually between 1.1 μm to 1.4 μm), as well as the contribution of side lobes that
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should be less than 10% were determined over the whole image. Thereby, the image
area in which the light sheet thickness does not vary significantly and side lobe
contribution is small, was determined. Later, region of interests were recorded within
this area to ensure homogeneous observation volume extension. Finally, the tube lens
was adjusted using a grid mounted into the sample chamber. Typically, a 60x mag-
nification was chosen. One pixel on the camera corresponded to 400 nm in the sample.
a b
c d
Figure 2.1: Volume overlap of the observation plane and light sheet, and the
principle of determining the light sheet thickness in SPIM (image adapted
from Krieger et al. (2015)). a) Illustration of the importance of volume overlap of
the observation plane and light sheet. For different displacements of the illumination
and detection objective, diffusion coefficient D and particle number N strongly fluctuate.
b) Further, the effect of misaligned volume overlap is shown for a sample of fluorescent
beads. Positions of the detection plane (red), light sheet (blue) and detection objective for
all images are depicted in cartoons. c) Visualization of a light sheet by focusing the light
sheet onto a mirror using wide-field illumination. Some scratches or dirt on the mirror are
in focus. The well-focused area is highlighted. d) Image of the light sheet using a mounted
mirror and its line profile (blue line). The line profile and side lobes are fitted using a
Gaussian fit (dashed line) to determine the light sheet thickness.
Eventually, transfected A549 cells grown on small coverglass slides were mounted
into the sample chamber with an angle of 45° relative to the illumination laser.
Measurements were performed in HBBS. Typically, 100,000 to 150,000 frames with
an image region of 20 x 40 pixels (equals 8 μm x 16 μm) spanning the nuclear and
cytoplasmic interface of a cell, a laser power of 5 μW to 7 μW, and exposure times of
740 μs and 1ms were used. Image frames were stored in 16 bit tiff format, and analysed
using a custom-written MATLAB code provided by M.Sc. Valentin Dunsing. In brief,
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first, long fluctuations on the scale of several seconds were corrected by adapting
the bleaching correction described in Section 2.2.8.1, Eq. 2.10. This was necessary
as the system appeared to be quite unstable, i.e. showing long-term fluctuations
in independent regions of the sample, such as nucleus and cytoplasm. To correct
for these extraneous fluctuations, the frame-averaged intensity time series was first
calculated and binned in bins of 20 frames, providing a trend line that is dominated
by external fluctuations, such as variations in the excitation power. This function
was then used to approximate the intensity time series in each pixel, by performing
a linear fit with a multiplicative factor and an offset as fit parameters. The thus
obtained trend function was finally used to apply the mathematical correction formula
used previously to compensate for photobleaching, resulting in intensity time series
in each pixel that are more stable compared to the raw data (see Fig. 2.2).
a b
Figure 2.2: Correction of long-term fluctuations of SPIM-FCS measurements.
a) Example of an uncorrected fluorescence intensity trace of the whole image, and segmented
nucleus and cytoplasm of an A549 cell. The red curve illustrates the trend line that is
dominated by external fluctuations and provided by first calculating the frame-averaged
intensity time series followed by binning in bins of 20 frames. b) Corrected fluorescence
intensity trace for the nucleus and cytoplasm shown in a).
Second, a bleaching correction was performed as described for FCS and FCCS. Third,
nuclear and cytoplasmic regions were manually segmented using either wide-field
or fluorescence images. Then, diffusion and concentration maps were calculated for
both regions, and pixels that did not provide enough signal for statistical analysis
of the fluctuations were filtered out. The mathematical model for free diffusion in
SPIM-FCS is as follows (Krieger et al., 2015, Wohland et al., 2010):
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G(τ) =VeffN
1√
piwza2
1√
1 + 4Dτw2z
√
4Dτ+ w2xy√
pia
(
exp(– a
2
4Dτ+ w2xy
) – 1
)
+ erf
 a√
4Dτ+ w2xy
2
(2.22)
in which a is the pixel size on the camera, wxy the lateral waist of the PSF, and
wz the longitudinal waist of the PSF. The lateral waist wxy was set to 1.1 μm (i.e.
extends over ∼3 pixels) as determined earlier in the lab of Thorsten Wohland, the
longitudinal waist was calculated from the light sheet thickness, taking into account
the NA (NA=1.0) of the detection objective and used wavelength λ:
wz =
thickness · NA
λ
. (2.23)
Eventually, pCF analysis was performed to analyse molecule dynamics in space, here,
from cytoplasm to nucleus over the nuclear envelope and vice versa. A region of
three pixels spanning the nuclear envelope was excluded from pCF analysis to avoid
spatial cross-talk that would lead to a false positive correlation. Then, pCF analysis
was performed over a total distance of up to 7 pixels (2.8 μm in the sample) for all
possible pixel combinations and distances in 2-D, and all corresponding distances
averaged for all image frames of the same sample type. The mathematical expression
for the performed pCF analysis can be found in Cardarelli and Gratton (2010). The
analytical model that was fitted to the data is as follows:
G(τ,~d) = VeffN
1
2
√
pia2wz
1√
1 + 4Dτw2z∏
i=x,y
1
a
(a + di)erf( a + di√
4Dτ+ w2xy
) + 2dierf(–
di√
4Dτ+ w2xy
) + (a – di)erf(
a – di√
4Dτ+ w2xy
)

+
√
4Dτ+ w2xy√
pi
[
exp(– (a + di)
2
4Dτ+ w2xy
) – 2exp(– d
2
i
4Dτ+ w2xy
) + exp(– (a – di)
2
4Dτ+ w2xy
)
]
(2.24)
using a Veff calculated as follows:
Veff =
√
pia2wz[
erf( awxy ) +
wxy√
pia
(
exp(–( awxy )
2) – 1
)]2 (2.25)
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in which ~d = (0, dx, dy) is the lateral distance between pixels, a is the pixel size on
the camera, wxy the lateral, and wz the longitudinal waist of the PSF.
An example of a pCF analysis and resulting pCF is illustrated in Fig. 2.3. However, no
analytical model describing the transport across the nuclear envelope exists, therefore
relative peak positions of pCFs were compared to gain excess to the transport
mechanism of proteins across the nuclear envelope.
Correlation time (s)
a b c
Correlation time (s) Correlation time (s)
Figure 2.3: Pair correlation function (pCF) analysis (image adapted from Dig-
man and Gratton (2009)). a) pCF analysis results for a simulation assuming 500 freely
diffusion particles with a diffusion coefficient D=1.0 μm2s–1. pCF analysis was performed
for different pixel distanced as indicated in brackets. For very narrow distances function
shape is very similar to that of an ACF. The larger the distance, the more uncorrelated are
fluctuations at two spatially separated pixels on the short time scale (here: ms), thus the
amplitude converges to zero. However, since the particle moves in space the fluctuations at
two spatially separated pixels on the long time scale (here: s) will be correlated as it is
more likely to observe the same particle again. Hence, a peak is observed. b) pCF analysis
of beads measured in solution. pCF were calculated at distances ranging from 1 to 6 pixels.
c) pCF analysis for a simulation of particles possessing different diffusion coefficients D.
Analysis was performed for a spatial distance of 10 pixels. The peak of pCF(10) moves
towards longer correlation times as D decreases.
2.2.8.4 Fluorescence lifetime imaging microscopy
Fluorescence lifetime imaging microscopy (FLIM) measurements were performed on
an Olympus Fluoview FV-1000 inverted laser scanning microscope, equipped with
a time-resolved PicoQuant fluorescence lifetime setup. EGFP was excited with a
pulsed-laser diode at 488 nm and images of 512x512 pixels per frame were acquired.
Emission was detected using a SPAD detector after passing through a 520/35 nm
bandpass filter. A minimum of 105 photons was recorded by accumulation of 60 frames
over a time period of 90 s. Then, regions of interest in the cytoplasm of cells were
manually selected and analysed using SymPhoTime64 software. Resulting lifetime
decay curves were fitted using a software implemented mono-exponential function,
taking into account the instrument response function determined by measuring a
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saturated Erythrosine B solution according to manufacturer’s instructions. Finally,
FRET efficiency EFRET was calculated based on the obtained fluorescence lifetime f
as follows:
EFRET = 1 –
fn–mer
fmonomer
(2.26)
2.2.9 Statistical analyses
All data were analysed using self-written R scripts in RStudio and GraphPad
Prism. Statistical tests used to verify statistically significant differences are indicated
individually for each result. Sample sizes and p-values are given in figure captions.
For molecular brightness measurements, corrected brightness values were used to
test for significance. Plotted data are usually depicted as mean±SD unless specified
otherwise. All data displayed as box plots indicate the median values and whiskers
ranging from minimum (min.) to maximum (max.) values. Quantities in the main
text are given as mean±SEM.
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3 Results
In this study, the stoichiometry of viral nuclear export complexes bound to vRNPs,
and the intermolecular interactions between viral nuclear export complexes and
components of progeny vRNPs was investigated in vitro and in situ. For the modular
organization of the IAV nuclear export complex a ’daisy-chain model’ has been
proposed in which progeny vRNPs are connected to the cellular export factor CRM1
through an M1-NEP-scaffold (Boulo et al., 2007). However, recent data suggest a
more sophisticated model, in which the regulatory influence of NEP on the viral RdRP
activity by direct binding to PB1 and PB2 is taken into account (Brunotte et al.,
2014). Thus, neither the exact protein interactions of the nuclear export complex are
known, nor the stoichiometry of nuclear export complexes bound to progeny vRNPs.
Powerful tools allowing for the quantification of molecular interactions directly in
the native cellular environment encompass FCS, FCCS, and molecular brightness
analysis. Herein, signal fluctuations emitted by fluorescent proteins genetically fused
to a protein of interest are statistically analysed. Thus, information about molecule
dynamics, concentration and interactions can be extracted by analysing the temporal
evolution and magnitude of the signal, respectively.
First, limitations of the used microscope instrumentation and fluorescent protein
pairs were characterized to ensure precise quantification of interactions applying FCS
and FCCS. Second, optimal fluorescent protein tags with high apparent fluorescence
probability were identified to ensure exact quantification of protein oligomerization
using molecular brightness analysis. Eventually, fluorescence fluctuation spectroscopy
was applied to quantify the binding stoichiometry of M1 with vRNPs. Therefore,
recombinant expression of M1 and labelling with organic dyes was optimized. Ad-
ditionally, extraction of essentially M1-free vRNPs from either A/WSN virions or
transiently transfected cells was optimized and validated to finally perform FCCS
measurements to probe the interaction stoichiometry of M1 on vRNPs. Further, the
regulation of NEP’s subcellular translocation mechanism was investigated in situ. To
this aim, the localization-dependent oligomerization of NEP wt and several mutants
was analysed, and these information combined with their respective localization
phenotypes.
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3.1 Instrument characterization and optimization for
fluorescence cross-correlation spectroscopy
In FCCS measurements the fraction of complexed molecules is reported, and thus
allows quantification of interaction stoichiometries. Hence, this method is suitable
to approximate the number of nuclear export complexes bound to vRNPs, and
further to investigate interactions between nuclear export complex components and
vRNPs. In FCCS measurements the fraction of complexed molecules is calculated
by determining the amplitude ratios of the CCF and ACFs. In the simplest model,
assuming a 1:1 stoichiometry, these ratios can very between ’0’ (no binding) and ’1’
(complete binding). Nevertheless, several factors affect the correlation amplitudes
and therefore minimize the expected amplitude ratios. As a consequence, reported
maximum cross-correlation values are usually as low as 0.5 (Foo et al., 2012). Factors
affecting the correlation amplitudes include limitations of the used fluorescent proteins,
and the instrumentation itself. In detail, background fluorescence, photophysical
effects or inefficient maturation leading to dark fluorophores, cross-talk, FRET,
and misalignment of the observation volumes influence the obtained amplitude
ratios. Therefore, both FCCS and FCS, depend on careful instrument alignment and
characterization, which will be addressed in the following sections. Measurements
were routinely performed using two monomeric fluorescent proteins, mEGFP and
mCherry2. Their excitation and emission spectra, and the used filter settings to
properly separate both spectra are depicted in Fig. 3.1.
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Figure 3.1: Instrument setup to perform FCS and FCCS measurements using
the monomeric fluorescent proteins mEGFP and mCherry2. mEGFP is excited
at 488 nm using an argon laser, mCherry2 is excited at 559 nm using a diode laser, even
though its excitation maximum is at 587 nm. Emitted photons were spectrally separated
using a dichroic mirror at 570 nm. Emission of mEGFP (max: 509 nm) was then collected
with a narrow filter ranging from 502.5 to 537.5 nm. Photons emitted by mCherry2 were
collected from 635 nm upwards to reduce cross-talk from the green channel (max: 601 nm).
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3.1.1 Evaluation of instrument parameters to achieve maximum
brightness and cross-correlation
3.1.1.1 Coverglass thickness correction
In general, in an inverse microscope setup, foci of the excitation and detection
path of each channel coincide for precise auto-correlation. However, when high NA
immersion-objectives are used with coverglasses, aberrations caused by differences of
the refractive indices (coverglass verses water-immersion) can lead to observation
volume distortion and displacement in z-direction. The standard glass-bottom dish
used for all measurements in this study possesses a thickness of 170±5 μm with a
refractive index n=1.5230, and was used in combination with a water-immersion
objective (H2O refractive index n=1.333). The objective correction collar ring is
adjusted to correct for aberrations through adjustment of a central lens group
within the objective to coincide with the coverglass thickness and thereby correct
for observation volume displacement. In principle, observation volume alignment in
z-direction through correction collar ring adjustment can only be analysed presciently
by performing a z-scan using a hetero-dimeric fluorescent protein restricted in a 2-D
environment (Bacia and Schwille, 2007). However, in this study optimal ring position
was analysed by measuring mEGFP-mCherry2 hetero-dimers in the cytoplasm of
A549 cells. Since these hetero-dimers are not restricted in a defined 2-D environment,
detection volume overlap through variation of the z-position can not be analysed.
Instead, compensation for aberrations due to coverglass thickness was analysed by
determining the ring position leading to highest molecular brightness ε and SNR for
both fluorescent proteins, and in parallel resulting in maximum cross-correlation. In
all cases, parameters of interest, shown in Fig. 3.2 on the following page, are plotted
against correction collar ring position for coverglass thicknesses theoretically ranging
from 150 μm to 190 μm in 10 μm steps. For simplification, collar ring position at the
objective and the theoretical coverglass thickness they would compensate for are
termed equally.
For both fluorescent proteins of the hetero-dimer, molecular brightness increased with
ring position change from 150 to 170. At this collar ring position, optimal for coverglass
with a thickness of 170 μm, molecular brightness for both fluorescent proteins was
maximal: εmEGFP=0.85±0.12 kHz, εmCherry2=0.45±0.04 kHz. When the central lens
group was further adjusted, a drastic decrease in molecular brightness was observed,
εmEGFP,190=0.32±0.02 kHz, εmCherry2,190=0.21±0.03 kHz, respectively. Consistent
with the collar ring position at which maximal molecular brightness is achieved,
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highest SNR for all correlation functions was observed (SNRmEGFP=3.26±0.09,
mCherry2 SNRmCherry2=1.64±0.07, SNRCC=1.18±0.10). This effect was strongest
for mEGFP: 1.7-fold increase compared to the lowest SNR at compensation position
190 (SNRmEGFP,190=1.95±0.12). For mCherry2 and the cross-correlation, SNRs
increase about 1.3-fold and 1.31-fold, respectively.
Finally, the maximum cross-correlation that can be achieved with different collar
ring positions was determined. The observed cross-correlation slightly increased from
55±7% at position 150 to 65±6% at position 170. Afterwards no further increase of
the cross-correlation was observed. Based on these results, collar ring position was
kept at position 170 for all measurements.
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Figure 3.2: Correction collar ring adjustment to correct for differences in re-
fractive indices, and its influence on molecular brightness and cross-correlation.
A549 cells were transiently transfected with mEGFP-mCherry2 hetero-dimer expression
plasmid. Fluorophores were excited at 488 nm and 559 nm using relative laser powers of
0.5%, respectively. Pinhole diameter size was fixed to 90 μm. Correction collar ring positions
equal the coverglass thicknesses they compensate for: 150 μm, 160 μm, 170 μm, 180 μm, and
190 μm. a) Molecular brightness of mEGFP (green) and mCherry2 (orange) for each ring
position. b) Box plots of SNRs calculated for both ACFs of mEGFP (green) and mCherry2
(orange), and the CCF (purple) for each ring position. c) Cross-correlation for each ring
position was obtained by calculating the amplitude ratios of the ACFs and CCF. Data were
pooled from two independent experiments, each encompassing 6 individual cells (n=12).
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3.1.1.2 Determination of the optimal pinhole diameter size
In confocal microscopy, a detection pinhole is placed in front of the detection element
to remove any extra non-focal emission, thus restricting the signal detection to the
focal plane and increasing the resolution in z-, but not x-y-direction. In FCS and
FCCS the choice of pinhole diameter is a trade-off between fit accuracy and SNR.
Therefore, to find optimal pinhole diameter settings, different diameters ranging
from 50 μm to 300 μm were tested and evaluated for their influence on molecular
brightness ε, SNR and cross-correlation as shown in Fig. 3.3.
A549 cells were transiently transfected with an expression plasmid encoding for
mEGFP-mCherry2 hetero-dimers. For both fluorescent proteins, molecular brightness
first strongly increased with increasing pinhole diameter until reaching maximum val-
ues for a diameter of 120 μm: εmEGFP=1.20±0.07 kHz, and εmCherry2=0.76±0.09 kHz.
Afterwards, with further increasing pinhole diameter, a slight decrease in brightness
was observed.
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Figure 3.3: Influence of pinhole diameter on molecular brightness and cross-
correlation. A549 cells were transiently transfected with mEGFP-mCherry2 hetero-dimer
expression plasmid. Fluorophores were excited at 488 nm and 559 nm using relative laser
powers of 0.5%. Collar ring position was fixed to 170. Several pinhole diameters were tested:
50, 70, 80, 90, 100, 120, 150, 200, and 300 μm. a) Molecular brightness for mEGFP (green)
and mCherry2 (orange) was determined for each pinhole diameter. b) Box plots of SNR
calculated for both ACFs of mEGFP (green) and mCherry2 (orange), as well as the CCF
(purple). c) Cross-correlations were obtained by calculating the amplitude ratios of the
ACFs and CCF. Data were pooled from two independent experiments, each encompassing
6 individual cells (n=12).
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Similar trends were observed when analysing the SNRs of correlation functions for dif-
ferent pinhole diameter settings. Consistent with observations for the molecular bright-
ness, an amplitude was reached at a pinhole diameter of 120 μm: SNRmEGFP=4.9±0.3,
SNRmCherry2=3.0±0.2, SNRCC=1.8±0.2. Finally, cross-correlation values were found
to be quite constant over a wide range of pinhole diameters, fluctuating around 45%.
However, even though not statically significant, the highest cross-correlation was
observed for a pinhole diameter of 90 μm: 56±4%.
3.1.1.3 Determination of optimal laser power settings
Next, optimal laser power settings were assessed. Laser power should be as high
as possible to obtain maximum molecular brightness ε and with that SNR, but
low enough to prevent strong photobleaching and excitation saturation. Therefore,
linearity of molecular brightness increase and consistency of ACF parameters (am-
plitude, i.e. molecule number N, and relaxation time τd) in dependence of relative
laser powers ranging from 0.2% to 1% were investigated for mEGFP-mCherry2
hetero-dimers. Different laser power settings were measured within the same cell,
always using equal relative laser power settings for both laser lines. Important to
highlight here, absolute laser powers are not the same for both laser lines; a relative
laser power of 0.5% for the argon laser corresponds to ∼3.3 μW (488 nm, excitation
of mEGFP), whereas for the diode laser it corresponds to ∼6 μW (559 nm, excitation
of mCherry2). However, due to simplification, all relevant parameters were plotted
against relative laser power values only. Results of all measurements are depicted in
Fig. 3.4.
For the laser power range examined in this study, mEGFP brightness increased lin-
early with laser power (εmEGFP,0.5%=0.74±0.06 kHz, εmEGFP,1%=1.63±0.17 kHz),
whereas mCherry2 asymptotically reached a threshold value of ∼0.55±0.06 kHz using
higher relative laser powers than 0.5% (ε0.2%=0.21 kHz, ε0.4%=0.38 kHz). Further-
more, almost no bleaching was observed for mEGFP, whereas bleaching fraction of
mCherry2 first increased proportional with laser power and then reached a threshold
value of around 25% with higher excitation powers (see Fig. 3.4a). As depicted in
Fig. 3.4b and c, diffusion times τd and number of molecules N extracted from ACF
were quite constant for the whole tested relative laser power range. Nevertheless,
resulting values for mCherry2 were generally lower than for mEGFP. For mEGFP
τd values alternated around 0.75ms, N values around 110 molecules on average,
for mCherry2 τd values alternated around 0.6ms, N values around 70 molecules
on average. Consistent with molecular brightness data, SNRs for mEGFP linearly
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increased with laser power increase, whereas SNRs of mCherry2, and CCFs only
slightly increased with higher laser power. Interestingly, as shown in Fig. 3.4e, cross-
correlation values were constant only over a very narrow laser power range from
0.4% to 0.6% (CC≈50%). A maximum cross-correlation of 64±5% was observed
for 0.2% relative laser power, a minimal cross-correlation of around 37±2% at 1%
relative laser power.
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Figure 3.4: Influence of laser power on molecular brightness, molecule dy-
namics and cross-correlation. A549 cells were transiently transfected with mEGFP-
mCherry2 hetero-dimer expression plasmid. Fluorophores were excited at 488 nm and
559 nm using a variety of relative laser powers ranging from 0.2% to 1% for argon and
diode lasers, respectively. Collar ring position was fixed to 170, pinhole diameter to 90 μm.
a) Molecular brightness for mEGFP (green) and mCherry2 (orange) was determined for
each laser power. Additionally, the bleaching fraction of mCherry2 was plotted (black).
b) Diffusion times τd and c) number of molecules in dependence of relative laser powers
were plotted for mEGFP (green) and mCherry2 (orange). d) Box plots of SNRs calculated
for both ACFs of mEGFP (green) and mCherry2 (orange), as well as the CCF (purple)
for each relative laser power. e) Cross-correlation values were obtained by calculating
the amplitude ratios of the ACFs and CCF. Data were pooled from two independent
experiments, each encompassing 6 individual cells (n=12).
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3.1.2 Evaluation of cross-correlation artefacts
After assessing measurement parameters (i.e. correction collar ring position 170,
pinhole diameter 90 μm, 0.5% relative laser power for argon and diode lasers), the
contribution of cross-correlation artefacts in the used setup were examined. Three
important parameters, cross-talk, FRET, and a lack of observation volume overlap
can direct towards cross-correlation artefacts. Whereas positive cross-correlation
artefacts, i.e. a false positive increase of CCF amplitudes, arise from cross-talk,
FRET and observation volume displacement direct towards negative cross-correlation
artefacts, i.e. CCF amplitudes decrease (Bacia and Schwille, 2007, Foo et al., 2012).
3.1.2.1 Evaluation of cross-talk and FRET
The contribution of cross-talk and FRET was accessed using the fluorescent proteins
mEGFP and mCherry2, as shown in Fig. 3.5. First, for precise evaluation of any
cross-correlation artefact, detector dark counts and background fluorescence of A549
cells were determined (see Fig. 3.5a). Dark counts for both SPAD detectors under
standard FCCS measurement conditions were in the very low Hz range. Of note, dark
counts were two-times higher in the red than in the green detection channel. Next,
background fluorescence of non-transfected A549 cells was measured and the obtained
intensities corrected for the dark count contribution. Background intensity I of A549
cells in the green channel (i.e. mEGFP detection channel) was higher than in the red
channel (i.e. mCherry2): IG=2.5±0.3 kHz, IR=1.1±0.2 kHz. For comparison, in an
actual FCCS measurement in A549 cells expressing both, mEGFP and mCherry2,
intensity values range from 30 to 150 kHz (average molecule number: 30 to 200) and
20 to 85 kHz (average molecule number: 35 to 150), respectively.
Second, unidirectional cross-talk of mEGFP into the red detection channel was
evaluated, taking dark counts and background fluorescence into account. Therefore,
A549 cells expressing only mEGFP were analysed, and signals were detected in
the red and green detection channels. Cross-talk was calculated by determining the
intensity ratio of the red channel to the overall signal, since both signals originated
from the same excited mEGFP molecules only. The resulting median cross-talk was
as low as 0.13% (mean cross-talk: 1.1±0.5%).
Third, FRET was evaluated by performing FCCS measurements in A549 cells
expressing mEGFP-mCherry2 hetero-dimers albeit exciting mEGFP only. Then,
signal intensities obtained in both channels were corrected for background fluorescence
78
Results
and cross-talk, before quantifying ratiometric FRET efficiency. This way, an average
FRET efficiency of 6.4±0.5% was calculated.
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Figure 3.5: Evaluation of cross-correlation artefacts due to cross-talk or FRET
considering detector dark counts and background fluorescence of A549 cells.
Fluorophores were excited at 488 nm and 559 nm using relative laser powers of 0.5%
for argon and diode lasers, respectively. Collar ring position was fixed to 170, pinhole
diameter to 90 μm. a) Detector dark counts for the green (mEGFP) and red (mCherry2)
channels were detected in 6 and 5 measurements, using empty MatTek glass bottom dishes.
Background fluorescence of non-transfected A549 cells was determined in both, green
(mEGFP) and red (mCherry2) channels, for 9 individual cells each. b) Cross-talk was
determined using mEGFP expressing A549 cells. Cross-talk of mEGFP (green) to the red
detection channel was quantified by calculating the red to overall signal ratio, taking into
account dark counts and background fluorescence. c) FRET efficiency was determined in
A549 cells expressing mEGFP-mCherry2 hetero-dimers. Only mEGFP was excited, but
photons were detected in mEGFP and mCherry2 detection channels. FRET efficiency was
determined by calculating the red to overall signal ratio, taking into account background
fluorescence and cross-talk.
3.1.2.2 Evaluation of single-wavelength FCCS
In FCCS measurements two spectrally different fluorescent species are usually ex-
cited using two laser lines optimal for the respective excitation maximum. The thus
obtained two observation volumes vary slightly in dimensions based on the used
wavelengths, and additionally can be displaced in 3-D, thereby potentially reducing
cross-correlation amplitudes (Weidemann et al., 2002). Hence, a lack of observa-
tion volume overlap in two-wavelength excitation can direct towards false negative
cross-correlation artefacts, i.e. resulting amplitudes of CCFs are lower then expected.
Alternatively a single excitation laser line can be used, leading to a single observation
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volume only (Foo et al., 2012). This approach was tested using mEGFP and mCherry2
expressed in A549 cells. To compromise for their difference in excitation maxima
and instrument limitations, both dyes were excited using a single laser excitation
wavelength of 515 nm. Due to the suboptimal configuration in single-wavelength
excitation (compare settings to spectra in Fig. 3.1), careful system validation is
necessary, especially to avoid cross-correlation artefacts.
First, A549 cells expressing only mEGFP were used to assess unidirectional cross-talk
of the green signal into the red detection channel. Cross-talk was calculated by deter-
mining the red to overall signal ratio. In single-wavelength excitation cross-talk was
significantly higher than in two-wavelength excitation. In two-wavelength excitation
an average cross-talk of only 1.1±0.5% was observed, whereas in single-wavelength
cross-talk increased up to 17.8±0.8% (see Fig. 3.6b). Next, cross-correlation artefacts,
potentially arising from spectral cross-talk, were determined in A549 cells simul-
taneously expressing mEGFP and mCherry2 in form of single fluorescent proteins
instead of a hetero-dimeric variant. Compared to standard two-wavelength excitation,
a two-times higher false positive cross-correlation was observed.
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Figure 3.6: Validation of spectral cross-talk and resulting cross-correlation arte-
facts in single-wavelength FCCS. For single-wavelength FCCS, mEGFP and mCherry2,
expressed in A549 cells, were excited with a relative laser power of 0.6% using a single
laser line at 515 nm. Emission was detected using 536/40 nm (mEGFP) and 595/50 nm
(mCherry2) bandpass filters. Pinhole diameter was fixed to 90 μm, collar ring position
to 170. Observation volume parameters were calibrated using an aqueous rhodamine 6G
(R6G) solution measured under the same conditions (Emission max: 560 nm). Results
were compared to standard two-wavelength excitation. a) Cross-talk of mEGFP (green)
into the red detection channel was assessed by calculating the ratio of the red to the
overall signal. b) False positive cross-correlation was evaluated by measuring mEGFP and
mCherry2 simultaneously expressed in A549 cells. Cross-correlation values were obtained
by calculating the amplitude ratios of the ACFs and CCF. Data were pooled from two
independent experiments. **** and * indicates significance with p<0.0001 and p<0.01,
respectively, obtained by using an unpaired two-tailed t-test with Welch’s correction.
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Even though high cross-talk was observed, single-wavelength excitation for mEGFP-
mCherry2 hetero-dimer constructs expressed in A549 cells was validated for FCCS
relevant parameters as illustrated in Fig. 3.7: molecular brightness ε, SNR of corre-
lation curves, and cross-correlation. In all cases, results were directly compared to
standard two-wavelength excitation measurements.
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Figure 3.7: Validation of single-wavelength FCCS using mEGFP-mCherry2
hetero-dimers. For single-wavelength FCCS, mEGFP-mCherry2 hetero-dimers were
excited with a relative laser power of 0.6% using a single laser line at 515 nm. Emission
was detected using 536/40 nm (mEGFP) and 595/50 nm (mCherry2) bandpass filters.
Pinhole diameter was fixed to 90 μm, collar ring position to 170. Observation volume
parameters were calibrated using an aqueous rhodamine 6G (R6G) solution measured
under the same conditions (Emission max: 560 nm). All results were compared to standard
two-wavelength excitation. a) Box plots of molecular brightness for mEGFP (green) and
mCherry2 (orange). b) Box plots of SNRs calculated for both ACFs of mEGFP (green) and
mCherry2 (orange), as well as the CCF (purple). c) Cross-correlations were obtained by
calculating the amplitude ratios of ACFs and CCF. d) Representative correlation functions
and fit curves (solid lines): green, ACF of mEGFP; orange, ACF of mCherry2; purple, CCF
calculated for both spectral channels. Fit curves were obtained from fitting a 3-D anomalous
diffusion model to the data. Data were pooled from two independent experiments, each
encompassing 5 individual cells (n=10) for single-wavelength excitation experiments, and 8
individual cells (n=16) for standard two-wavelength excitation. ** indicates significance
with p<0.001, using non-parametric Mann-Whitney test, ns indicates no significance.
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In suboptimal single-wavelength excitation effective molecular brightness was gener-
ally low, and almost identical for both fluorescent proteins (εmEGFP=0.24±0.02 kHz,
εmCherry2=0.25±0.03 kHz), whereas higher signals and strong differences were ob-
served for two-wavelength excitation (εmEGFP≈0.75 kHz, εmCherry2≈0.40 kHz). Fur-
thermore, SNRs for both ACFs and the CCF were lower than in two-wavelength
excitation. This effect is less pronounced for mCherry2 even though variations were
higher than for two-wavelength excitation, thus potentially leading to more inaccurate
fits. Indeed, data seemed to be more noisy for single-wavelength excitation than for
two-wavelength excitation (compare Fig. 3.7d and Fig. 3.8b). Consistent with these
observations, obtained cross-correlation values varied stronger in single-wavelength
excitation than two-wavelength excitation, resulting in an average cross-correlation
of only 62±6%, that was lower than in two-wavelength excitation (∼65±6%).
3.1.3 Performance comparison of mCherry and mCherry2 in
FCCS measurements
The most commonly used fluorescent protein pair in FCCS measurements is mEGFP
and mCherry. Therefore, after accessing suitable measurement parameters and cross-
correlation artefacts, mEGFP-mCherry and mEGFP-mCherry2 hetero-dimers were
compared for their performance in FCCS. For this purpose, mEGFP-mCherry or
mEGFP-mCherry2 hetero-dimers were analysed for their maximum cross-correlation,
green to red ACF amplitude ratios, and SNRs. Resulting correlation functions of both
hetero-dimer measurements are exemplarily depicted in Fig. 3.8a and b, respectively.
Fit curves (solid lines) were obtained from fitting a 3-D anomalous diffusion model
to the data. For mEGFP-mCherry hetero-dimers, ACF amplitudes for mEGFP
and mCherry did not overlap, resulting in different average molecule number. The
obtained cross-correlation in this example was 30%. In contrast, ACF amplitudes
for mEGFP and mCherry2 in the corresponding hetero-dimer almost completely
overlapped. The obtained cross-correlation for this measurement was 37.5%. These
differences were additionally highlighted when calculating the ACF amplitude ratios
for mEGFP (G) and mCherry/mCherry2 (R) (ACFG/ACFR ratio). The amplitude
ratio for mEGFP-mCherry2 (0.97±0.05) was significantly higher than for mEGFP-
mCherry (0.65±0.03). Interestingly, although these differences did not result in
variations of the median cross-correlation (see Fig. 3.8c), the SNR of the measured
CCFs was 40% higher for mCherry2-mEGFP (SNRmCherry-mEGFP=1.38±0.10) than
for mCherry-mEGFP (SNRmCherry2-mEGFP=1.93±0.10).
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Figure 3.8: Performance comparison of mEGFP-mCherry and mEGFP-
mCherry2 hetero-dimers in FCCS application (adapted from Dunsing, Luckner
et al. (2018)). Representative correlation functions and fit curves (solid line) are shown
for a) mCherry-mEGFP and b) mCherry2-mEGFP hetero-dimers transiently expressed
in A549 cells: green, ACF of mEGFP; orange, ACF in red channel (mCherry/mCherry2);
purple, CCF calculated for both spectral channels. Fit curves were obtained from fitting a
3-D anomalous diffusion model to the data. c) Box plots of cross-correlations measured
for mCherry-mEGFP and mCherry2-mEGFP hetero-dimers and mCherry/mCherry2 and
mEGFP co-expressed in A549 cells. Cross-correlation was obtained by calculating the
amplitude ratio of the ACFs and CCF. d) Box plots of amplitude ratios of the green to red
ACFs for both hetero-dimers. e) Box plots of SNRs of the CCFs for both hetero-dimers.
Presented data were obtained from three independent experiments, n=35 cells (mCherry-
mEGFP) and n=32 cells (mCherry2-mEGFP). **** and *** indicate significance with
p<0.0001 and p=0.0003, respectively, obtained by applying an unpaired two-tailed t-test
with Welch’s correction.
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3.2 Optimization of molecular brightness analysis in
one-photon excitation
Fluorescence fluctuation spectroscopy approaches such as FCCS aid to quantify
the interaction stoichiometry of two differently labelled proteins. In contrast, the
quantification of protein oligomerization is more easily assessed by performing
molecular brightness analysis. To probe the oligomerization of a protein directly
in living cells, it is genetically fused to a fluorescent protein. From the number
of fluorescent protein units the oligomeric state of a protein can be determined.
Hence, it is assumed that each fluorescent protein actually emits a fluorescence signal.
Certainly, in the following section, the contribution of non-fluorescent states of several
fluorescent proteins and its dependency on the used fluctuation spectroscopy method,
cellular localization and environmental condition will be characterized. Finally, a
two-state model (see Method section 2.2.8.2) will be used, allowing for unbiased and
accurate quantification of protein oligomerization. All results described in this section
were recently published as a shared-first authorship manuscript: Dunsing, Luckner et
al. (2018). Scanning FCS (sFCS) and N&B analysis shown in this section were usually
performed in HEK 293T cells by M.Sc. Valentin Dunsing, unless specified otherwise.
Point FCS (pFCS) measurements were performed by M.Sc. Madlen Luckner, usually
using HEK 293T and A549 cells. Nevertheless, in this publication we could show,
that the herein described effects in molecular brightness analysis are independent of
the used cell lines (see Fig. 4.3 in Appendix).
3.2.1 Influence of fluctuation spectroscopy methods, cellular
localization, and temperature on molecular brightness
In an ideal case, i.e. if all fluorescent protein subunits of an oligomer were fluorescent,
a homo-dimer would emit twice as many photons as a monomer. To test, whether this
correlation holds true in experimental conditions, HEK 293T cells were transiently
transfected with plasmids either expressing mEGFP monomers (1xmEGFP) or homo-
dimers (2xmEGFP). Molecular brightness values were determined in dependence
of the subcellular localization, using different fluorescence fluctuation spectroscopy
methods. In all cases, values were normalized using the respective monomer median
value. Results for mEGFP measurements are shown in Fig. 3.9a. First, two methods,
pFCS and N&B analysis, were compared by analysing normalized molecular bright-
ness of 2xmEGFP in the cytoplasm of cells. Both methods led to similar results:
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εpFCS=1.59±0.04, εN&B=1.69±0.05. Second, the influence of subcellular localiza-
tions was investigated. Therefore, molecular brightness of 2xmEGFP located in the
nucleus was determined using N&B, and normalized values compared to measure-
ments performed in the cytoplasm. Results were very similar for both compartments.
Third, molecular brightness of 2xmEGFP localizing to the plasma membrane was
determined using sFCS. Here again, normalized homo-dimer brightness values were
comparable to all other measurements: ε2xmEGFP, sFCS=1.69±0.05.
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Figure 3.9: Influence of fluorescence fluctuation spectroscopy methods, sub-
cellular localization, and environmental conditions on the molecular brightness
of monomers and homo-dimers (adapted from Dunsing, Luckner et al. (2018)).
In all cases HEK 293T cells were transfected with indicated monomer (1x) or homo-dimer
(2x) expression plasmids, and brightness values normalized to the median brightness of
the respective monomer. a) Normalized brightness values were obtained by performing
either pFCS or N&B in the cytoplasm, N&B in the nucleus, or sFCS perpendicular to
the plasma membrane of cells. For membrane measurements myristoylated-palmitoylated
(mp) monomer and homo-dimers were used. Presented data were pooled from two to
three independent experiments. pFCS/N&B, cytoplasm: 1x: n=39/47 cells, 2x: n=38/48
cells; N&B, nucleus: 1x: n=47 cells, 2x: n=48 cells; sFCS, membrane: n=55 cells each.
b) N&B measurements were performed in the cytoplasm (cyto) and nucleus (nuc), and the
brightness ratio between both compartments was calculated (n=37 cells). c) and d) Box
plots of pFCS measurements performed at 23 ◦C (white boxes) or 37 ◦C (grey boxes) for
monomer and homo-dimers of mEGFP (1x/2x 23 ◦C: n=39/38 cells, 1x/2x 37 ◦C: n=64/63
cells) and mCherry2 (1x/2x 23 ◦C: n=18/20 cells, 1x/2x 37 ◦C: n=34/33 cells).
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Interestingly, as shown in Fig. 3.9b, a 10% lower brightness for 1xmEGFP was
observed within the nucleus compared to the cytoplasmic fraction. In summary,
normalized molecular brightness values for mEGFP homo-dimers were constantly
lower than two, independent of the used method or subcellular localization.
One reason for the observed discrepancy between theoretical expectation and experi-
mental evidence could be the maturation time of fluorescent proteins. Insufficient
maturation might lead to a certain fraction of non-fluorescent proteins and with that
to a decreases of homo-dimer brightness. The maturation time of fluorescent proteins
can depend on the temperature at which experiments are performed (Balleza et al.,
2017). Therefore, the homo-dimer brightness of two fluorescent proteins mainly used in
this study, mEGFP and mCherry2, was investigated under two different temperature
conditions: 23 ◦C and 37 ◦C. As shown in Fig. 3.9c and d, for both fluorescent proteins
only a slight increase in normalized homo-dimer brightness was observed for measure-
ments performed at 37 ◦C: ε2xmEGFP,23 ◦C=1.59±0.04, ε2xmEGFP,37 ◦C=1.69±0.04
and ε2xmCherry2,23 ◦C=1.56±0.07, ε2xmCherry2,37 ◦C=1.68±0.05.
3.2.2 Determination of the oligomeric state of proteins taking
into account apparent fluorescence probabilities
In the previous section it was shown that normalized molecular brightness values
for mEGFP and mCherry2 homo-dimers were constantly lower than two. Therefore,
it was investigated whether it is nevertheless possible to correctly determine the
oligomeric state of higher-order oligomers. For that reason, mEGFP homo-oligomers of
different sizes, i.e. monomers to homo-tetramers (1xmEGFP, 2xmEGFP, 3xmEGFP,
4xmEGFP), were expressed in A549 cells and pFCS measurements were performed
in the cytoplasm. Their subcellular localization is exemplarily shown in Fig. 3.10a.
Whereas mEGFP monomers and homo-dimers were homogeneously distributed
throughout the cytoplasm and nucleus, homo-trimers and -tetramers were more
prominently present in the cytoplasm, showing stronger exclusion from the nucleus.
Similar to previous observations, lower than expected normalized brightness values
were observed for all homo-oligomers (Fig. 3.10b, white boxes). Hence, a molecular
brightness correction was performed based on a two-state model (see Methods section
2.2.8.2). In this model the probability pf that each fluorescent protein subunit of
an oligomer emits a fluorescence signal is taken into account. This probability is
extracted from the normalized median brightness value of 2xmEGFP, which was
ε2xmEGFP=1.65±0.05 in the shown example. Using Eqn. 2.18 and Eqn. 2.19 the
apparent fluorescence probability for this example was determined to be pf=0.65.
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All obtained brightness values for the shown homo-oligomers were corrected with
this fluorescence probability using Eqn. 2.20. As a result, the oligomeric states of
all mEGFP-homo-oligomers were correctly determined as shown in Fig. 3.10b, grey
boxes.
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Figure 3.10: Determination of the precise oligomeric state of mEGFP homo-
oligomers (adapted from Dunsing, Luckner et al. (2018)). a) Representative inten-
sity images of A549 cells expressing mEGFP monomers (1x), homo-dimers (2x), -trimers
(3x) and -tetramers (4x), from left to right. Yellow crosses indicate positions of the pFCS
scan point. Scale bars are 5 μm. b) Box plots represent data obtained from at least three
independent experiments (1x/2x/3x/4x: n=52/42/43/59 cells) before correction (white
boxes), and after correction (grey boxes) of the molecular brightness. First, a normalization
of the uncorrected brightness data was performed using the median brightness value of
1xmEGFP. Second, a correction was performed as described in the Methods section, using a
fluorescence probability pf=0.65, as obtained from 2xmEGFP measurements. c) Normalized
average ACFs, d) diffusion times τd, and e) diffusion anomaly parameter α obtained from
the measurements described in b).
Diffusion dynamics that can be extracted from ACFs of pFCS measurements, for
all mEGFP homo-oligomers, are depicted in Fig. 3.10c and d. Fig. 3.10c shows the
normalized correlation functions in dependence of τ. In dependence of the homo-
oligomer size (1xmEGFP: 27 kDa, 2xmEGFP: 54 kDa, 3xmEGFP: 81 kDa, 4xmEGFP:
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108 kDa) the normalized ACFs shifted towards slower diffusion times. This increase
in diffusion times is further illustrated in Fig. 3.10d. Moreover, the introduction of
an anomaly parameter α into the 3-D diffusion model was needed to appropriately
fit the model to the data obtained in A549 cells. An α-value of one indicates normal,
free diffusion, an α-value lower than one indicates sub-diffusion in a molecular crowed
environment such as the cytoplasm of cells. As illustrated in Fig. 3.10e α-values for
all investigated mEGFP homo-oligomers were lower than one. Interestingly, the same
average α-value of 0.89 was observed for all mEGFP homo-oligomers.
Additionally, FLIM was performed in the cytoplasm of A549 cells expressing mEGFP
homo-oligomers, since energy transfer between different brightness states or to
non-fluorescent subunits could lead to decreased brightness values as described
previously. All obtained lifetime decays were fitted by a single exponential component
fit, taking into account the instrument response function (IRF) measured for each
independent experiment seperatly. An example for a single exponential component
fit for 1xmEGFP is illustrated in Fig. 3.11b. Only minor lifetime differences were
observed for all mEGFP homo-oligomers (Fig. 3.11a). These lifetime differences
corresponded to FRET efficiencies of ∼1.5%.
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Figure 3.11: Fluorescence lifetime measurements of mEGFP homo-oligomers
(adapted from Dunsing, Luckner et al. (2018)). A549 cells were transiently trans-
fected with plasmids expressing mEGFP monomers (1x), homo-dimers (2x), -trimers
(3x), and -tetramers (4x). a) Box plots of fluorescence lifetimes of indicated mEGFP
homo-oligomers measured in the cytoplasm of A549 cells in two independent experiments
(1x/2x/3x/4x: n=16/20/15/8 cells). b) Representative lifetime histogram for 1xmEGFP
(light green) fitted with a single exponential component fit (solid, black line) taking into
account the instrument response function (IRF, grey).
Finally, to examine whether the above described correction provides reliable quan-
titative results, biologically relevant protein complexes were investigated. To this
aim, two protein complexes were chosen: IAV HA which forms homo-trimers in the
plasma membrane of cells (Copeland et al., 1986, Wilson et al., 1981), and E.coli
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glutamine synthetase type I (GlnA) that forms dodeca-mers (Finan et al., 2015).
Results are shown in Fig. 3.12.
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Figure 3.12: Oligomerization of IAV hemagglutinin (HA) and bacterial GlnA
(adapted from Dunsing, Luckner et al. (2018)). a) Representative intensity images
of HEK 293T cells expressing myristoylated-palmitoylated mEGFP monomers (mp 1x),
homo-dimers (mp 2x), HA transmembrane domain (TMD) (HA-TMD), and HA-wt fused to
mEGFP, from left to right. Yellow lines indicate sFCS scan lines, performed perpendicular
to the membrane. Scale bars are 5 μm. b) Box plots of normalized brightness values of
sFCS measurements. Data were obtained from at least three independent experiments
(mp 1x/mp 2x/HA-TMD/HA-wt: n=55/54/37/36 cells) before (white boxes) and after
correction (grey boxes) with pf=0.65, as obtained from measurements of mp 2xmEGFP.
c) Representative intensity images of U2OS cells expressing 1xmEGFP, 2xmEGFP and
GlnA-mEGFP. Scale bars are 5 μm. d) Box plots of normalized brightness values of N&B
measurements performed in the cytoplasm of cells. Data were obtained from at least three
independent experiments (1x/2x/GlnA: n=34/35/41 cells) before (white boxes) and after
correction (grey boxes) with pf=0.72, as obtained from measurements of 2xmEGFP.
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HA fused to mEGFP was expressed in HEK 293T cells and sFCS was performed
perpendicular to the plasma membrane. Furthermore, an HA mutant in which
the ectodomain is replaced by mEGFP was investigated. This mutant (HA-TMD-
mEGFP) was shown to mainly form homo-dimers (Scolari et al., 2009). Monomers
and homo-dimers of myristoylated-palmitoylated mEGFP were used as brightness
controls, respectively. Fig. 3.12a illustrates the localization of all four protein species
in HEK 293T cells. In all cases, proteins localized to the plasma membrane. For all
examined proteins normalized brightness values were constantly lower than expected,
as shown in Fig. 3.12b, white boxes. Only after correction for the fluorescence proba-
bility pf=0.65, an average normalized brightness as high as predicted was observed:
εHA-TMD=1.82±0.07, εHA wt=3.17±0.12.
Furthermore, E.coli GlnA was expressed in U2OS cells and N&B was performed to
examine whether the described correction provides reliable results also for very large
protein complexes. In Fig. 3.12c the localization of both controls, 1xmEGFP and
2xmEGFP, as well as GlnA is shown. In both controls, proteins were homogeneously
distributed throughout the whole cell, whereas GlnA was strongly excluded from the
nucleus. Again, without correction for non-fluorescent states, normalized brightness
values were lower than expected (Fig. 3.12d, white boxes). For GlnA a normal-
ized brightness as low as εGlnA=8.8±0.3 was obtained. Nevertheless, correction of
the normalized brightness with pf=0.72 led to an overall molecular brightness of
εGlnA=11.9±0.4.
3.2.3 Performance of different red fluorescent proteins in
molecular brightness analysis
For investigations of hetero-interactions, red fluorescent proteins with different spec-
tral properties than mEGFP are needed. In order to identify red fluorescent proteins
with high apparent fluorescence probability, several proteins were screened and anal-
ysed for their photostability, brightness, and fluorescence probability by performing
N&B measurements in HEK 293T cells. All results for the investigated red fluores-
cent proteins mCherry, mCherry2, mCardinal, mRuby3, mScarlet and mScarlet-I are
depicted in Fig. 3.13. First, photostability was assess using 19.6 μW laser power. The
normalized intensity over time is plotted in Fig. 3.13a. In terms of their photostability
the red fluorescent proteins can be divided into two groups of rather photostable
proteins with bleaching half-times of around 100 s (mCherry, mCherry2 and mCar-
dinal), and a group of less photostable proteins with short bleaching half-times of
20-30 s (mRuby3, mScarlet and mScarlet-I). Therefore, to avoid photobleaching when
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examining the effective molecular brightness, N&B measurements were conducted
at lower excitation powers than for the more photostable proteins (exact excitation
powers: see figure caption).
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Figure 3.13: Performance comparison of different monomeric red fluorescent
proteins in photostability, molecular brightness, and apparent fluorescence
probability (adapted from Dunsing, Luckner et al. (2018)). Different red fluo-
rescent proteins, mCherry, mCherry2, mCardinal, mRuby3, mScarlet, and mScarlet-I were
expressed in monomeric or homo-dimeric variants in HEK 293T cells. a) Bleaching curves
of normalized intensity of indicated red fluorescent proteins, obtained in three independent
N&B measurements (n=18 cells each), with 19.6 μW laser power (four-fold compared to
standard N&B settings). Solid lines show average curves, dashed lines show mean±SD.
b) Box plots of effective molecular brightness values of red fluorescent proteins (white
boxes). N&B measurements were performed at different laser powers to avoid strong
bleaching for less photostable proteins (i.e. mRuby3, mScarlet, mScarlet-I). Laser power:
mCherry/ mCherry2/mCardinal (n=51/49/32 cells): 4.9 μW; mRuby3 (n=33 cells): 1.6 μW;
mScarlet/mScarlet-I (n=36/34 cells): 3.9 μW. Shaded boxes indicate brightness values inter-
polated to 4.9 μW laser power, assuming a linear brightness increase with excitation power.
c) Box plots of normalized molecular brightness of red fluorescent protein monomers (white
boxes) and homo-dimers (grey boxes) measured with N&B. Data were pooled from three
independent experiments (mCherry/mCherry2/mCardinal/mRuby3/mScarlet/mScarlet-I:
monomers, n=50/49/42/33/36/34 cells; homo-dimers, n=53/54/42/31/41/31/41/39 cells).
Indicated p-values were obtained by comparing mCherry2 with all other red fluorescent
proteins using a one-way ANOVA, followed by Bonferroni’s multiple comparisons test.
Additionally, effective brightness values are depicted in Fig. 3.13b. Of note, for the
less photostable proteins determined effective brightness values were interoplated
to a laser power of 4.9 μW as used for the photostable proteins (shaded boxes).
All together, mCardinal, mScarlet and mScarlet-I show high effective brightness
values of ε=2.1-2.7 kHz even without interpolation. Although, mRuby3 would show
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the highest effective brightness of ε=3.05±0.12 kHz at a laser power of 4.9 μW,
its strong photobleaching required a very low excitation power, and thus a low
effective brightness of only ε=1.06±0.07 kHz was observed. Eventually, mCherry
showed a slightly higher effective brightness value (ε=1.73±0.04 kHz) than mCherry2
(ε=1.50±0.04 kHz). However, for precise determination of the oligomeric state of
proteins the fluorescence probability is important. Thus, the normalized homo-dimer
brightness of these red fluorescent proteins was determined. Results are shown in
Fig. 3.13c. Among all tested red fluorescent proteins, mCherry2 resulted in the highest
fluorescence probability: ε=1.71±0.05, pf=0.71. This probability was approximately
1.8-fold higher than for the commonly used mCherry (pf=0.41), or mScarlet (pf=0.40).
Only mScarlet-I showed a fluorescence probability (pf=0.63) comparably high to
mCherry2, while mCardinal and mRuby3 showed very low fluorescence probabilities
of only pf=0.24, and pf=0.22, respectively.
3.3 Quantification of the interaction stoichiometry of
M1 with vRNPs in vitro
It is not yet known if progeny vRNPs are bound by only one single, few, or several
viral nuclear export complexes to promote translocation of progeny vRNPs to the
cytoplasm of cells. To gain insight into the abundance of viral export complexes bound
to vRNPs, initially the stoichiometry of M1 as first part of the nuclear export complex
on isolated vRNPs should be investigated by performing FCCS measurements in
vitro. Second, when the number of possible export complexes can be estimated based
on the determined abundance of M1 bound to vRNPs, additionally the abundance
of NEP should be determined. Therefore, M1 of IAV A/WSN was recombinantly
expressed and purified from E.coli. Next, M1 was labelled with either AlexaFluor™
488 or 647 succinimidyl esters (NHSs). Additionally, vRNPs were isolated either
from IAV A/WSN virions directly, or from HEK 293T cells transfected with a set of
plasmids that give rise to complete vRNPs. Isolates of vRNPs of A/WSN virions
were labelled with AlexaFluor™ 647 NHS. Both, M1 and vRNPs were finally used
to initially perform FCS measurements on individual samples, followed by FCCS
measurements on mixed samples to determine the fraction of M1 bound to vRNPs.
3.3.1 Recombinant expression and purification of A/WSN M1
M1 of A/WSN was expressed in E.coli using pET-15b expression system. Thereby, M1
is N-terminal fused to a His-tag allowing for purification by affinity chromatography.
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Protein expression is facilitated by a T7 RNA polymerase under control of a lac
operator, thus allowing for protein expression induced through addition of IPTG.
Optimal protein expression was examined for different expression conditions as
shown in Fig. 3.14. Samples were taken and analysed for the abundance of M1 (MW:
∼28 kDa) by SDS-PAGE following protein visualization either by coomassie staining
or Western Blot.
Prior to protein expression, a bacteria culture sample was taken to examine basal
protein expression in the absence of inducer (’before IPTG’). Neither the less sensitive
coomassie staining, nor the more sensitive Western Blot, resulted in a detectable
signal within the MW range of 20 to 30 kDa. Then, after supplementation of 0.1mM
IPTG, protein expression was performed either slowly at low temperature but a long
time period, or at higher temperatures but for shorter time periods. At the end of each
protein expression experiment, one sample termed IPTG induced ’I’, was collected
before harvesting cultures. Eventually, bacteria lysates were separated into pellet
’P’ and supernatant ’S’ fractions. For all fractions, IPTG induced and supernatant,
equal total protein amounts were used for SDS-PAGE analysis. Notably, protein
concentration in pellet fractions was not determined. In all samples a strong signal
band in the MW range slightly above 25 kDa was detected by coomassie staining,
although the signals appeared more prominent for shorter protein expression periods
at higher temperatures than for proteins expressed for 24 h at 22 ◦C.
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Figure 3.14: Comparison of several expression conditions for recombinante
protein expression of A/WSN M1 in E.coli. Recombinant expression of A/WSN M1
(∼28 kDa) in E.coli under indicated conditions was visualized by a) SDS-PAGE following
coomassie staining and b) Western Blot using anti-M1 (mouse) and anti-mouse-IR Dye
680 antibodies. One sample of transformed bacteria was collected before inducing protein
expression by adding 0.1mM IPTG (’before IPTG’). After expression induction, bacteria
cultures were cultivated for indicated time periods and temperatures, and one sample
termed IPTG induced (’I’) collected. Subsequently, harvested bacteria were lysed, and
lysates separated into pellet (’P’) and supernatant (’S’) fractions. Marker: kDa.
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In general, pellet fractions showed stronger signals, not only in the MW range
where M1 was assumed, but also in total protein amount. Similarly, in Western Blot
analysis M1 was specifically detected in all fractions with most prominent signals in
pellet fractions. However, no strong differences in signal intensities were observed for
all other samples. Eventually, recombinant protein expression of M1 was routinely
performed at 37 ◦C for 3 h.
3.3.2 Fluorescence labelling of A/WSN M1
Using optimized expression conditions, M1 was isolated from bacteria cultures and
labelled either with AlexaFluor™ 488 or AlexaFluor™ 647. Purification and labelling
conditions were first optimised using influenza A/FPV M1 and AlexaFluor™ 647.
A/FPV M1 was fused to a His-tag, allowing for affinity chromatography based
protein purification. Flow through fractions ’F’ contained all non-bound proteins,
wash fractions ’W’ contained proteins with low affinity to the Co2+ surface, elution
fractions ’E’ contained proteins specifically bound to the Co2+ surface. Represen-
tative results are shown in Fig. 3.15a. In elution fractions ’E’ a dominant protein
fraction slightly above the marker lane of 25 kDa (MW M1: ∼28 kDa) was detected
by coomassie staining of a SDS-PAGE. Western Blot analysis using monoclonal
anti-M1 antibody identified these bands as M1 proteins. Furthermore, extracted M1
was labelled using AlexaFluor™ 647 NHS. Determined labelling efficiencies were as
low as 0.5, i.e. only every second M1 protein was labelled with a single fluorescent
dye. However, successful labelling was visualized directly in SDS-PAGE gel by using
700 nm excitation wavelength of an infrared scanner. Thus, labelling of A/FPV M1
with AlexaFluor™ 647 was verified directly.
Nevertheless, for FCCS measurements vRNPs were routinely labelled using Alex-
aFluor™ 647, thus M1 needed to be labelled with a spectrally different fluorescent
dye. Therefore, after optimizing purification and labelling, A/WSN M1 was routinely
purified as performed with A/FPV M1, and subsequently labelled using AlexaFluor™
488 NHS. Labelling efficiencies were slightly lower; only every fourth M1 protein
was successfully labelled with one dye. In Fig. 3.15b a representative FCS mea-
surement with resulting ACF and fit curve (solid line) is illustrated. The obtained
diffusion coefficient D was 114±5 μm2/s-1. An average diffusion coefficient D of
107.6±2.8 μm2/s-1 was determined (see Fig. 3.15c). Furthermore, A/WSN M1 was
present in monomeric form over the concentration range used in this study as shown
by molecular brightness analysis of M1-Alexa488 normalized to free, monomeric
AlexaFluor™ 488 NHS (see Fig. 3.15d).
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Figure 3.15: FCS measurements of isolated and fluorescently labelled M1.
a) A/FPV M1 affinity chromatography purification was verified by SDS-PAGE, following
coomassie staining (first panel) and Western Blot using anti-M1 (mouse) antibody and
anti-mouse IR Dye 680 (second panel). Furthermore, AlexaFluor™ 647 labelled M1 was
directly visualized in SDS-PAGE using Odyssey infrared scanner (third panel). Protein
marker size: kDa. Fractions: Flow through ’F’, wash fraction ’W’, elution fraction ’E’
(adapted from Jähne (2016)) b) Representative ACF and fit curve (purple, solid line)
of a pFCS measurement performed with AlexaFluor™ 488 labelled A/WSN M1. A free
3-D diffusion model was fitted to the obtained data, assuming the presence of a single
component, and taking a triplet-fraction into account. Lower fit-bound was set to 0.001ms.
c) Diffusion coefficient D determined for A/WSN M1-Alexa488. Data were pooled from
three independent experiments, each encompassing several elution fractions of freshly
isolated M1 samples. d) Normalized brightness for M1 data obtained from measurements
in c). Brightness was normalized to AlexaFluor™ 488.
3.3.3 Isolation of vRNPs from A/WSN virions or transiently
transfected HEK 293T cells
In this study, two approaches were pursued for vRNP isolation: direct isolation
from A/WSN virions, and isolation from transiently transfected HEK 293T cells
followed by affinity chromatography purification. Direct isolation from A/WSN
virion concentrates theoretically would allow isolation of high amounts of vRNPs.
However, these vRNP samples are (I) heterogeneous in composition as all eight
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vRNPs might be present, (II) might be bound by M1, (III) additionally need to
be labelled with fluorescent markers to perform FCS or FCCS measurements. In
contrast, vRNP-isolation from transiently transfected cells, would lead to samples
of (I) homogeneous composition as vRNP type, and thus length is determined by
the applied plasmid system, (II) is devoid of M1, (III) does not need any further
labelling since PB2-subunits were fused to the fluorescent protein mCherry2. Both
approaches will be compared in the following sections.
3.3.4 Isolation and labelling of vRNPs from A/WSN virions
For isolation of vRNPs, viral concentrates were used to start with high amounts of
source material. Detergent disrupted virions were fractionated by ultracentrifugation
through a glycerol density gradient containing different buffer conditions, that are
depicted in detail in cartoons of Fig. 3.16. After centrifugation collected fractions
were analysed by SDS-PAGE and silver-staining. Fractions were analysed for the
occurrence of NP (MW: ∼56 kDa) as major component of vRNPs, and if detectable
for the presence of RdRP subunits (MW: ∼82 - 87 kDa), but most importantly for the
absence of contaminating M1 (MW:∼28 kDa). For all tested conditions vRNP relevant
protein bands were detected in fractions of gradient layers containing 40% or 50%
glycerol (w/v). In Fig. 3.16a and b representative results for buffers of physiological
pH, but different salt-composition are shown. Several protein bands with strong
signal intensities were observed throughout all fractions. In both setups, proteins
with MWs corresponding to NP and RdRP subunits were detectable. Nevertheless,
signals in the range of 50 kDa, and most importantly also in the MW range of M1
were detected (25 - 37 kDa). Based on these observations, buffer conditions mimicking
environmental conditions of late endosomes, and thus the uncoating process of IAV
life cycle in which M1 dissembles from vRNPs were tested instead (Stauffer et al.,
2016). Whereas results for two conditions depicted in Fig. 3.16d and f were very
similar to the previous results, results of isolation conditions depicted in Fig. 3.16c
and e showed very clear patterns. In both cases, bands with high signal intensities in
the MW range expected for NP were detected. Nevertheless, slight differences for
both conditions were observed. For isolation performed at pH 5.8, only in elution
fraction (’E’) two and three signals of low intensities were observed between 75 and
100 kDa. Additionally, several faint bands were detected in the range of 25 to 37 kDa.
In contrast, in isolation experiments performed at pH 5.8 in presence of different ions,
only a faint band at ∼25 kDa was detected, whereas no distinct bands in the range
of 75 to 100 kDa were observed. Eventually, vRNP isolation was routinely performed
under acidic pH conditions as illustrated in Fig. 3.16c.
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Next, to perform FCS or FCCS measurements with isolated vRNPs, vRNPs were
labelled under slightly basic pH conditions using AlexaFluor™ 647 NHS. After
labelling the buffer was exchanged with buffer of pH 7.4 using spin columns with
a MW cut-off of 50 kDa. Thereby, vRNPs were retained under physiological buffer
conditions and in parallel separated from free fluorescent dye. Usually, labelling ratios
of vRNPs were in the range of 3 to 10 dyes per vRNP, but never lower than one or
higher than 25.
Figure 3.16: Comparison of various buffer conditions for M1-free vRNP isola-
tion from A/WSN virions. a-f) A/WSN virus concentrates (2mg/mL) were disrupted
with detergent, and subsequently fractionated by ultracentrifugation through a glycerol
density gradient. Glycerol layers were as followed: 3mL 70%, 0.75mL 50%, 0.375mL 40%,
1.8mL 33% glycerol (w/v). The different tested buffer conditions are indicated as cartoons,
respectively. After ultracentrifugation one fraction of ∼1.5mL was collected, followed by
fractions of 250 μL throughout the remaining gradient. All fractions were analysed for the
presence of the major proteins of vRNPs by SDS-PAGE under denaturating conditions,
followed by silver staining: NP (56 kDa), RdRP subunits (82 - 87 kDa). Furthermore, the
presence or absence of M1 (28 kDa) was evaluated. For all conditions, only elution fractions
(’E’) 1 to 9 are shown. Protein marker size: kDa (adapted from Jähne (2016))
.
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3.3.5 Isolation of M1-free, artificial fluorescent vRNPs from
transiently transfected HEK 293T cells
An alternative approach to acquire isolated vRNPs of defined size with a single
fluorescence label only, is based on affinity chromatography purification of vRNPs
from transfected cells. Therefore, HEK 293T cells were either mock transfected, or
with a mixture of four plasmids encoding for A/WSN PA, PB1, PB2 N-terminally
fused to a His-tag and mCherry2, and a pHW2000 plasmid encoding for NP protein
and NP-vRNA. Transiently transfected cells were harvested 48 h post transfection,
and following lyses one sample of the pelleted cell debris ’P’ and supernatant ’S’
was collected. The supernatant ’S’ was then used for affinity chromatography using
a resin conjugated with Co2+ that interacts with the His-tag fused to PB2. Flow
through fractions ’F’ contain all unbound proteins, wash fractions ’W’ contain eluted
proteins with low affinity to the Co2+ surface. Finally, bound proteins were eluted
’E’, and all fractions analysed by SDS-PAGE under denaturating conditions. SDS-
PAGEs were visualized by coomassie staining and Western Blot. A representative
result of a mock transfected control is shown in Fig. 3.17a. In all fractions, ’P’, ’S’,
’F’, and ’W’, proteins were detected by coomassie staining. Most importantly, no
specifically bound and subsequently eluted proteins were detected in all depicted
elution fractions. Fig. 3.17b shows a representative coomassie stained SDS-PAGE of
an actual vRNP isolation. In all fractions, until wash fraction ’W1’, a vast amount
of proteins of different sizes were detected. No non-specifically bound proteins were
observed in the last wash fraction ’W13’. However, two distinct bands around 100 kDa
and above 50 kDa were detected in the first two elution fractions. Collected fractions
were partially analysed by Western Blot using monoclonal anti-NP and polyclonal
anti-PB2 antibodies. Thus, the detected band above 50 kDa was identified as NP.
Furthermore, the prominent protein band at 100 kDa seen in coomassie staining
was specifically identified as protein PB2 fused to mCherry2, thus possessing a
MW of ∼113 kDa. Two additional bands were specifically detected using anti-PB2
antibody, one at around 250 kDa, and another with slightly lower MW than the most
prominent band. Of notice, Western Blot was performed following SDS-PAGE under
non-denaturating conditions; a complete hetero-timeric polymerase complex would
possess a total MW of ∼280 kDa.
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Figure 3.17: Isolation of an artificial vRNP containing PA, PB1, His-PB2-
mCherry2, NP and NP vRNA from transiently transfected HEK 293T cells.
HEK 293T cells were either a) mock transfected or b) transiently transfected with four
plasmids all together encoding for an artificial vRNP corresponding to segment 5 of
A/WSN: wild-type PB1 (86.5 kDa), PA (82.5 kDa), a variant of PB2 N-terminally fused to
a His-tag and mCherry2 (∼113 kDa), NP (56 kDa) and NP-vRNA from the same plasmid
using pHW2000 expression system. Cell extracts of both samples were used for affinity
chromatography to isolate vRNPs. Pellet ’P’, supernatant ’S’, flow through ’F’, wash
fractions ’W’, and eluates ’E’ were subsequently analysed by SDS-PAGE and visualized
by coomassie staining. c) Western Blot analysis of isolated fractions shown in b), using
anti-PB2 (rabbit) and anti-rabbit IR Dye 800 CW, anti-NP (mouse) and anti-mouse IR
Dye 680 antibodies. Protein marker size: kDa.
3.3.6 In vitro FCS measurements of fluorescent vRNPs
FCS measurements of vRNPs isolated either from A/WSN virions directly, or tran-
siently transfected HEK 293T cells were performed. For a mixture of all eight
possible genome segments, as obtained from virion purified vRNPs, MWs range from
∼2.35MDa for the smallest to ∼5.75MDa for the largest vRNP. The approximate
MW for an artificial vRNP corresponding to segment five, as obtained from trans-
fected cells, is around 4MDa.
In Fig. 3.18a and b on the following page, two representative FCS measurements
are illustrated. To precisely fit a 3-D free diffusion model to the obtained data it
was either sufficient to assume a single component (a), or necessary to take two
components (b) into account. In example a, the basal intensity was in the very low
Hz range (0.05 kHz), with single peaks of high intensities at 7 s or 25 s.
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Figure 3.18: FCS measurements of vRNPs isolated from A/WSN virions or
transiently transfected HEK 293T cells. a) and b) Representative FCS results of
AlexaFluor™ 647 labelled vRNPs isolated from A/WSN virions. Intensity traces of 60 s
measurements, resulting ACF, and fit curves (solid lines) with residuals are depicted. Lower
fit-bound was set to 0.001ms, a possible triplet-fraction was taken into account. a) A free
diffusion model assuming a single component was fitted to the data (solid, purple line).
b) A free diffusion model assuming two components was fitted to the data (solid, cyan
line). Resulting diffusion coefficients D for both components are additionally depicted
in c) as cyan dots, respectively. c) Dot plots of diffusion coefficients D measured for
AlexaFluor™ 647 labelled vRNPs isolated from A/WSN virions. Each dot represents a
single measurement with vRNP samples obtained from three independent extractions. Data
were obtained by fitting a free diffusion model, assuming a single component (black dots),
or two components (coloured dots). Equal dot colours correspond to data extracted from
the same measurement and fit result. d) Dot plot of diffusion coefficient D measured for
vRNPs isolated from transiently transfected HEK 293T cells. Polymerase subunit PB2 was
N-terminal fused to mCherry2. Each data point represents a single measurement of vRNPs
exacted in two independent experiments.
Independent of the used fitting routine, i.e. only fitting the region of burst inten-
sities or taking into account the whole intensity trace, a single component fit as
shown in Fig. 3.18a was sufficient to describe the diffusion dynamics. In contrast, in
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example b the basal intensity was higher than in the previous described example
(∼1 kHz). However, single peaks of high intensities were observed between 40 to
50 s. For prescience fitting, it was necessary to take into account two components.
Component one possessed a D of 5.7±0.6 μm2/s-1, whereas D for component two was
298±8.5 μm2/s-1. Finally, all extracted data are depicted as dot plots in Fig. 3.18c.
In case of a single component fit data points are shown in black, in case data were
obtained from two component fits both determined diffusion coefficients are depicted
in corresponding colours. Fit curve colour of the measurement illustrated in Fig. 3.18b
corresponds to data points of equal colour in Fig. 3.18c. In summary, the average D
for component one was around 4.8±0.9 μm2/s-1, the average D for component two
around 270.4±7.3 μm2/s-1. Eventually, A/WSN M1 labelled with AlexaFluor™ 488
was added in molecular excess to vRNP-containing samples, and FCCS measurements
were performed for 120 s every 5min over a time period of 30min. However, neither a
positive cross-correlation was observed, nor a decrease in D for M1 (data not shown).
Moreover, FCS measurements with samples possibly containing vRNPs extracted
from transfected HEK 293T cells were performed, and diffusion coefficients extracted
from fitting a free 3-D diffusion model to the data. The determined average D was
at 36.8±3.9 μm2/s-1 as illustrated in Fig. 3.18d.
3.4 Investigations on the IAV nuclear export complex
interaction network, and its diffusion dynamics
using fluorescence correlation spectroscopy
In parallel to in vitro studies to investigate the M1 stoichiometry on single vRNPs,
the composition and modularity of the viral nuclear export complex should be
investigated directly in living A549 cells using molecular brightness analysis, FCS,
and FCCS.
Final measurement parameters for two-wavelength FCCS studies were as follows:
correction collar ring position 170, pinhole diameter of 90 μm, 0.5% relative laser
power for both laser lines. Nevertheless, independently of the used parameters, a
cross-correlation of 100% was not achieved. Hence, to calculate the fraction of
the interacting species by analysing the cross-correlation (’CC’), results need to be
compared to appropriate positive and negative controls. Therefore, mEGFP-mCherry2
hetero-dimers referred to as ’tandem’ were used as a positive interaction control
defining the cross-correlation peak value. Additionally, A549 cells simultaneously
co-expressing mEGFP and mCherry2 monomers were used as negative interaction
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control defining cross-correlation artefact peak values.
Further, to determine the oligomeric state of viral proteins, molecular brightness
analysis was performed following the implementations described in the previous
section. First, obtained brightness values were routinely normalized using the median
brightness value of 1xmEGFP in dependence of its subcellular localization, i.e.
cytoplasm or nucleus. Second, a correction was performed using the fluorescence
probability as obtained from 2xmEGFP measurements in dependence of its subcellular
localization. Hence, brightness data shown in the following section are depicted as
corrected brightness values. Finally, monomer and dimer fractions were calculated
using the resulting median corrected brightness values. Information on the exact
normalization and correction procedure, as well as calculation of the oligomer fractions
can be found in Methods section 2.2.8.2.
3.4.1 Investigation of the interaction network of nuclear export
complex components using FCCS
Huet et al. (2010) were the first to confirm the now well accepted assembly model of
the IAV hetero-trimeric polymerase by applying FCCS. They found that PB1 and PA
first form hetero-dimers in the cytoplasm of cells and then translocate into the nucleus,
whereas PB2 localizes to the nucleus directly in transfected cells. Finally, only in the
nucleus the hetero-trimeric polymerase is formed. In the present study, these results
were reproduced to verify the used FCCS instrumentation. Second, combinations of
several IAV proteins possibly interacting with each other within the nuclear export
complex were analysed. All results are depicted in Fig. 3.19. To verify the formation
of a hetero-trimeric polymerase, PB2-mCherry2, PB1-mEGFP, and unlabelled PA
were co-expressed in A549 cells and FCCS measurements performed in the nucleus.
In comparison to the positive control (CC=42.6±1.3%), an interacting fraction of
approximately 73% for PB2-mCherry2 and PB1-mEGFP proteins (CC=31.0±2.1%)
were observed in the nucleus. Interestingly, interaction of co-expressed NEP-mEGFP
and NEP-mCherry2 was observed in the cytoplasm and nucleus of transfected cells:
CCCP=16.0±2.1%, CCN=6.1±2.7%.
Furthermore, the interaction of several NEP and M1 variants was investigated as
both proteins are predicted to interact within the nuclear export complex. Certainly,
fluorescent protein tags can lead to misfolding of proteins, especially if protein
tags are relatively large in comparison to the actual protein. NEP and M1 possess
MWs of ∼14 kDa and ∼28 kDa, respectively, whereas mEGFP and mCherry2 both
possess a MW of ∼27 kDa. Therefore, several fusion constructs were tested in
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different combinations: mEGFP/mCherry2-N1 refer to constructs in which the
fluorescent protein tag is fused to the C-terminal end of the respective protein,
whereas mEGFP/mCherry2-C1 refer to constructs in which the fluorescent protein
is fused to the N-terminus of proteins.
0
20
40
60
80
C
ro
ss
-c
or
re
la
tio
n 
[%
]
mEGPF-
mCherry2
Tandem
mEGFP +
mCherry2
PB2 + PB1
+ (PA) NEP-mEGFP-N1 +
NEP-mCherry2-N1
CP N
-20
0
20
40
60
80
C
ro
ss
-c
or
re
la
tio
n 
[%
]
mEGPF-
mCherry2
Tandem
mEGFP +
mCherry2 NEP-C1 +
M1-C1
NEP-N1 +
M1-C1
NEP-N1 +
M1-N1
NEP-C1 +
M1-N1
CP N CP N CP N CP N
a
b
c
10-5 10-4 10-3 10-2 10-1 100
-0.5
0.0
0.5
1.0
1.5
2.0
τ [ms]
N
or
m
al
iz
ed
 G
(τ
)
Tandem
M1-C1
1xmCherry2
M1-N1
NEP-N1
NEP-C1
Figure 3.19: In situ FCCS measurements of several NEP-mEGFP and M1-
mCherry2 variants. pFCCS measurements were performed in the cytoplasm (’CP’) or
nucleus (’N’) of transfected A549 cells. Cross-correlation values were obtained by calculating
the amplitude ratios of the ACFs and CCF. a)Dot plots of pFCCS measurements of mEGFP-
mCherry2 tandems, co-expressed mEGFP and mCherry2, co-expressed IAV PB2-mCherry2,
PB1-mEGFP and unlabelled PA, and co-expressed NEP-mEGFP-N1 with NEP-mCherry2-
N1. Each data point represents a single measurement. Data were pooled from three
independent experiments. Tandem/mEGFP+mCherry2/PB2-PB1/NEP: n=50/38/27/22
cells. b) Dot plots of pFCCS measurements of mEGFP-mCherry2 tandems, co-expressed
mEGFP and mCherry2, and several combinations of M1-mCherry2 and NEP-mEGFP. N1
corresponds to plasmids mEGFP/mCherry2-N1, i.e. the fluorescent protein is C-terminally
fused to NEP or M1. In turn, C1 corresponds to plasmid mEGFP/mCherry2-C1, i.e. the
fluorescent protein is N-terminally fused to NEP or M1. Each data point represents a
single measurement of one experiment. c) Normalized average ACFs of 5 representative
measurements of indicated samples, obtained from measurements described in b).
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For none of the NEP-mEGFP and M1-mCherry2 combinations tested a distinct in-
teraction fraction was observed (see Fig. 3.20b). All obtained cross-correlation values
fluctuated around 5 to 8%. The highest average cross-correlation value was observed
in the cytoplasm of A549 cells co-expressing NEP-mEGFP-N1 and M1-mCherry2-C1
(CC=17.4±7.8%). However, the resulting median cross-correlation of ∼8.2% was
very similar to that of all other combinations. For positive and negative controls cross-
correlation values of CCTandem=50.9±2.8% and CCmEGFP,mCherry2=3.3±0.7% were
observed. Additionally, normalized ACFs of mEGFP-mCherry2 tandem proteins, 1xm-
Cherry2, M1-mCherry2-N1/-C1 (’M1-N1/-C1’) and NEP-mEGFP-N1/-C1 (’NEP-
N1/-C1’) are depicted in Fig. 3.20c. Whereas similar diffusion times τd were observed
for mEGFP-mCherry2 tandem proteins, M1-C1, NEP-N1 and -C1, measurements
of mCherry2 monomers (’1xmCherry2’) and M1-N1 resulted in increased diffusion
times.
3.4.2 Functional relevance of NEP fusion proteins
Untill today, no enzymatic activity was reported for NEP. Therefore, to ensure
functionality of the used fusion protein NEP-mEGFP-N1, localization of NEP in
a natural infection of A549 cells with A/WSN virus (see Fig. 3.20) was compared
to the localization in transiently transfected cells (see Fig. 3.21). In a natural
infection, NEP expression levels were constantly low. Early in infection (4 and 6 hpI)
a predominantly cytoplasmic punctuated localization of NEP was observed, whereas
later in infection NEP additionally translocated into the nucleus (8 hpI). Only after
multiple infection rounds occurring over a time period of 24 h, a more heterogeneous
NEP distribution with partially higher expression levels was observed. A selection of
observed phenotypes is shown in Fig. 3.20, 24 h. The vast majority of cells showed a
punctuated expression pattern very similar to early infection time points, whereas a
high concentration of NEP was observed in the nucleus or in the nuclear periphery
only in a few cells.
In contrast to a natural infection, NEP localization in transfected A549 cells appeared
to be different. A selection of observed phenotypes for different expression constructs
is composed in Fig. 3.21, page 106. NEP expressed without a fluorescent protein tag,
but specifically detected by indirect immunofluorescence staining resulted in a similar
localization pattern to the fluorescent protein tagged version NEP-mEGFP-N1. In
both cases, NEP mainly localized to the cytoplasm of transfected cells (compare
Fig. 3.21a and b). This was additionally verified by analysing the intensity profile of
line sections of representative images. Additionally, NEP-mEGFP-N1 was specifically
probed by indirect immunofluorescence staining using polyclonal anti-NEP antibody,
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resulting in a similar intensity pattern for mEGFP and secondary antibody signals (see
Fig. 3.21c). However, cells transiently transfected with NEP-mEGFP-C1 expression
construct mostly showed a homogeneous NEP distribution throughout the whole
cell (see Fig. 3.21d). In contrast to NEP-mEGFP-N1, EGFP in this construct is
N-terminally fused to NEP. It is important to emphasize at this point, that NEP-
mEGFP-N1 expression construct was used for all further described experiments of
this study, since transfected cells showed the same subcellular localization of NEP as
compared to the untagged version.
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Figure 3.20: Subcellular localization of IAV NEP. Representative intensity images
of A549 cells infected with IAV A/WSN at either MOI 1 (4,6,8 hpI) or 0.01 (24 hpI).
Infection medium was supplemented with 2.5 μg/mL TPCK-Trypsin to allow multiple
infection rounds. A549 cell were fixed 4, 6, 8, and 24 hpI using 4% paraformaldehyde (PFA),
and probed for NEP by indirect immunofluorescent staining using a polyclonal anti-NEP
antibody, followed by anti-rabbit-Alexa488 antibody detection (green). Nuclei were stained
using DAPI (blue). Scale bars: 5 μm
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Figure 3.21: Subcellular localization of transiently transfected NEP variants.
Representative intensity images of A549 cells transfected with plasmids expressing different
NEP variants. a) Subcellular localization of NEP without a fused fluorophore (plasmid:
pCMV3). NEP was specifically stained using polyclonal anti-NEP antibody, followed by anti-
rabbit-Alexa488 antibody detection (green). b) Subcellular localization of NEP-mEGFP-N1
(mEGFP located C-terminally). c) Subcellular localization of NEP-mEGFP-N1 additionally
detected using polyclonal anti-NEP antibody, followed by anti-rabbit-Alexa594 antibody
staining (magenta). Nuclei were stained using DAPI (blue). d) Subcellular localization of
NEP-mEGFP-C1 (mEGFP located N-terminally). Scale bars: 5 μm. Right panels show
normalized intensity profiles of line sections indicated as white arrows within corresponding
images. Nuclear region of all line profiles are highlighted in grey. Red arrows indicate
strength of translocation direction. CP: Cytoplasm, N: Nucleus.
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3.4.3 Localization-dependent dimerization of NEP
FCCS analysis of NEP-mEGFP and NEP-mCherry2 revealed an interacting fraction
in both, the cytoplasm and nucleus of transfected cells, although the average inter-
acting fraction was higher in the cytoplasm of A549 cells (see Fig. 3.19). Therefore,
oligomerization of NEP was investigated in dependence of its subcellular localization
for several conditions using molecular brightness analysis. All results will be described
in the following sections.
First, the subcellular localization phenotypes of several constructs were quantified
by calculating the nucleus to cytoplasm intensity ratios (’N/CP’) (see Fig. 3.22).
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Figure 3.22: Quantification of the subcellular localization pattern of NEP.
a) Representative intensity images of A549 cells transfected with plasmids expressing
the indicated proteins. Upper panel, from left to right: EGFP monomers (’1xmEGFP’),
EGFP homo-dimers (’2xmEGFP’), EGFP fused to a NLS or NES. Lower panel, from left
to right: NEP C-terminally tagged with mEGFP (’NEP-mEGFP-N1’), NEP-mEGFP-N1
expressing cells additionally treated with 6 nM leptomycin B (LMB) for 4 h, or co-infected
with concentrated A/WSN virus for 3.5 h or 6.5 h. Scale bars: 5 μm. b) Frequency distribu-
tion of the nucleus to cytoplasm ratio (’N/CP’) of EGFP intensities. Altogether 300 to
600 cells were analysed in three independent experiments. First, the median intensity of a
region of interest in each compartment was recorded. Second, background substraction was
performed individually for each image. CP: Cytoplasm, N: Nucleus.
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EGFP monomers (’1xmEGFP’) and homo-dimers (’2xmEGFP’) showed a homoge-
neous intensity distribution throughout the whole cell. In contrast, EGFP fused to the
NLS of cMyc (cancer Myelocytomatosis) showed a strong preference to translocate
into the nucleus of transfected cells, whereas EGFP fused to the NES of ADAR1
(Adenosine deaminases acting on RNA 1) was predominately found to be excluded
from the nucleus. Although less strong than for EGFP-NES, NEP showed a simi-
lar intensity distribution in A549 cells. However, when NEP expressing cells were
additionally treated with 6 nM LMB, an inhibitor of CRM1, the observed intensity
distribution shifted towards a similar pattern as observed for 1xmEGFP or 2xmEGFP
with a N/CP-ratio close to one. Interestingly, even if not quantified, NEP expressing
cells that were co-infected with A/WSN virus concentrates showed a heterogeneous
intensity distribution. Part of the cells showed a similar to wild-type subcellular
localization, whereas other cells showed a more homogeneous distribution. This effect
appeared to be slightly stronger with prolonged infection.
Next, oligomerization of NEP was analysed by performing molecular brightness
analysis (see Fig. 3.23). The average brightness value for NEP was significantly
higher in the cytoplasm than nucleus of transfected cells: εNEP,CP=1.34±0.03, and
εNEP,N=1.15±0.03. Additionally, diffusion dynamics were extracted from ACFs of the
performed pFCS measurements for 1xmEGFP, 2xmEGFP and NEP (see Fig. 3.23b
and c). The normalized ACFs for measurements performed in the nucleus of cells
were generally shifted towards higher diffusion times compared to the cytoplasm.
Furthermore, obtained diffusion times for NEP increased compared to 1xmEGFP,
but were very similar to the resulting diffusion times of 2xmEGFP. These differences
are additionally reflected in the obtained diffusion coefficients D of the same samples.
Generally, diffusion coefficients for proteins measured in the nucleus of cells were lower
than in the cytoplasm. Additionally, obtained diffusion coefficients for NEP were more
similar to the average values obtained for 2xmEGFP than 1xmEGFP measurements:
D1xmEGFP,CP=∼26, D1xmEGFP,N=∼24, D2xmEGFP,CP=∼23, D2xmEGFP,N=∼18,
DNEP,CP=∼23, and DNEP,N=∼18 μm2s–1.
Interestingly, NEP expressing cells additionally treated with the nuclear export
inhibitor LMB displayed higher average brightness values in both compartments
compared to untreated samples. Besides, average brightness values were very sim-
ilar in both compartments. However, in comparison to untreated cells, the aver-
age brightness value obtained from nuclear measurements was significantly higher
(εNEP+LMB,N=1.27±0.06), although no comparable difference was observed for the
cytoplasmic fractions. Moreover, competition experiments were performed, i.e. NEP
expressing cells were co-infected either for 3.5 or 6.5 h with concentrated A/WSN
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virus. Hence, untagged and fluorescently tagged NEPs were simultaneously present
in A549 cells. Whereas the nuclear brightness values were similar for NEP wt and
co-infected samples, the averaged brightness values in the cytoplasm significantly
decreased when cells were co-infected with A/WSN viruses (ε3.5h,CP=1.12±0.08,
ε6.5h,CP=1.10±0.08). Interestingly, once EGFP is fused to the N-terminus of NEP
(’NEP-mEGFP-C1’) neither an increase in the average brightness compared to
1xmEGFP was observed, nor a difference between cytoplasmic or nuclear NEP
fractions.
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Figure 3.23: Molecular brightness analysis of NEP-mEGFP expressed in A549
cells. a) Box plots represent corrected molecular brightness data obtained from pFCS
measurements. Either untreated A549 cells expressing NEP-mEGFP-N1 (’NEP wt’)
were used, or cells were additionally treated with 6 nM LMB for 4 h prior to measure-
ments, or co-infected with concentrated A/WSN virus for 3.5 h or 6.5 h. Brightness cor-
rection was performed, using a fluorescence probability of pf=0.72, as obtained from
2xmEGFP measurements. Presented data were pooled from at least two independent exper-
iments; 1xmEGFP/2xmEGFP/NEP wt/NEP+LMB/NEP+3.5 h co-infection/NEP+6.5 h
co-infection/NEP-mEGFP-C1: n=310/268/273/22/22/16/27 cells. ****, **, and * indi-
cate significance with p<0.0001, p<0.002, and p<0.03, respectively, obtained by using a
one-way ANOVA Turkey’s multiple comparisons test; ns indicates no significance. b) Nor-
malized average ACFs of 10 representative measurements of 1xmEGFP, 2xmEGFP, and
NEP-mEGFP-N1 in dependence of their subcellular localization. c) Average diffusion
coefficients D of 1xmEGFP, 2xmEGFP, and NEP-mEGFP-N1 in dependence of their sub-
cellular localization. Data were extracted from measurements described in a) and plotted
as mean±SD.
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Figure 3.24: Quantification of monomer- and dimer-fractions of NEP in depen-
dence of its subcellular localization in A549 cells. All data used for the depicted
quantifications belong to the same data set already described in detail in Fig. 3.23a.
a) Monomer- and dimer-fractions of indicated samples were calculated from median
corrected brightness values as described in the Methods section 2.2.8.2. b) Theoretical
proportion of n-mers in a mixture of monomers and higher-ordered oligomers for the ob-
tained median corrected brightness values of NEP-mEGFP-N1, assuming a homo-dimeric
(’Dimer’), -trimeric (’Trimer’), or -tetrameric (’Tetramer’) oligomer state. Fractions were
calculated as described in the Methods section 2.2.8.2. c) Corrected brightness values
of 1xmEGFP, 2xmEGFP (both: cytoplasmic fraction only), and NEP-mEGFP-N1 as a
function of protein concentration. Dotted lines indicate median values obtained from pooled
data for each sample, respectively. Plotted data are shown as mean±SD.
Finally, the monomer- and dimer-fractions of NEP in dependence of its subcellular
localization were calculated from median brightness values of experiments previously
described (see Fig. 3.24). In the cytoplasm of transfected cells ∼20% of the observed
NEPs formed homo-dimers. In contrast, the homo-dimer fraction in the nucleus
was reduced by one half. Additionally, Fig. 3.24b shows a theoretical prediction for
the proportion of n-mers with respect to the homo-oligomer size, assuming that
NEP does not partially form homo-dimers as done in this study, but is present in
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a mixture of monomers and homo-trimers or -tetramers. For both compartments,
resulting homo-oligomer fractions would be in a range lower than 5% of all observed
molecules. Furthermore, in Fig. 3.24c brightness values for NEP and both controls,
1xmEGFP and 2xmEGFP, are plotted as a function of protein concentration. All
average brightness values fluctuated around the median values obtained from pooled
data for the concentration range (10 to 500 nM) tested in this study.
Consistent with the previously described brightness analysis results, NEP homo-
dimer fractions increased in both compartments when cells were additionally treated
with LMB. However, the differences in dimer-populations were less pronounced
than in untreated samples. In contrast, in competition experiments, i.e. co-infected
with A/WSN virus, almost all observed NEP proteins appeared monomeric in both
compartments. Finally, in contrast to NEP-mEGFP-N1, in cells expressing NEP
with a N-terminal fusion tag (’NEP-mEGFP-C1’) no homo-dimers were observed,
neither in the cytoplasm, nor in the nucleus.
3.4.4 Influence of the conserved residue Ser24 on NEP
dimerization
NEP is known to be phosphorylated during the course of infection (Richardson and
Akkina, 1991). In between the two NESs of NEP three highly conserved consecutive
serins are located. Of these conserved three residues Ser24 is surface-exposed and
unambiguously phosphorylated (Darapaneni et al., 2009, Hutchinson et al., 2012).
Therefore, two NEP mutants with AA-exchange of Ser24 were investigated for their
influence on NEP dimerization. In NEP-S24E Ser24 is exchanged against Glu to
introduce a permanent negative charge, thus mimicking constant phosphorylation. In
NEP-S24A Ser24 is exchanged against Ala to introduce a permanent neutral charge,
thus mimicking constant de-phosphorylation. Furthermore, to rescue mutant viruses,
an alternative pHW2000 plasmid seperatly expressing NS1 and NEP, was cloned. In
this plasmid alternative splicing of NS1-NEP-mRNA is prevented by mutation of the
NS1 splice acceptor. To ensure protein expression of both proteins, the 2A moiety
of porcine teschovirus-1 (PTV2A) is encoded in between NS1 and NEP sequences.
PTV2A allows the ribosome to ’skip’ during elongation, i.e. two proteins without
a linker are synthesized without stopping translation (Donnelly et al., 2001). In
this way, viral mutants possessing distinct NEP mutations can be rescued without
altering the NS1 sequence. Cartoons depicting the different expression constructs are
shown in Fig. 3.25a. Moreover, it was shown that late in infection plasma membrane
bound HA induces MAPK signalling, potentially phosphorylating a target protein
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within the nucleus to promote export of progeny vRNPs (Marjuki et al., 2006, 2007).
Therefore, two kinase inhibitors, H7 and U0126, were tested for their influence on
NEP dimerization. The mode of action of these kinase inhibitors is illustrated in
Fig. 3.25b.
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Figure 3.25: Expression constructs and kinase inhibitors used to investigate ef-
fects of Ser24 phosphorylation on NEP dimerization. a) Cartoons of NEP-mEGFP-
N1 wt, NEP-S24E/-S24A mutant constructs, and the NS1-NEP pHW2000 plasmid. This
construct expresses NS1, and NEP separatly. In between both coding sequences the 2A
moiety of porcine teschovirus-1 (PTV2A) is encoded to allow the ribosome to ’skip’ dur-
ing elongation, i.e. to translate two proteins without a linker and stopping translation.
b) Schematic representation illustrating the mode of action of two kinase inhibitors: H7 and
U0126. Both act on the MAPK signalling pathway. PKC: Protein kinase C, MEK/MAP2K:
Mitogen-activated protein kinase kinase, ERK: extracellular signal-regulated kinase.
First, NEP localization phenotypes of NEP-S24/-S24A, and cells expressing NEP
wt but treated with kinase inhibitors U0126 and H7 were quantified by calculating
the nucleus to cytoplasm intensity ratios (’N/CP’) (see Fig. 3.26a and b). Although
neither the two mutants, nor kinase treatment resulted in distinct differences to the
NEP wt localization phenotype, distributions of the N/CP-ratio shifted marginally
towards 1 for mutant S24A and kinase-treated cells expressing NEP wt. Nevertheless,
exchange of Ser24 against Glu or Ala resulted in a significant slow-down of growth
kinetics for the corresponding mutant viruses. Moreover, although not significantly
different, viral titer for mutant S24E viruses were slightly lower than for virus mutant
S24A. In contrast, wild-type A/WSN virus rescued using the standard pHW2000
plasmid system, and A/WSN viruses rescued using the modified NS1-NEP version
resulted in similar growth kinetics.
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Figure 3.26: Effect of Ser24 phosphorylation on the subcellular localization of
NEP, and viral growth. a) Representative intensity images of A549 cells transiently
transfected with plasmids expressing NEP-mEGFP-N1, NEP-S24E-mEGFP, and NEP-
S24A-mEGFP. Additionally, A549 cells expressing NEP-mEGFP were treated with two
kinase inhibitors, U0126 (50 μM) and H7 (75 μM), for 4 h before measurements were
performed. Scale bars: 5 μm. b) Frequency distribution of the nucleus to cytoplasm ratio
(’N/CP’) of EGFP intensities of indicated samples. Altogether 300 to 500 cells obtained
from three independent experiments were analysed. First, the median intensity of a region of
interest in each compartment was recorded. Second, background substraction was performed
individually for each image. CP: Cytoplasm, N: Nucleus. c) Viral growth curves of mutant
viruses were analysed in duplicates for two independent experiments. First, viruses were
rescued from transfected HEK 293T cells as described in Methods section 2.2.5. A/WSN
was grown using the standard pHW2000 plasmid system. NS1-NEP virus was rescued using
the pHW2000 construct illustrated in Fig. 3.25a, lower panel. The same plasmid was used
to generate mutant viruses with AA-exchange of Ser24. After virus rescue, 3.2x106 MDCK
II cells were infected with 200PFU/mL of indicated viruses. Samples were taken 12, 24,
48, and 74 hpI, and virus titers determined as described in Methods section 2.2.5. ****, **,
and * indicate significance with p<0.0001, p<0.002, and p<0.03, respectively, obtained
by comparing mutants to NS1-NEP using a two-tailed t-test with Welch’s correction; ns
indicates no significance. Plotted data are shown as mean±SD.
Then, oligomerization of NEP mutants was analysed by performing molecular bright-
ness analysis, and monomer- and dimer-fractions were calculated using the obtained
average brightness values (see Fig. 3.27 on the following page). Whereas the average
brightness values and related NEP dimer populations did not significantly change
with kinase treatment, AA-exchange showed a stronger effect on NEP dimerization.
Although brightness values in both, cytoplasm and nucleus for NEP-S24E were
not significantly different from NEP wt, the resulting dimer fractions considerably
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decreased. Only a small dimer population with equal amounts in both compartments
was observed. In contrast, Ser24 exchange against Ala resulted in a strong increase
in dimer fractions in the cytoplasm and nucleus of transfected cells. However, the
relative difference of dimer populations in both compartments observed for NEP wt
(CP/N ∼2.4) did not change drastically for S24A (CP/N ∼1.9).
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Figure 3.27: Effect of Ser24 phosphorylation on the oligomerization of NEP.
a) Box plots represent corrected molecular brightness data obtained from pFCS measure-
ments. A549 cells were transfected with plasmids expressing NEP-mEGFP-N1 (’NEP wt’),
or the mutated variants NEP-S24E and NEP-S24A. Additionally, cells expressing NEP
wt were treated with U0126 (50 μM), or H7 (75 μM) 4h prior to pFCS measurements.
Brightness correction after normalization was performed using a fluorescence probability of
pf=0.72, as obtained from 2xmEGFP measurements. Presented data were obtained from
at least four independent experiments; 1xmEGFP/2xmEGFP/NEP wt/NEP-S24E/NEP-
S24A/NEP+U0126/NEP+H7: n=358/318/275/119/67/66/63 cells. ****, and ** indicate
significance with p<0.0001 and p<0.002, respectively, obtained by using a one-way ANOVA
Turkey’s multiple comparisons test; ns indicates no significance. b) Monomer- and dimer-
fractions of indicated samples were calculated from median corrected brightness values of
a) following the description in Methods section 2.2.8.2.
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3.4.5 Role of NES1 and NES2 on NEP dimerization
The two NESs of NEP are highly conserved among IAVs (Huang et al., 2013).
Hypothesizing an influence of the oligomeric state of NEP on its nuclear export
dynamics in dependence of the two NESs, several NES mutants were investigated
for their influence on subcellular localization and NEP dimerization. Schematic
representations highlighting the mutations in NEP are shown in Fig. 3.28. In mutants
mNES1 and mNES2 conserved hydrophobic residues were exchanged against the
hydrophpbic AA Ala. These mutations are known to decrease interaction of NEP with
CRM1 by influencing the interaction of either NES1 (’mNES1’) or NES2 (’mNES2’)
with CRM1 (Huang et al., 2013). Further, several deletion or exchange mutants,
namely ’2xNES1’, ’2xNES2’, ΔNES1, ΔNES2, and NES2-1 were tested.
Figure 3.28: Schematic illustration of NEP-NES mutants. Cartoons of expression
constructs of NEP-mEGFP-N1 wt, and indicated NEP-mEGFP-NES1 and -NES2 mutants.
In mutants mNES1 and mNES2 conserved hydrophobic residues were exchanged against
the hydrophpbic AA Ala as indicated.
The subcellular localization of these mutants in A549 cells is exemplarily shown in
Fig. 3.29a. Further, subcellular localization phenotypes were quantified and nucleus
to cytoplasm (’N/CP’) intensity ratios calculated (see Fig. 3.29b). The observed
phenotypes can be grouped into three sub-groups: (I) stronger exclusion from the
nucleus than NEP wt (2xNES2 and NES2-1), (II) similar subcellular localization as
NEP wt (2xNES1 and mNES2), and (III) shift towards a homogeneous distribution
between nucleus and cytoplasm (mNES1, ΔNES1, and ΔNES2).
Furthermore, mutant viruses using the alternative pHW2000 plasmid, seperatly
expressing NS1 and NEP as already described, were rescued. Whereas no mutant
viruses were successfully rescued for ΔNES1, ΔNES2, and NES2-1 NEP mutants
(see Fig. 3.29c, inset plot), viral mutants possessing NEP variants with either two
NES1 or two NES2 were rescued and showed similar growth kinetics as NS1-NEP or
wild-type A/WSN virus.
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Figure 3.29: Effect of NES1 and NES2 mutations on the subcellular localization
of NEP, and viral growth. a) Representative intensity images of A549 cells transiently
transfected with plasmids expressing NEP-mEGFP-N1 wt, and indicated NES1 and NES2
mutants. Scale bars: 5 μm. b) Frequency distribution of the nucleus to cytoplasm ratio
(’N/CP’) of EGFP intensities of indicated samples. Altogether ∼300 to 500 cells obtained
from three independent experiments were analysed. First, the median intensity of a region of
interest in each compartment was recorded. Second, background substraction was performed
individually for each image. CP: Cytoplasm, N: Nucleus. c) Viral growth curves of mutant
viruses were analysed in duplicates for two independent experiments. First, viruses were
rescued from transfected HEK 293T cells as described in Methods section 2.2.5, see also
inset plot for several mutants. After virus rescue, 3.2x106 MDCK II cells were infected
with 200PFU/mL of indicated mutants. Then, samples were taken 12, 24, 48, and 74 hpI,
and virus titers determined as described in Methods section 2.2.5.
Eventually, molecular brightness analysis for all NEP-NES mutants was performed
and the dimer- and monomer-fractions in dependence of the subcellular localization
were quantified as depicted in Fig. 3.30a and b, respectively. Exhibited brightness
values, and thus dimerization in dependence of the subcellular localization were very
different for the different NES mutants of NEP. For mutants mNES1 and ΔNES1
equal brightness values in the cytoplasm and nucleus were observed, and thus also
the difference in dimer-fractions between both compartments as observed for NEP
wt was not present. Besides, for both mutants an increase in dimer fractions was
observed in both compartments.
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Figure 3.30: Influence of NES1 and NES2 on the oligomerization of NEP.
a) Box plots represent corrected molecular brightness data obtained from pFCS
measurements. A549 cells were transiently transfected with plasmids expressing NEP-
mEGFP-N1 (NEP wt), or the indicated mutant variants. Brightness correction was
performed, using a fluorescence probability of pf=0.72, as obtained from 2xmEGFP
measurements. Presented data were pooled from at least three independent experiments;
1xmEGFP/2xmEGFP/NEPwt/mNES1/mNES2/2xNES1/2xNES2/ΔNES1/ΔNES2/NES2-1:
n=310/268/273/29/29/48/39/36/38/34 cells. ****, and * indicate significance with
p<0.0001 and p<0.03, respectively, obtained by using a one-way ANOVA Turkey’s multiple
comparisons test; ns indicates no significance. Results of cytoplasmic measurements for all
mutants were compared to NEP wt cytoplasmic fraction (’CP/CP’), nuclear measurements
to NEP wt data obtained from nuclear measurements (’N/N’), respectively. b) Monomer-
and dimer-fractions of indicated samples were calculated from median corrected brightness
values of a) following the description in Methods section 2.2.8.2.
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In contrast to that, mutants mNES2 and ΔNES2 resulted in only minor differences
compared to the distributions in brightness, and thus dimer fractions of NEP wt.
Nevertheless, dimer fractions for mNES2 were slightly higher than observed for NEP
wt. For NEP mutants still possessing two functional NESs of either different position
(NES2-1), or twice the same NES (2xNES1, 2xNES2), distinctly different results were
observed. In all cases brightness values were higher in the cytoplasm compared to the
nucleus, similar to the observations made for NEP wt. However, whereas for 2xNES1
distribution and level of dimer fractions in both compartments was very similar to
that of NEP wt, for 2xNES2 and NES2-1 a drastic decrease in dimer fractions was
observed. Whereas a small dimer-fraction was still observed in the cytoplasm, NEP
mutants were purely monomeric in the nucleus.
3.4.5.1 Influence of NES mutants on CRM1-dependent nuclear export
Although the two NESs of NEP are highly conserved among IAVs, the CRM1
dependence of NES1 and NES2 of NEP is still not fully investigated and contradictory
results are obtained for different virus subtypes, mutant NES versions, and differently
labelled fusion proteins of NEP. Therefore, the dependence of successful NEP export
on the respective interaction of its two NESs with CRM1 was indirectly investigated
by quantifying the subcellular localization of NEP and mutant versions in the presence
of the small molecule inhibitor LMB. In Fig. 3.31a representative intensity images
of A549 cells expressing either NEP wt or mutant versions are shown as indicated.
In all cases, NEP distribution appeared more homogeneous in LMB treated cells
(’+LMB’) compared to untreated samples (’-LMB’). Additionally, the localization
phenotype of all mutants was quantified for LMB treated cells and compared to
the respective untreated localization pattern, as well as NEP wt localization as
shown in Fig. 3.31b - g. The localization of NEP wt shifted from a predominantly
cytoplasmic localization towards a more homogeneous distribution when cells were
treated with 6 nM LMB. Similar results were observed for NEP mutants possessing
either two NESs1 (’2xNES1’), two NESs2 (’2xNES2’), or a position exchange of NES1
and 2 (’NES2-1’). Although not all mutants showed an exclusively homogeneous
intensity distribution after LMB treatment, the relative change in intensity was very
similar for all three mutants, even if slightly less pronounced for the mutant 2xNES1.
For NEP mutants possessing only one of the two NESs, i.e. ΔNES1 or ΔNES2, a
rather homogeneous intensity distribution was observed already in untreated cells.
Nevertheless, the N/CP-peak of the observed frequency distribution for cells treated
with LMB slightly shifted towards a more homogeneous intensity distribution between
nucleus and cytoplasm.
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Figure 3.31: Role of NES1 and NES2 in CRM1 binding investigated using
the small molecule inhibitor LMB. a) Representative intensity images of A549 cells
transiently transfected with indicated NEP mutants, either untreated (’-LMB’) or treated
with 6 nM LMB (’+LMB’) for 4 h. Frequency distributions of the nucleus to cytoplasm
ratio (’N/CP’) of EGFP intensities of b) NEP wt, c) NEP-2xNES1, d) NEP-2xNES2,
e) NEP-ΔNES1, f) NEP-ΔNES2, and g) NEP-NES2-1. Results of untreated samples were
taken from experiments described in Fig. 3.29. Altogether ∼300 to 500 cells obtained
from three independent experiments were analysed. For LMB treated samples, data were
obtained from ∼100 to 300 cells of two independent experiments. Scale bars: 5 μm. CP:
Cytoplasm, N: Nucleus.
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3.4.6 Transport dynamics of NEP across the nuclear envelope
It was already shown that NEP passively diffuses into the nucleus (Gao et al., 2014),
but is exported by hijacking the CRM1-dependent nuclear export pathway (Huang
et al., 2013). Hypothesising a regulation mechanism for NEP translocation across
the nuclear envelope based on a masking-unmasking process for both NESs through
dimerization, transport dynamics in dependence of the oligomeric state were analysed.
Therefore, SPIM-FCS measurements were performed followed by pCF analysis. First,
shuttling dynamics of NEP wt were investigated to test whether passive diffusion
into the nucleus and active transport out of the nucleus can be distinguished by pCF
analysis.
In Fig. 3.32 results of a SPIM-FCS measurement of NEP-mEGFP are shown. A region
spanning the nuclear envelope of A549 cells expressing NEP-mEGFP was imaged with
an exposure time of 1ms and an acquisition of 100,000 frames in total. Cytoplasmic
and nuclear regions were manually segmented and fluorescence fluctuations analysed
for each pixel individually over all frames, i.e. over time. Resulting ACFs for each
pixel, diffusion maps, and frequency distributions of obtained diffusion coefficients
D are shown in Fig. 3.32b and c. Average diffusion coefficients of ∼16.5 μm2s–1 and
∼19.3 μm2s–1 were observed in the cytoplasm and nucleus, respectively.
Next, diffusion dynamics were additionally extracted from pCF analysis performed in
space and time individually for each compartment. In both compartments, cytoplasm
(Fig. 3.33) and nucleus (Fig. 3.34), all pixels with equal distances were correlated and
resulting pCFs averaged. Then, a free diffusion model was fitted to the data (solid
lines) as described in Methods section 2.2.8.3 using Eq. 2.24. An example explaining
pCF analysis is given in Fig. 2.3 in Methods section 2.2.8.3. In brief, the closer two
spatially separated pixels are, the more likely it is to observe a molecule diffusing
from one into the second pixel. Thus, for short distances, fluctuations in space will
be correlated on short time scales. Further, due to spatial cross-talk, obtained pCFs
with one to two pixels distance appear very similar to an actual ACF. The longer the
distance between two pixels, the more uncorrelated fluctuations on the short time
scale are, as the molecule detected in the first pixel needs a certain time to reach the
second pixel, in dependence of its diffusion dynamics. Hence, for short time scales
the amplitudes of pCFs converge to zero, whereas a correlation, and thus peak will
be observed for longer time scales. Furthermore, the longer the distance between
two pixels, the more unlikely it is to observe a correlation as the molecule moves in
3-D, and thus may not pass the second pixel. This way, diffusion dynamics can be
extracted from the peak position of pCFs.
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NEP-mEGFP 
Figure 3.32: NEP-mEGFP dynamics in dependence of the subcellular localiza-
tion determined by SPIM-FCS. a) The left panel shows an average intensity projection
of an image frame of a region of interest spanning the nuclear envelope of an A549 cell
expressing NEP-mEGFP. The right panel shows the intensity distribution of the same
region, and was used to manually segment the cytoplasm and nucleus of the cell for further
analysis. From top to bottom: Intensity distributions, diffusion maps, ACFs for each pixel
of the respective diffusion map, and frequency distributions of the resulting diffusion
coefficients D as obtained from NEP-mEGFP in the b) cytoplasm and c) nucleus of the
measurement depicted in a).
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For both compartments, cytoplasm and nucleus, the longest possible distance that
could be correlated was a seven-pixel distance (equals 2.8 μm). Already at this distance,
data were difficult to fit with a 3-D free diffusion model. However, in both cases,
diffusion coefficients D could be extracted from fit curves for five individual A549
cells expressing NEP-mEGFP. In the cytoplasm and nucleus diffusion coefficients
D obtained from ACFs and pCFs(1) were in the range of ∼35-38 and 21-24 μm2s–1,
respectively. For larger distances diffusion coefficients D decreased, reaching values
of ∼7 μm2s–1 in the cytoplasm, and ∼8 μm2s–1 in the nucleus of A549 cells.
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Figure 3.33: Diffusion dynamics of NEP-mEGFP in the cytoplasm of A549
cells obtained from pCF analysis. SPIM-FCS measurements were performed in A549
cells expressing NEP-mEGFP. 100,000 frames per cell were acquired with an exposure time
of 1ms. a) Representative results of ACF and pCF analysis for indicated pixel distances.
pCFs were calculated by averaging all data with same pixel distances in the cytoplasm of
A549 cells. Fit curves (solid line) were obtained by fitting a 3-D free diffusion model to
the data. pCF(1) corresponds to one pixel distance, pCF(2) to two pixels distance, etc.
One pixel corresponds to a distance of 400 nm within the cell. b) Diffusion coefficients D
of NEP-mEGFP in the cytoplasm of A549 cells obtained from fitting a 3-D free diffusion
model to the data. Data were pooled from five cells of two independent experiments.
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Figure 3.34: Analysis of diffusion dynamics of NEP-mEGFP in the nucleus of
A549 cells obtained from pCF analysis. SPIM-FCS measurements were performed
in A549 cells expressing NEP-mEGFP. 100,000 frames per cell were acquired with an
exposure time of 1ms. a) Representative results of ACF and pCF analysis for indicated
pixel distances. pCFs were calculated by averaging all data with same pixel distances in the
nucleus of A549 cells. Fit curves (solid line) were obtained by fitting a 3-D free diffusion
model to the data. pCF(1) corresponds to one pixel distance, pCF(2) to two pixels distance,
etc. One pixel corresponds to a distance of 400 nm within the cell. b) Diffusion coefficients
D of NEP-mEGFP in the cytoplasm of A549 cells obtained from fitting a 3-D free diffusion
model to the data. Data were pooled from five cells of two independent experiments.
Then, diffusion dynamics across the nuclear envelope were investigated by pCF
analysis performed in both directions: from cytoplasm to nucleus and from nucleus
to cytoplasm. To avoid spatial cross-talk, pixel pairs closer than three pixels distance
around the nuclear envelope were excluded from the analysis. Analysis was performed
for A549 cells, expressing either NEP-mEGFP, or one of the two controls: EGFP
fused to a NES or NLS. Whereas EGFP-NES should be exported out of the nucleus
by active transport but diffuse into the nucleus, EGFP-NLS should translocate into
the nucleus by active transport and diffuse out of the nucleus. In all three samples,
pCFs of pixel pairs with distances ranging from three to eight pixels were analysed
as shown in Fig. 3.35.
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Figure 3.35: Analysis of translocation dynamics of NEP-mEGFP through the
nuclear envelope of A549 cells using pCF analysis. SPIM-FCS measurements were
performed in A549 cells expressing NEP-mEGFP, or EGFP fused to a NES or NLS.
100,000 frames per cell were acquired with an exposure time of 1ms. pCF analysis for all
measurements was performed across the nuclear envelope. To avoid spectral cross-talk,
pixel pairs closer than three pixels distance were excluded from calculations. Thus far,
there is no analytical model for pCF analysis describing the transport of molecules across a
diffusion barrier. Therefore, no analytical model was fitted to the obtained data. a) pCFs
for indicated pixel distances were calculated by averaging all data with same pixel distances
for five individual cells expressing NEP-mEGFP. b) pCFs for indicated pixel distances were
calculated by averaging all data with same pixel distances for five individual cells expressing
mEGFP-NES. c) pCFs for indicated pixel distances were calculated by averaging all data
with same pixel distances for seven individual cells expressing mEGFP-NLS.
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Thus far, there is no analytical model for pCF analysis describing the transport
of molecules across a diffusion barrier. Hence, an analytical model could not be
fitted to the obtained data; nevertheless, peak positions can be estimated. Peak
positions for NEP measurements were in the range of ∼0.01 to 0.1ms for pCF(3) to
pCF(5), whereas for longer distances peak positions were around 0.1ms. However,
no shifts between peaks obtained from directional analysis, i.e. from cytoplasm to
nucleus or vice versa, were observed. Similar results were observed for EGFP-NES
and EGFP-NLS measurements, although no peaks could be identified for distances
larger than six or seven pixels. In general, data obtained for EGFP-NES were more
noisy than for EGFP-NLS. For this reason, no diffusion times could be estimated
for EGFP-NES, whereas for EGFP-NLS peak positions were ∼0.5ms. Again, no
differences for data obtained from directional analysis were observed.
Eventually, fit curves obtained from analysis in single compartments were plotted
together with data obtained from analysis of directional transport across the nuclear
envelope to distinguish transport dynamics of NEP. For 4 to 6 pixels distance the
apparent peaks of pCFs across the nuclear envelope were slightly sifted towards faster
diffusion times compared to the peaks of fit-curves calculated from data in single
compartments. However, differences in peak positions of directional transport from
cytoplasm to nucleus and vice versa were not observed.
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Figure 3.36: Comparison of translocation dynamics of NEP-mEGFP within
single compartments, and through the nuclear envelope of A549 cells. Fit curves
of pCF(4), pCF(5), pCF(6), and pCF(7) obtained from SPIM-FCS measurements in the
cytoplasm or nucleus of A549 cells were taken from measurements described in Fig. 3.33a,
and Fig. 3.34a, respectively. Furthermore, corresponding pCFs of translocation dynamics
across the nuclear envelope of NEP-mEGFP in A549 cells are plotted. Data were taken
from measurements described in Fig. 3.35a.
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4 Discussion and Outlook
The main focus of this study was to probe interactions of IAV proteins building
up the viral nuclear export complex. These days, a vast amount of biochemical
and biophysical methods exist to investigate protein interactions, all possessing
different advantages and disadvantages. Classical biochemical assays are mainly bulk
techniques only reporting general informations of a heterogeneous sample. Commonly
used examples are co-immunoprecipitation (co-IP) or pull-down assays (reviewed in
Phizicky and Fields (1995) and Xing et al. (2016)). In co-IP a whole protein complex
is specifically precipitated from a heterogeneous sample in vitro, using an immobilized
antibody reacting with one protein out of the complex. Thus, the whole complex
is co-precipitated. In contrast, in pull-down assays one protein (’bait’) predicted
to interact with other proteins, is directly used to purify any other protein of a
heterogeneous sample that binds to the bait. Finally, in both approaches samples are
routinely analysed by SDS-PAGE and Western Blot. Usually, when applying these
methods, strong protein interactions are necessary, as well as careful evaluation of
buffer conditions during precipitation to avoid disruption of the complex (reviewed in
Phizicky and Fields (1995) and Xing et al. (2016)). This issue can be circumvented
by performing chemical cross-linking before complex isolation. However, whether
an interaction will be observed or not, may strongly depend on the spacer length
of the chosen cross-linker. For example, Akarsu et al. (2003) used EGS (spacer
length: 16Å) to probe oligomerization of purified IAV NEP, which resulted in a not
further discussed small dimer-fraction. In contrast, Golovko et al. (2017) recently
detected a significant NEP-dimer fraction in purified samples by using a different
cross-linker, glutaraldehyde, that possesses a significantly shorter spacer length of
only 5Å. These contradictory results clearly demonstrate the importance of carefully
choosing the right experimental conditions in biochemical assays. However, one major
advantage of biochemical assays is, that they are mainly label-free, thus avoiding any
issues regarding fluorescent protein maturation or inhibition of interactions due to
steric interference by a huge label. Nevertheless, despite improvements in extraction
conditions and sensitivity of downstream analysis such as mass spectrometry to
detect weaker protein interactions, all applications lack spatial and/or temporal
resolution, since mainly bulk experiments are performed.
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These disadvantages have been partially overcome by applying different microscopy
techniques directly in living cells, e.g. FRET or BiFC (reviewed in Kerppola (2006)
and De Los Santos et al. (2015)). In both approaches, proteins predicted to interact
are genetically fused to fluorescent proteins. In FRET, interacting partners are fused
to spectrally different fluorescent proteins with overlapping emission and excitation
spectra. Only when both protein partners interact, the fused fluorescent proteins are
in close proximity. Then, the fluorescence acceptor will be excited by emitted photons
of the fluorescent donor through energy transfer. However, this method is highly
sensitive to fluorophore concentration and emission intensity. This disadvantage was
overcome by combining FRET with FLIM. Herein, the energy transfer from donor to
acceptor will lead to a decrease in fluorescence lifetime of the donor molecule. FLIM-
FRET is therefore donor lifetime dependent, but intensity independent, and thus a
more reliable reference to report protein interactions (reviewed in De Los Santos et al.
(2015)). In BiFC, N- and C-terminal fluorescent protein fragments are genetically
fused to two proteins that are predicted to interact. Only when both proteins interact,
the fragments will be brought into close proximity, allowing the fluorescent protein to
reconstitute into its native structure, thus emitting a fluorescent signal. However, this
reconstitution can take up to 50min, thereby strongly reducing temporal resolution
(reviewed in Kerppola (2006)). Although both methods overcome spatial and partially
temporal resolution limits, both methods are highly distance dependent. Hence,
successful application relies on carefully choosing the label position. Alternative
approaches encompass several fluorescence fluctuation spectroscopy methods. For
instance FCS, FCCS, and N&B allow for the quantification of molecule dynamics and
interactions directly in living cells. Although proteins of interest are genetically fused
to a certain fluorescent protein, and thus proper protein maturation and function
need to be ensured, these methods provide high spatial and temporal information.
FCS allows for the quantification of very fast dynamics raging from ns to the ms range.
Although the diffusive motion of molecules is usually analysed in FCS, any other
process causing characteristic fluctuations including chemical reactions, excitation
state transitions, specific diffusion types or flow, and bleaching can be observed
(reviewed in Fitzpatrick and Lillemeier (2011)). Theoretically, protein interactions or
ligand binding to a receptor can be investigated by analysing differences in diffusion
dynamics applying single-colour FCS (a list of applications can be found in Briddon
and Hill (2007)). However, this is only possible when the majority of molecules undergo
a significant reduction in mobility. According to the Stokes-Einstein equation D can
be described as:
D = kBT6piηRh
, (4.1)
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where kB is the Boltzmann’s constant, T the temperature, η the viscosity of the
solvent, and Rh the hydrodynamic radius of the molecule. Since D is inversely pro-
portional to the hydrodynamic radius, D will also be inversely proportional to the
cubic root of the molecule volume (important: not the same as MW). Thus, a large
change in molecule volume (e.g. eight-times increase) is necessary to observe a small
change in D (e.g. two-times decrease), and thus binding or interaction of molecules
in FCS applications. Therefore, to probe interaction of molecules using fluorescence
fluctuation spectroscopy, two more elegant ways can be applied: dual-colour FCCS
and molecular brightness analysis.
In FCCS simultaneous fluctuations of two differently labelled species are statisti-
cally analysed by calculating the amplitude ratios of the ACFs and obtained CCF
(see Method section 2.2.8.1 and Eqn. 2.15). Only when both fluorescent labels con-
tribute to simultaneous time-dependent fluctuations due to protein interaction, a
positive cross-correlation will be observed. Thus, detection of interaction is no longer
dependent on a subtle shift in mobility. In particular, hetero-interactions of 1:1
stoichiometry can easily be investigated. For other stoichiometries, more complex
analyses, or a combination with molecular brightness analysis is necessary (Huet
et al., 2010, Kim et al., 2005). Molecular brightness analysis is a powerful tool
to especially probe oligomerization of proteins. The molecular brightness ε of a
fluorescent protein denotes the average photon number detected per molecule per
second. Therefore, by comparing the obtained brightness value of an oligomer to a
monomeric reference, information about the number of fluorescent protein subunits,
and thus the oligomeric state of a protein can be investigated.
In summary, fluorescence fluctuation spectroscopy methods are powerful tools to
study various biological processes relying on time-, and localization-dependent pro-
tein interactions; hundreds of proteins are simultaneously analysed during a single
measurement, and measurements can be performed in the native environment of
living cells at specific locations.
4.1 Characterization of the applied microscopy
instrumentation and used fluorescent proteins
In principle, all considerations drawn for FCCS and discussed in this section, apply
similarly to FCS. However, whereas few parameters are very important to consider in
FCCS as they lead to cross-correlation artefacts, such as observation volume displace-
ment or spectral cross-talk, they are irrelevant for single-colour FCS applications.
Therefore, first, optimal instrumentation parameters were determined to successfully
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perform FCS, and FCCS measurements and second, cross-correlation artefacts will
be discussed. In this study, all fit curves of in-cell measurements were obtained from
fitting a 3-D anomalous diffusion model to the data (see Methods section 2.2.8.1,
Eqn. 2.14), assuming a Gaussian-shaped observation volume. However, Hess and
Webb (2002) were able to show, experimentally and theoretically, that the assumption
of a Gaussian-shaped observation volume is only true for very specific measurement
conditions in one-photon excitation, whereas in two-photon excitation artefacts
are almost eliminated. In general, for precise model fitting, and thus extraction of
information about the diffusion time τd and number of molecules N, a high signal
per molecule and with that a high SNR of ACFs and CCFs is necessary. Nevertheless,
according to Hess and Webb (2002), in measurements performed with one-photon
excitation there is always a trade-off between optimizing SNR for precise fitting, and
reducing experimental artefacts. Therefore, optimal correction collar ring position
(see Fig. 3.2), pinhole diameter (see Fig. 3.3), and laser power (see Fig. 3.4) were
evaluated for their influence on (I) molecular brightness ε, (II) SNRs of the obtained
correlation functions, and (III) maximum cross-correlation amplitude by measuring
mEGFP-mCherry2 hetero-dimers expressed in the cytoplasm of A549 cells.
When using water-immersion objectives, a correction collar ring on the objective
is used to correct for aberrations caused by the coverglass of a certain thickness
(here: 170±5 μm) that possesses another refractive index than water (nglass=1.5230,
nH2O=1.333). A central lens group is adjusted such that aberrations coincide with
coverglass thickness, thereby correcting for observation volume distortions and dis-
placement in z-direction, which potentially causes a decrease of cross-correlation
amplitudes (Weidemann et al., 2002). The correction collar position compensating
for a coverglass thickness of 170 μm resulted in the best compromise between molec-
ular brightness, and therewith SNR for both fluorescent proteins, and maximum
cross-correlation (see Fig. 3.2). A compensation for thicker coverglass (collar position
180 and 190) resulted in a strong decrease in brightness and, most drastically for
mEGFP, a decrease in SNR, even though the cross-correlation was almost constant.
This indicates that axial overlap of the two observation volumes is already maximal,
and further correction may only lead to distortions of the detection volumes as
brightness decreased (Bacia and Schwille, 2007). Therefore, to avoid distortion of the
observation volume and thus non-precise fitting, correction collar compensation was
restricted to position 170. Theoretically, alignment of the two observation volumes
through lens group adjustment can be verified by performing a z-scan of a fluorescent
dye pair. As recommended by Bacia and Schwille (2007), a phospholipid bilayer
simultaneously labelled with a green and red dye could be used to analyse the
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intensity overlap relative to the z-position for different collar ring positions, since
labels are almost restricted in 2-D. After finding the optimal intensity overlap, and
thus observation volume overlap, a solution of molecules simultaneously labelled with
the same dyes would be used to analyse the influence on correlation-amplitude ratios.
Due to the fact that all measurements in this study were performed within nucleus
and cytoplasm of cells, a precise z-scan that would be necessary for this optimization,
was not performed, since the fluorescent proteins are not restricted in 2-D.
Further, in confocal microscopy a detection pinhole is placed in front of the detection
element. It removes any extra non-focal emission, thus restricting the signal detection
to the focal plane and increasing resolution in z-direction, but not x-y-direction.
Only the inner part of a diffraction pattern is transmitted through the pinhole. The
size of this feature, also termed airy disc, highly depends on the used wavelength,
the numerical aperture, and the lateral magnification of the objective. In the setup
used in this study, the optimal pinhole diameter for the combination of objective
and excitation at 488 nm is 135 μm, as recommended by the manufacturer. Indeed,
brightness, and thus SNR increased from rather small pinhole diameters, starting at
50 μm (smallest size possible), up to 120 μm (compare Fig. 3.3a and b). As a rule of
thumb, widefield-illumination is reached when the pinhole diameter is bigger than
two airy disc units, i.e. for the used setup when the pinhole diameter is larger than
270 μm. Thus, the further the pinhole diameter increases, the more the overall signal
will increase as more non-focal emission is detected. For the pinhole diameter range
tested here, SNRs reached a plateau, whereas molecular brightness of mEGFP and
mCherry2 started to decrease again. This effect is expected to be even stronger with
further increasing the pinhole diameter. However, this was not done in this study as
it is recommended to use a smaller pinhole diameter than the optimal value to avoid
optical artefacts, although reducing brightness and SNR (Hess and Webb, 2002).
Furthermore, FCCS should finally be applied to quantify the stoichiometry of IAV
nuclear export complexes on isolated vRNPs of which interaction strengths are not
known yet. For observation volumes of ∼0.2 fL Kd-values of ∼30 nM can be measured,
whereas for weaker interactions a larger observation volume of ∼1 fL is necessary
to increase detection statistics of these rare interaction events (Bacia and Schwille,
2007, Schwille et al., 1997). For comparison, EGFR, a receptor predicted to be
important for IAV internalization, was reported to exist in two receptor populations;
one with high binding affinity of 10 - 100 pM, and one with lower binding affinity
of 1 - 10 nM (Özcan et al., 2006). At least the lower binding affinity could still be
measured using FCCS with a rather large observation volume. As recommended
for cell measurements by Bacia and Schwille (2007), a pinhole diameter of 90 μm
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was finally used to increase brightness even though fit accuracy might decrease, to
compromise between observation volume distortion and possibly weak interaction
kinetics. Using these settings resulted in an observation volume of ∼0.6 - 0.9 fL.
Eventually, optimal laser power settings were determined. Usually, molecular bright-
ness should increase linearly with laser intensity and, in an appropriate laser intensity
range, parameters extracted from correlation functions, i.e. τd and N should stay
constant (Bacia and Schwille, 2007). Extracted parameters were quite constant
over the whole laser intensity range tested (see Fig. 3.4). As expected, molecular
brightness and with that SNR of the ACFs for mEGFP and mCherry2 increased
linearly for the same absolute laser power range (i.e. relative laser power of 0.5%
for the diode laser and 1% for the argon laser). When further increasing the laser
power in mCherry2 measurements, a threshold value is reached asymptotically, likely
due to excitation saturation (Nagy et al., 2005). It was decided to perform FCCS
measurements with 0.5% relative laser power for both fluorescent species, instead of
using a combination of 1% (mEGFP, argon laser) and 0.5% (mCherry2, diode laser),
since the contribution of cross-correlation artefacts would increase with increasing
ratio of mEGFP to mCherry2 signal.
Finally, in FCCS measurements, positive and negative cross-correlation artefacts can
occur and might need to be corrected. Positive cross-correlation artefacts direct to-
wards an overestimation of the interacting fraction as the cross-correlation amplitude
will increase. Such artefacts arise mainly from spectral cross-talk. Spectral cross-talk
leads to an increase in the cross-correlation amplitude, since emitted photons of one
of the excited fluorescent proteins contribute partially to the signal detected in the
second channel if both dyes are spectrally not well separated. Therefore, to avoid
spectral cross-talk, detection filters have been chosen in a way to minimizes cross-talk
(see Fig. 3.1). Indeed, for the used microscope setup, unidirectional spectral cross-talk
from mEGFP into the red detection channel (usually mCherry2) was marginal (see
Fig. 3.5b).
In the opposite case, negative cross-correlation artefacts, i.e. decreased cross-correlation
amplitudes, and thus an underestimation of the interacting fraction can occur. Three
parameters promote negative cross-correlation artefacts: (I) dark states, (II) FRET,
and (III) lack of observation volume overlap. Indeed, throughout all measurements
performed with mEGFP-mCherry2 hetero-dimers, a maximum cross-correlation of
50±10% was observed (see results in section 3.1). As determined in molecular bright-
ness analysis, which will be discussed in detail later in this section, mEGFP and
mCherry2 both have similar apparent fluorescent probabilities of ∼70%. Hence, not
all fluorescent proteins will emit photons, and contribute to intensity fluctuations
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over time. Thus, for fluorescent proteins the maximum achievable CCF amplitude will
always be lower than 100%. Therefore, for precise quantification of protein-protein
interactions it is necessary to perform control experiments, i.e. measuring a positive
control (mEGFP-mCherry2 hetero-dimer) and a negative control (mEGFP, mCherry2
co-expressed in a single cell), and finally relate the measured values to the maximum
achievable cross-correlation. Further, FRET can direct towards cross-correlation
artefacts, since the red shifted fluorescent protein will not only be excited by the
respective laser, but also by energy transfer of photons emitted by the fluorescent
protein excited at shorter wavelength. Actually, emission spectrum of mEGFP and
excitation spectrum of mCherry2 slightly overlap (see Fig. 3.1). Determination of an
intensity based FRET resulted in an efficiency of ∼6% for mEGFP-mCherry2 hetero-
dimers with a linker length of seven AAs. Theoretically, hetero-dimers with different
linker lengths, and its influence on FRET efficiency could be tested (Foo et al., 2012).
However, in an actual FCCS measurement both fluorescent protein tags might be
spatially not as close as in a hetero-dimer, thus FRET efficiency is expected to be
even lower, and therefore contribution to cross-correlation artefacts should decrease.
It is worth noting, that FRET efficiency was measured using mEGFP-mCherry2
hetero-dimers but exciting mEGFP only. Thus, all fully fluorescent active hetero-
dimers can contribute to the observed FRET signal. In contrast, if both fluorescent
proteins of the hetero-dimer are excited, FRET will actually lead to a decrease of the
CCF amplitude, since (I) not all fluorescent proteins might be fluorescently active,
and (II) not all red fluorescent proteins necessarily have a green interaction partner
(Foo et al., 2012). For precise determination of the FRET contribution to the CCF an
alternative excitation scheme, pulsed interleaved excitation (PIE), would be necessary.
Herein, two excitation sources are interleaved in a way that the photon emission
generated from the first excitation pulse is completed before the next excitation
pulse in the second channel arrives on the detector. Hence, the excitation source,
i.e. fluorescent protein, for each detected photon is known, and FRET can precisely
determined (Foo et al., 2012). However, PIE is not available on the used microscope
setup. In summary, spectral cross-talk was marginal and FRET contribution can not
be precisely determined with the used microscope instrumentation, but is expected
to be lower than determined for the hetero-dimer construct mEGFP-mCherry2.
Hence, corrections for cross-correlation artefacts were not performed. Finally, a lack
of observation volume overlap in one-photon excitation can occur. This lack depends
mainly on two parameters: First, using two different excitation wavelength results
in two observation volumes with slightly different dimensions, i.e. the observation
volume created by the longer wavelength excitation is slightly bigger, resulting in
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a higher molecule number N and increase in diffusion time τd. Second, the two
observation volumes can be displaced in 3-D, thereby reducing the cross-correlation
amplitude (Weidemann et al., 2002). One possibility to overcome these limitations is
to avoid usage of two different pathways by performing FCCS with single-wavelength
excitation (Hwang and Wohland, 2004). In this mode, two fluorescent proteins ideally
possessing similar excitation maxima, but largely different Stokes shifts to mini-
mize cross-talk, are excited using only one single laser line. Therefore, with the
setup used in this work, single-wavelength excitation of mEGFP, and a large Stokes
shift variant of mKate1 (LSS-mKate1, excitation maximum 463 nm) using 488 nm
argon laser excitation was tested (data not shown). Whereas mEGFP possesses
an emission maximum at 509 nm, LSS-mKate1 possesses an emission maximum
at 624 nm, and thus the fluorescent protein pair theoretically would be suitable
for single-wavelength excitation (Piatkevich et al., 2010). However, although LSS-
mKate1 was reported to be only 1.9-fold less photostable compared to mEGFP in
two-photon excitation (Piatkevich et al., 2010), LSS-mKate1 in one-photon excitation
almost immediately bleached, being completely dark at the end of the performed
experiment (data not shown). Therefore, single-wavelength FCCS was tried using
mEGFP (Ex./Em.: 488 nm/509 nm) and mCherry2 (Ex./Em.: 587 nm/601 nm) with
suboptimal excitation and detection settings (laser excitation: 515 nm, 0.6% power;
bandpass filter mEGFP 536/40, mCherry2 595/50). As expected from suboptimal
excitation and detection settings, spectral cross-talk was significantly higher (almost
20-fold) in single-wavelength excitation, and as explained previously, additionally
resulted in significant stronger positive cross-correlation artefacts (see Fig. 3.6).
Further, effective brightness of both fluorescent proteins and as a result SNRs of
both ACFs and especially the CCF is strongly reduced in single-wavelength FCCS.
These observations can explain the unexpectedly low average cross-correlation values
that additionally varied stronger than in two-wavelength FCCS (see Fig. 3.7c). In
summary, single-wavelength excitation performed with the fluorescent protein pair
mEGFP and mCherry2 on the available instrumentation does not direct towards an
increase in cross-correlation, but high spectral cross-talk and decreased SNRs, and is
thus no suitable alternative for two-wavelength excitation.
Eventually, after accessing suitable measurement conditions, fluorescent protein pairs
mCherry-mEGFP and mCherry2-mEGFP were compared for their performance in
FCCS. The derivate mCherry2 is a not yet entirely characterized mCherry variant,
that is reported to maturate faster than mCherry itself, even though still not as
fast as mEGFP: t50,mEGFP=14.5min, t50,mCherry=37.0min, t50,mCherry2=22.8min
(Balleza et al., 2017). Slow maturation times can lead to a high fraction of non-
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fluorescent proteins, and therewith to low fluorescence probabilities. Thus, less
interactions might be observed and by that the reported cross-correlation amplitude
decreases. Therefore, to make use of the maximal possbile cross-correlation amplitude
range, a fluorescent pair with high probabilities to emit photons is beneficial in FCCS
measurements. As will be discussed later, high fluorescence probabilities for mEGFP
(pf≈70%) and mCherry2 (pf≈70%), but not mCherry (pf≈40%) were observed in
this study. In agreement with that, the observed amount of hetero-dimers contain-
ing fully fluorescently active proteins is significantly higher for mEGFP-mCherry2
hetero-dimers than mEGFP-mCherry hetero-dimers (see Fig. 3.8d, and compare
ACFs amplitudes in Fig. 3.8a and b). Consistent with that, SNR of the CCF for
mCherry2-mEGFP increased by 40% compared to mCherry-mEGFP. This could be
of particular interest for investigations of weak interactions, in which, compared to
the vast amount of non-interacting molecules, only a small number of hetero-dimer-
complexes might be present and precise fitting is more important.
Whereas FCCS is well-suited for hetero-protein interactions, molecular brightness
analysis is especially applicable to investigate homo-oligomerization of proteins. To
probe protein homo-oligomerization directly in living cells, the protein is genetically
fused to a fluorescent protein. In an ideal case, i.e. all fluorescent protein subunits
within an oligomer are fluorescent, a homo-dimer would emit twice as many photons
as a monomeric reference, a homo-trimer three-times more photons. Hence, when
determining the oligomeric state from the number of fluorescent protein units, it is
often assumed that each fluorescent protein emits a fluorescence signal. However,
when comparing the normalized brightness of homo-dimeric fluorescent proteins to
the respective monomer, constantly a lower than two-times increase was observed (see
Fig. 3.9a and Fig. 3.13c). This effect was independent of (I) the particular fluorescence
fluctuation spectroscopy method, as shown by comparing pFCS, sFCS, and N&B
analysis (see Fig. 3.9a), (II) the cellular localization, as shown by comparing results
for cytoplasm, nucleus, and plasma membrane (see Fig. 3.9a), and (III) the used cell
line, as shown by comparing HEK 293T, A549, CHO, and HeLa cells (see Fig. 4.3 in
Appendix). Interestingly, in comparison to the cytoplasmic fraction, a ∼10% lower
molecular brightness for monomeric fluorescent proteins in the nucleus was observed.
This is of particular importance when IAV NEP oligomerization in dependence of its
localization is investigated, since brightness normalization needs to be performed
for the respective monomeric fluorescent protein measured at the same subcellular
localization. Related to these observations, lower than expected brightness values
were constantly observed, also for higher-ordered homo-oligomers, i.e. homo-trimers
and -tetramers (see Fig. 3.10b and Fig. 3.11b), and even homo-dodecamers (see
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Fig. 3.11d). For instance, the obtained brightness of 4xmEGFP was closer to the
theoretical homo-trimer brightness (see Fig. 3.10b), the brightness of the 12-meric
E.coli GlnA closer to a homo-nonamer (Finan et al., 2015) (see Fig. 3.11d). Thus,
results could lead to strong misinterpretation of the data. Altogether, these results
indicated the presence of non-fluorescent proteins, that strongly affects quantification
of protein oligomerization by molecular brightness analysis. Non-fluorescent states
of fluorescent proteins can be induced by complex photophysical properties like
long-lived dark states, transitions between different brightness states, or flickering
(Haupts et al., 1998, Schenk et al., 2004, Wu et al., 2009a). Additionally, limited mat-
uration and folding efficiency were reported for different fluorescent proteins, which is
partially dependent on the temperature at which experiments are preformed (Balleza
et al., 2017). Nevertheless, homo-dimer brightness for mEGFP and mCherry2 only
marginally increased at 37 ◦C compared to RT (see Fig. 3.9c and d). Alternatively,
energy transfer between different brightness states or to non-fluorescent protein
subunits could result in a decrease of molecular brightness values (Vámosi et al.,
2016, Wu et al., 2009a). However, lifetime decays of performed FLIM measurements
on mEGFP homo-oligomers could be fitted using a single exponential component,
indicating the presence of only one brightness state for all mEGFP homo-oligomers
(see Fig. 3.11b). Further, energy transfer to non-fluorescent states was excluded, since
obtained lifetime differences and corresponding FRET efficiencies for homo-dimer,
-trimer, and -tetramers were negligible (see Fig. 3.11a). Taken together, these results
indicate that the effect of non-fluorescent states is a fluorophore-inherent property. To
correct for this, a simple two-state model (see Methods section 2.2.8.2), i.e. modelling
non-fluorescent states independent of their source, was applied. This model takes into
account the probability that each fluorescent protein subunit of an oligomer emits a
fluorescence signal, and is determined from the brightness value obtained for homo-
dimeric fluorescent proteins. Applying this model allowed for precise determination of
all investigated homo-oligomers that were otherwise underestimated in oligomer-size.
Additionally, using this two-state model allowed for the correct determination of
the oligomeric state of IAV HA directly within the plasma membrane of living cells,
which was until know only biochemically well characterized (Copeland et al., 1986,
Wilson et al., 1981).
Similar to FCCS, molecular brightness analysis can be extended to investigate pro-
tein hetero-interactions. Typically, red fluorescent proteins are used as they possess
spectrally different properties from the most widely used fluorescent protein mEGFP.
For the commonly used fluorescent protein mCherry a very low apparent fluorescence
probability of only 40% was observed (see Fig. 3.8), in agreement with previous
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studies (Foo et al., 2012). Thus, mCherry severely suffers from a low dynamic range
as brightness increase per subunit is only marginal, i.e. a mCherry homo-tetramer
would be only 2.2-fold brighter than a monomer, and could be mistakenly interpreted
as a homo-dimer. Therefore, several red fluorescent proteins (mCherry, mCherry2,
mCardinal, mRuby3, mScarlet, mScarlet-I) were investigated for their suitability for
fluorescence fluctuation spectroscopy, which depends mainly on three fluorophore
characteristics: (I) high photostability to enable continuous illumination over time,
(II) high effective molecular brightness to obtain a SNR of the ACF sufficient to detect
single-molecule fluctuations, (III) high apparent fluorescence probability to obtain a
maximal dynamic range. In general, fluorescent proteins which fulfil only one or two
of these criteria are not well suited for fluorescence fluctuation spectroscopy. In this
study, it was found that only mCherry2 fulfilled all three criteria (see Fig.3.13). The
remaining red fluorescent proteins either suffered from low photostability albeit high
effective monomer brightness (mRuby3, mScarlet, mScarlet-I) (see Fig.3.13a and b),
or very low apparent fluorescence probability of only 20 - 45% (mCardinal, mCherry,
mRuby3, mScarlet) (see Fig.3.13c). Recent studies on maturation times of fluorescent
proteins reported faster maturation for mCherry2 and mScarlet-I compared to their
progenitors mCherry and mScarlet (Balleza et al., 2017). Although mScarlet-I is less
photostable than mCherry2, their apparent fluorescent probabilities of 63% and 71%
are very similar. Taken together, this indicates that fast fluorophore maturation can
direct towards a higher fluorescence probability, and thus higher dynamic range for
improved oligomerization studies.
Resuming these observations, when molecular brightness analysis was later in this
study performed to probe oligomerization of IAV NEP in dependence of its localiza-
tion, obtained brightness values were first normalized to the respective monomeric
fluorescent protein measured in the same compartment (cytoplasm and nucleus),
and then corrected for the fluorescence probability determined by measuring the
respective homo-dimeric fluorescent protein. Finally, corrected brightness values were
used to calculate monomer and dimer fractions of IAV NEP in dependence of its
subcellular localization.
4.2 Elucidating the protein interaction pattern of the
nuclear export complex in vitro and in situ
Translocation of progeny vRNPs into the cytoplasm is accomplished by a viral
nuclear export complex that mediates export by hijacking the CRM1-dependent
export pathway. Currently, two models exits, describing the interaction pattern of
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involved proteins. Both are depicted in detail in Fig. 1.6 in the Introduction section
1.1.3.2. In the context of nuclear export, a number of questions remain unanswered
such as how many M1-NEP export complexes bind to one single vRNP. An answer to
this particular question potentially helps elucidating the exact interaction pattern of
the export complex and vRNPs. Therefore, to gain access into the interaction network
of vRNPs with the relevant viral and cellular export components, two strategies were
pursued in parallel:
In a first approach, the approximate number of M1-NEP export complexes bound
to single vRNPs should be estimated by applying FCCS in vitro on isolated and
fluorescently labelled vRNPs and M1 proteins. Solving the question whether a single
vRNP is completely covered with M1 or not, already allows to draw conclusions
about the possbile number of viral nuclear export complexes bound to single vRNPs.
Once the bound fraction of M1 is determined, this approach could be extended by
additionally appending NEP to finally estimate the number of completely assembled
viral nuclear export complexes and additionally investigate the interaction network
of NEP with vRNPs to allow for the distinction between both described export
complex models.
In a second approach, proteins of the viral nuclear export complex predicted to
interact with each other should be investigated directly in living A549 cells, applying
a combination of several fluorescence fluctuation spectroscopy methods. However,
since very effective nuclear export of NEP was observed, the regulation mechanism of
its translocation activity was first investigated as preparatory work for in situ studies
on the viral nuclear export complex. Understanding the regulation mechanisms of
NEP export through CRM1 is potentially interesting for anti-viral drug development.
In recent years, Verdinexor, a reversible small molecule inhibitor against CRM1, was
shown to potently inhibit nuclear export of vRNPs by blocking the targeting of NEP
to the export machinery of host cells (reviewed in Pickens and Tripp (2018)). The
drug was shown to be active against a wide range of IAV subtypes (H1N1, pH1N1,
H3N2, H5N1, H7N3, H7N9) and IBV in vitro, and significantly reduced viral titers
in mice and ferrets when prophylactically or therapeutically applied. Moreover, no
emergence of drug resistance was observed and virus-associated immunopathology
was significantly reduced by decreasing inflammatory cytokine expression. Altogether,
these findings highlight the interest in understanding the vRNP export mechanisms
to finally exploit it as anti-viral target (Perwitasari et al., 2014, 2016).
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4.2.1 In vitro quantification of the M1 stoichiometry on isolated
A/WSN vRNPs using FCS and FCCS
For a precise quantification of interaction stoichiometries by applying FCCS in vitro,
the labelling ratio is critical when choosing a protein labelling strategy. Proteins
need to be uniformly labelled with a defined number of fluorescent molecules. Both,
unlabelled proteins or free dye molecules need to be avoided as they potentially
decrease the cross-correlation amplitude (Bacia and Schwille, 2007). Thus, ideally
each vRNP, and each M1 protein should be labelled with exactly one fluorescent dye
or protein. Additionally, neither vRNPs nor M1 should form aggregates in solution.
First, M1 was expressed in E.coli Rosetta and several expression conditions were
evaluated (see Fig. 3.14). Due to the fact that neither basal protein expression,
nor distinct differences in soluble and insoluble protein fractions were observed for
the tested conditions, expression was routinely performed as described earlier by
Hilsch et al. (2014). After successful purification and specific probing by Western
Blot (see Fig. 3.14a), M1 was routinely labelled using one of the two amine-reactive
fluorescent dyes: AlexaFluor™ NHS 488 or 647. For high labelling efficiencies it is
recommended by the manufacturer to use (I) high protein concentrations and (II) to
perform labelling at basic pH. However, it was already shown that M1 at neutral pH
forms a small fraction of homo-dimers, and tends to form higher-order oligomers at
high concentrations (Zhang et al., 2012). Only at low pH (pH ∼5.0) M1-oligomers
dissociate into an almost pure monomeric protein fraction in solution (Zhang et al.,
2012). Therefore, to avoid oligomerization of M1, labelling was performed at low
concentrations (∼10 μM), but near-neutral pH. Using more acidic buffer systems,
where M1 would be completely monomeric, comes to the cost of suboptimal conditions
for amine-reactive conjugation, since free amine-groups are protonated at low pH,
thus preventing amine-conjugation. Nevertheless, near-neutral pH promotes labelling
of only the free N-terminal amine-group, since the pKa of N-terminal amines is lower
than that of lysine amino groups. Hence, a more specific single dye labelling at the N-
terminus of proteins can be achieved. As a consequence M1 was fluorescently labelled
under suboptimal reaction conditions, thus leading to specific but very low labelling
ratios, i.e. only every second to forth M1 protein was labelled. FCS measurements
revealed a diffusion coefficient of D≈110 μm2/s-1 (see Fig. 3.15c), consistent with
values obtained for proteins in solution possessing similar MW, such as free GFP
(Swaminathan et al., 1997). Data were successfully fitted using a 3-D free diffusion
model, assuming the presence of only one single component, thus highlighting efficient
separation of non-reacted fluorescent dyes and M1. Molecular brightness analysis
revealed a monomeric state for M1 at concentrations ranging from 10 to 250 nM.
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However, due to low labelling efficiencies the presence of M1-oligomers consisting of
labelled and unlabelled M1 subunits can not be excluded completely. Nevertheless,
neither Western Blot analysis of purified M1, nor direct detection of labelled M1 in
SDS-PAGE by excitation of AlexaFluor™ NHS 647 using an IR-scanner, revealed any
protein bands at higher MWs. It was thus concluded, that purified M1 is monomeric
over the used concentration range. Nevertheless, for quantification of interaction
stoichiometries a homogeneous M1 sample with a defined number of fluorescent
labels is necessary. Theoretically, cysteins could be used for functionalization with
maleimide-reactive dyes. Since cysteins are less common than lysines in many proteins,
a more specific labelling would be achieved. However, labelling efficiency was already
very low; consequently, not only a more specific but at the same time more efficient
labelling is needed.
Currently, for proteins expressed and purified from E.coli, site-specific labelling
techniques are implemented. Bacterial strains have been engineered in a way that
they express the unnatural amino acid p-acetylphenylalanine and additionally an
aminoacyl-tRNA synthetase/suppressor tRNA pair derived from Methanocaldococcus
jannaschii. This system recognizes the rarely used TAG stop-codon and incorporates
the unnatural amino acid during protein translation instead of terminating translation
(Lemke, 2011). These unnatural amino acids can either be labelled using maleimide-
reactive dyes albeit suffering from the same disadvantages as described previously,
or functionalized using click-chemistry. In click-chemistry, a copper-based catalytic
reaction between an alkyne and azide-conjugated fluorescent dye is performed. These
reactions can be performed under a wide variety of conditions using different solvents,
temperatures, or pH-values ranging from 5 to 12, and additionally reach labelling
efficiencies of 80 to 95% in dependence of the used reaction conditions (Hein et al.,
2008, Li et al., 2010, Zhou et al., 2012). Although only a single label is incorporated
and labelling ratios can be increased, unconjugated proteins and labels still need
to separated efficiently from dye-conjugated proteins for example by applying fast
protein liquid chromatography (FPLC). Another labelling strategy would be the
direct incorporation of fluorescent amino acid analogues. However, until today these
amino acids highly suffer from low photostability, low quantum yield, or restriction
in the used excitation source (Krueger and Imperiali, 2013, Twine and Szabo, 2003).
Altogether, there is still a lack of efficient labelling strategies for proteins, other than
genetically encoding a fluorescent protein tag.
Next, two approaches were pursued for vRNP isolation: direct isolation from A/WSN
virions, and isolation from transiently transfected HEK 293T cells followed by affinity
purification. Direct isolation from concentrated A/WSN virions theoretically would
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allow for isolation of a sufficient amount of vRNPs that is necessary, first to perform
end-point measurements in which vRNPs are bound by as many labelled M1-proteins
as physiologically possible, and second to observe enough fluctuation events in FCCS.
Nevertheless, it was reported that vRNPs isolated from purified virions are present
in two different forms, M1-free and M1-associated (Yasuda et al., 1993). The latter
would be a huge disadvantage for stoichiometry measurements as potential binding
sites for M1 on vRNPs are already occupied by unlabelled M1. Commonly, when
vRNPs are isolated directly from virions, samples are analysed by SDS-PAGE and
monitored for the presence of the most abundant protein of vRNPs, NP (Stauffer
et al., 2016, Wu et al., 2009b). In this work, samples were additionally monitored
for the absence of M1 (MW: ∼28 kDa). Success of M1-free vRNP isolation was
investigated for several conditions; nearly neutral pH conditions, but different salt
compositions were compared to extraction buffers composed of acidic pH with
different salt concentrations mimicking the physiological conditions of endosomes
during viral uncoating (Babcock et al., 2004, Fontana and Steven, 2013, Li et al.,
2014, Martin and Helenius, 1991, Pinto et al., 1992, Stauffer et al., 2016, Wharton
et al., 1994, Wu et al., 2009b). Only low pH conditions resulted in vRNP extracts
of low, although not completely free M1 contamination. Since step-wise priming
(see Fig. 3.16f) (Li et al., 2014), and a variation of salt composition seem to have
less of an influence on M1-free vRNP extraction, isolation was routinely performed
using the simplest approach: low pH buffer only (see Fig. 3.16c). Moreover, under
this condition, faint protein bands in the MW-range of 75 - 100 kDa were observed,
potentially corresponding to viral polymerase subunits. However, both the presence
of NP and polymerase subunits, as well as the absence of M1 would additionally
need to be verified by Western Blot analysis. This was not done for vRNP isolates
from transiently transfected cells and will be discussed later.
An inhomogeneous sample consisting of all eight vRNPs resulted from virion isolates.
This is potentially disadvantageous for stoichiometry quantifications for two reasons:
(I) depending on the binding mechanism of M1 to vRNPs, quantification of binding
stoichiometry will only result in an approximation as the dimension of a single vRNP
can not be predicted, and (II) vRNPs additionally need to be labelled, and labelling
ratios of an inhomogeneous sample can again only be estimated. Labelling was
performed as described for M1, thus, the same limitations and strategies apply here.
However, labelling ratios, estimated based on the MW and concentration of vRNPs,
were usually in the range of 3 to 10 dyes per vRNP (see Eqns. 2.6, 2.7, and 2.9).
In contrast to M1, vRNPs could alternatively be labelled using the RNA content of
the sample. PNA-FIT-probes have been shown to be promising nucleotide sequence
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dependent probes to specifically label samples with a fluorescent dye. In these probes,
dyes of the thiazole orange family serve as fluorescent nucleotides that react to local
structural changes. Only after intercalation into double-strands a drastic increase in
fluorescence signals will be observed. Hence, labelling can be performed without the
need of an additional wash step (Hövelmann et al., 2016, Kummer et al., 2011). As a
huge benefit, this labelling strategy would additionally allow for the differentiation of
genome segments in a heterogeneous sample, and thus would simplify quantification
of M1 binding stoichiometries. However, application of these probes needs careful
evaluation in terms of photostability, quantum yield, molecular brightness, and
especially background fluorescence of non-hybridized probes to allow for successful
FCS or FCCS measurements.
Eventually, isolated vRNPs were successfully measured by FCS, although in few
samples a two component fit was necessary to fit a 3-D free diffusion model to the
obtained data. The baseline intensity of measurements that could only be fitted by
taking into account two components was generally higher than in samples where a
one component fit sufficiently described the underlying dynamics (compare Fig. 3.18a
and b). Furthermore, single intensity bursts were observed, e.g. at 8 and 24 s, or 40
and 47 s for the depicted measurements (see upper panel, Fig. 3.18a and b). This
observation already indicates the presence of only a very small fraction of vRNPs.
Nevertheless, the average diffusion coefficients of D≈5 μm2/s-1 and D≈270 μm2/s-1
extracted from the first and second fit component, respectively, were in very good
agreement with the expected diffusion coefficients for vRNPs in solution (D=7 to
15 μm2/s-1, Babcock et al. (2004)), and free AlexaFluor™ NHS 647 (D=280 μm2/s-1,
Jung et al. (2014)). It was thus concluded, that the second component, when observed,
likely corresponded to non-reacted fluorescent dyes that have not been successfully
separated from vRNP samples. Furthermore, resulting vRNP diffusion times of 1.5
to 3ms are in good agreement with diffusion times obtained for protein complexes in
the MDa range, such as the ribosomal complex of E.coli that has a size of 2.6MDa
and a diffusion time of 1.2ms as determined by FCS in solution (Jermutus et al.,
2002). It has to be noted, that for long diffusion times such as measured for vRNPs a
long measurement time is required to average over a sufficient number of independent
fluctuation events for precise evaluation of dynamics, otherwise limited statistics
will result in distorted ACFs, and thus restricted fit accuracy. Simulations showed,
that measurement times should be 103 to 104-times longer than the diffusion time
of the investigated molecules (Ries and Schwille, 2008). In the case of vRNPs this
corresponds to approximately 30 s measurement time. Here, measurements were
performed twice as long. Thus, although only few fluctuation events of vRNPs were
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detected due to low concentrations, these events seem to dominate the ACF signal
over noise or second component dynamics.
Additionally, FCCS measurements of M1 and vRNPs were performed, however, no
binding of M1 to vRNPs was observed. These measurements were carried out for
2min every 5min over a total measurement time of 30min. However, to analyse rare
events on the single molecule level, acquisition over time periods of hours instead
of minutes could be performed. This is already implemented in multi-parameter
fluorescence spectroscopy that allows for accurate and quantitative analyses of
several small fractions or conformational dynamic studies (Eggeling et al., 2001,
Kühnemuth and Seidel, 2001, Weidtkamp-Peters et al., 2009). Taken together, these
observations clearly demonstrate the need for samples with an increased number
of genome segments, and additionally prolonged measurement times to detect a
sufficient number of single events to increase the robustness of the analysis.
To circumvent labelling, heterogeneity, and concentration issues, an alternative vRNP
isolation approach was tested: isolation from transiently transfected cells followed
by affinity purification (Chase and Schwemmle, 2012). Isolation from transfected
cells would lead to samples of (I) a homogeneous vRNP composition as vRNP
type, and thus length is determined by the applied plasmid system, (II) devoid of
M1, (III) does not need any further labelling since PB2-subunits were genetically
fused to the fluorescent protein mCherry2. Nevertheless, isolation from transiently
transfected cells might lead to an decrease in vRNP concentration due to varying
transfection efficiencies, or the presence of incompletely assembled vRNPs. In this
study, an artificial vRNP corresponding to genome segment 5 (encodes NP) was
successfully expressed and purified from HEK 293T cells as shown by SDS-PAGE and
Western Blot analysis (see Fig. 3.17b and c), respectively. As stated by Chase and
Schwemmle (2012) a high NP:RdRP ratio indicates isolation of fully-formed vRNPs
with little contamination by soluble RdRP-complexes or disrupted vRNPs due to
RNase contamination. However, when Western Blot analysis was performed, the
NP:PB2 ratio changed compared to coomassie staining results. Stronger signals for
PB2 than NP were observed, indicating either a high fraction of free PB2-mCherry2
within the sample (Chase and Schwemmle, 2012), or differences in antibody affinities
to their epitopes. Further, a faint protein band of high MW was detected, possibly
corresponding to the fully assembled RdRP since the SDS-PAGE ran under non-
denaturating conditions (MW RdRP-mCherry2: ∼260 kDa). The second faint protein
band beneath the PB2-mCherry2 band could result from degraded protein or a
cross-reactivity, since a polyclonal antibody was used to probe PB2. In contrast to
FCS measurements performed with virion isolated vRNPs a faster than expected
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mean diffusion coefficient of D≈37 μm2/s-1 was obtained (see Fig. 3.18d). This value
is in the expected range for a protein of 100 - 200 kDa size (Krouglova et al., 2004).
Consistent with the interpretation of Western Blot data, FCS measurement results
indicated the presence of either only PB2-mCherry2, or fully assembled polymerase
complexes, but not fully assembled vRNPs. Hence, independently of the chosen
isolation method, supplementing controls should be performed to ensure observation
of completely assembled vRNPs using FCS or FCCS.
In addition to SDS-PAGE and Western Blot analysis that only probe the presence
or absence of certain proteins, presence of RNA bound to NP can be monitored.
A combinatory assay to verify the presence of nucleic acid in general, and further
probe accessibility for electrostatic interaction as described for NP and viral RNA
can be applied (Baudin et al., 1994, Höfer, 2014). In brief, the presence of nucleic
acid is first verified by the intercalator propidium iodide (PI), that shows a shift
in excitation and emission once bound to nucleic acid. Then, a second intercalator,
acridine orange (AO) a metachromatic fluorochrome, is used to probe accessibility
of single-stranded nucleic acid for electrostatic interaction (Darzynkiewicz, 1990,
Kapuscinski, 1990). When it intercalates into double-stranded nucleic acid it emits a
green fluorescence signal, whereas when it binds to single-stranded nucleic acid via
electrostatic interactions, a precipitate forms that possesses an emission maximum at
640 nm (Darzynkiewicz, 1990, Kapuscinski, 1990). Hence, once existence of nucleic
acid is confirmed by PI, but no increase in emission intensity at 640 nm for AO
is observed, the presence of viral single-stranded RNA electrostatically bound to
NP, and thus unable to be bound by AO is presumed (Baudin et al., 1994, Höfer,
2014). Alternatively, RNA could be detected by PNA-FIT probes as described earlier,
or other DNA/RNA-probes that are fluorescently labelled and hybridize sequence
specific to their targets. However, using the combinatory approach described by
Höfer (2014) single-stranded RNA electrostatically bound to NP would be detected,
and thus more likely an assembled vRNP instead of only free RNA. Beyond that,
direct evidence for the presence of completely assembled vRNPs can only be given by
direct visualization using for instance transmission electron microscopy. A resembled
rod-shaped structure with either particles of variable length for virion isolated vRNPs,
or a certain length for HEK 293T cell isolated vRNPs should be observed (Jennings
et al., 1983, Wu et al., 2009b). Additionally to these controls, vRNP concentration
needs to be increased for successful stoichiometry quantification, regardless of whether
vRNPs are isolated from virions or transfected cells. A very promising approach
was presented by York et al. (2013). In this system, a RNA secondary structure
was introduced into genome segment 6 (encodes for NA) of A/WSN virus. More
144
Discussion and Outlook
precisely, an RNA hairpin of Pseudomonas aerugionsa bacteriophage PP7 (PP7 ) was
introduced into the region that encodes the NA stalk. Successful rescue of mutant
virus and normal growth curve kinetics demonstrated that encoding of this RNA
secondary structure did not impair with genome encapsidation or virion release from
infected cells. Then, a HEK 293T cell line either stably or transiently expressing
the coat protein of Pseudomonas aerugionsa bacteriophage PP7 fused to a His-tag
(PP7CP-His) was infected with mutant viruses. Since PP7 binds with high affinity to
PP7CP-His, vRNPs of only genome segment 6 can be specifically isolated by affinity
purification. Approximately 11% of the total RNA input was successfully isolated.
Assuming that all vRNPs are present in equal amounts in infected cells, almost
all vRNPs of genome segment 6 were successfully recovered using this approach
(expected value 12.5%) (York et al., 2013). This system has several advantages over
the herein applied isolation methods:
1. isolation of fully assembled vRNPs, since an RNA secondary structure is used
for affinity purification instead of a polymerase subunit
2. the yield of isolated vRNPs potentially increases when using a mutant virus and
stable cell line, since transfection efficiencies will not vary between experiments
3. a homogeneous vRNP sample of genome segments with defined dimension is
obtained, as only genome segment 6 will be isolated.
Even though no M1 was detected in isolated vRNPs in the original work (York
et al., 2013), it is not yet known whether M1 in the viral nuclear export complex
dissociates from vRNPs after nuclear export, or again assembles to vRNPs later
in infection. Hence, alternatively to infection a one-plasmid system could be used
(Zhang et al., 2009). Consequently, transfection efficiencies are a negligible problem,
and M1 expression could be specifically suppressed by cloning. Furthermore, a
fluorescent protein could genetically be fused to one of the polymerase subunits to
ensure a specific single fluorescent label for each vRNP. Altogether, combining these
approaches would potentially result in a homogeneous sample of M1-free vRNPs
of defined dimension, carrying one fluorescent label per vRNP. Taking all these
improvements together, stoichiometry quantification of M1 on vRNPs by applying
FCCS should be possbile. Moreover, when successfully improving vRNP isolation
as described, and further extending this approach to other IAV genome segments,
FCCS provides a powerful tool-box that could potentially be used to answer a yet
unsolved question: whether there is an interaction hierarchy for IAV genome segments.
Borodavka et al. (2017) recently applied FCCS to partially unravel the sequence-
specific inter-segment interaction mechanism of rotavirus RNA. In their work, they
showed, that binding of the non-structural protein NSP2 to viral RNAs remodels
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their secondary structure, thus specifically strengthening interaction between different
rotavirus RNAs (Borodavka et al., 2017) .
4.2.2 In situ studies on the regulation mechanism of Influenza
virus nuclear export protein
In order to perform FCS or FCCS measurements directly in living cells, proteins need
to be labelled with a fluorescent tag. In living systems this is most easily achieved by
genetically fusing a fluorescent protein to a protein of interest. As a rule of thumb,
the size of a fluorescent tag should not be significantly larger than that of the protein
of interest itself to ensure its functionality. Whereas almost all viral proteins of the
nuclear export complex and vRNPs possess larger MWs than fluorescent proteins
(∼27 kDa), NEP is significantly smaller (∼14 kDa). Therefore, it is especially impor-
tant to ensure functionality of a fusion protein of NEP with a fluorescent protein.
Generally, to fulfil this task, enzymatic activity, a known interaction with other
proteins, or localization of proteins can be analysed.
Whereas no enzymatic activity was yet reported for NEP, its interaction with M1 is
biochemically well characterized (Akarsu et al., 2003, Brunotte et al., 2014). Thus, in-
teraction of several NEP and M1 variants was investigated. Surprisingly, independent
of the fluorescent protein position, i.e. N- or C-terminally fused, no interaction was
observed (see Fig. 3.19b). However, for M1 possessing a C-terminally fused mCherry2
lower diffusion times were observed than for its equivalent in which mCherry2 is
N-terminally fused. Instead, although the MW of a M1 fusion protein is similar
to that of the hetero-dimer mEGFP-mCherry2, and thus should result in similar
diffusion times, diffusion times were equal to that observed for mCherry2 monomers.
Hence, it is very likely that free mCherry2 was analysed, although sequencing of the
expression construct revealed successful cloning of M1-mCherry2-N1. To the best of
my knowledge, there is no report describing proteolytic cleavage of M1. Thus, it is
unlikely that mCherry2 is separated from M1 by a proteolytic pathway. Theoretically,
the plasmid sample could be a mixture of plasmids encoding the fusion protein and
mCherry2 only, resulting in dynamics dominated by free mCherry2. This issue clearly
needs further careful evaluation, since M1, according to current models, binds to NEP
with its N-terminal domain (Akarsu et al., 2003). Thus, there is a higher probability
to observe NEP-M1 interaction using M1-mCherry2-N1 (i.e. mCherry2 fused to the
C-terminus) as steric hindrance, that could explain the observed non-interacting
fractions, might be less pronounced than for M1-mCherry2-C1. It is important to
emphasize that these experiments were performed only once and should be repeated
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to gain insights into the ability of fluorescently tagged NEP to interact with M1.
Alternatively, localization of NEP fusion proteins was analysed. In general, in fusion
proteins, location of signal peptides have to be taken into account to avoid interfer-
ence with their function due to steric hindrance by the fluorescent protein (reviewed
in Snapp (2005)). Both NESs of NEP are N-terminally located, thus the protein
should preferably be tagged on its C-terminus. However, neither overexpression of
NEP-mEGFP-N1 (i.e. C-terminal EGFP), nor -C1 (i.e. N-terminal EGFP) did result
in similar localizations as observed in a natural infection (compare Fig. 3.20 and
3.21). There, slow accumulation of NEP ensures coordinated export of vRNPs late in
infection (Chua et al., 2013), which explains the observed constant low NEP levels.
Consistent with other studies, NEP predominantly localized to the cytoplasm early
in infection, and was more homogeneously distributed late in infection with few cells
showing an accumulation of NEP within the nucleus (Gao et al., 2014, Lamb et al.,
1978). For NEP-mEGFP-C1 an evenly distributed signal throughout the whole cell
was observed, consistent with few studies where NEP was tagged with EGFP on its
N-terminal domain (Gao et al., 2014, Huang et al., 2013). However, Gao et al. (2014)
additionally investigated the localization pattern of NEP possessing an N-terminally
fused cMyc-tag, a peptide consisting of only 10AAs. In contrast to the EGFP tagged
variant, this fusion protein was predominately found in the cytoplasm of cells as
shown by indirect immunofluorescence staining and Western Blot analysis. Unfor-
tunately, this discrepancy in localization for different NEP fusion proteins was not
further discussed (Gao et al., 2014). Nevertheless, this particular localization pattern
is not only very well in agreement with the localization of untagged NEP observed
in the current study, but also with that of NEP possessing a C-terminally fused
EGFP. Furthermore, NEP-mEGFP-N1 was successfully probed using polyclonal
anti-NEP antibody, thus epitopes within the fusion protein are still in their native
form, pointing towards correct folding of the protein. All together, based on these
observations it was decided to use NEP-mEGFP-N1 (from now on termed NEP wt)
for all experiments performed in the present study, although no interaction with M1
was proven. Nevertheless, since subcellular localization was very different for both
fusion proteins, the structure of untagged NEP should be additionally compared to
that of NEP-mEGFP-N1 and -C1 to enlightening a potential role of the fluorescent
protein position on the structure of NEP, and thus possibly on localization. For
this aim, UV/Vis-CD-spectroscopy could be performed (Lommer and Luo, 2002).
Using this approach, Golovko et al. (2017) were able to demonstrate, that neither
N-terminally, nor C-terminally fused His-tags influence the secondary structure of
NEP. However, EGFP is significantly larger than a His-tag, thus similar experiments
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should be repeated with EGFP-fused versions of NEP.
Originally, the interaction network of proteins participating in building up the nuclear
export complex should have been investigated in the nucleus of A549 cells. However,
since NEP mainly localized to the cytoplasm, first the mechanism regulating translo-
cation of NEP into the nucleus needed to be revealed.
In many studies NEP-mEGFP-C1 expression constructs were used to enlighten the
role of CRM1 in nucleocytoplasmic transport of NEP by performing LMB treatment.
LMB is a small molecule inhibitor, that alkylates a single cysteine residue in CRM1,
thereby leading to its inactivation (Kudo et al., 1999). However, as NEP-mEGFP-C1
is evenly distributed in cells, and the fusion construct is smaller than the MW
cut-off of NPCs for free diffusion (Wang and Brattain, 2007), it is standing to reason
that parallel treatment with LMB will not lead to a drastic change in subcellular
localization, although both NESs were shown to interact with CRM1 in a mammalian
two-hybrid assay (Elton et al., 2001, Huang et al., 2013). As a consequence, incon-
sistent conclusions regarding the activity of both NESs were drawn. Hence, using
the expression construct NEP-mEGFP-N1, is more suitable to investigate its depen-
dence on CRM1 export. Accordingly, LMB treatment resulted in a homogeneous
localization pattern of this NEP fusion protein (see Fig. 3.22). Apparently, export
capacity of both NESs appeared to be structure- and position-dependent. In contrast
to NEP wt, deletion of either NES1 or NES2 (i.e. ΔNES1, ΔNES2) resulted in a
rather homogeneous protein distribution, although in both mutants one of the two
NESs was preserved. However, the structure of these mutants might be disturbed,
as 10AAs are deleted. In contrast, in mutants mNES1 and mNES2 the structure is
preserved, and only the nuclear export activity abrogated by substitution of hydropho-
bic residues of the core motifs with alanines that possess weaker hydrophobicity
(Fridell et al., 1996, Lischka et al., 2006, Ryabov et al., 2004). When the structure is
preserved, but only NES2 is fully functional (as in NEP-mNES1) the N/CP-ratio
was sifted to ∼0.8, while NEP with a functional NES1 (as in NEP-mNES2) resulted
in a wild-type like distribution (NEP wt: N/CP-ratio ∼0.5). Hence, only when one
NES is present within α-helix N1 a nuclear export activity at least as strong as
for wild-type NEP was observed, whereas an active NES in α-helix N2 only is not
sufficient. Additionally, when NES2 was located in α-helix N1 an increased export
activity compared to NEP wt was observed (compare localization of NEP-2xNES2
and NEP-NES2-1 with NEP-2xNES1). Taken together, these results indicate that (I)
one NES must be present in α-helix N1, (II) export activity of both NESs is structure-
and position-dependent, and (III) NES2 possesses a stronger export activity than
NES1. Furthermore, when NES positions were exchanged (as in NEP-NES2-1), or
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the same NES was present twice (NEP-2xNES1, NEP-2xNES2) localization of NEP
changes towards a more even distribution after LMB. This effect was stronger for
NEP-2xNES2 and NEP-NES2-1 than for NEP-2xNES1, again directing towards the
hypothesis that NES2 is stronger than NES1, independent of its position within
NEP. Additionally, one could concluded, that a wild-type like NEP distribution is
only observed, when NES2 is located in α-helix N2, but not N1. This hypothesis is
further supported by results of biochemical assays exhibiting the interaction of each
of the two NESs with CRM1 (Huang et al., 2013). Herein, it was reported, that NES1
alone did not bind to CRM1, whereas NES2 alone resulted in a moderate binding
compared to NEP wt, which resulted in the strongest CRM1 binding. Altogether,
these observations indicate a cooperative regulation mechanism for both NESs to
balance the binding of NEP to CRM1. Moreover, no mutant virus possessing only
a single NES could be rescued, whereas mutants with two NESs were successfully
rescued and showed similar growth kinetics as wild-type viruses (see Fig. 3.29c).
However, since 2xNES2-mutants were successfully rescued, one would expect to
rescue mutant viruses also for NEP-NES2-1, unless the predicted cooperative of both
NESs depends on their positions. It is important to emphasize at this point, that
transfection efficiencies for the modified pHW2000 constructs were generally very
low (data not shown, but probed by anti-NEP antibody staining). Thus, to rule out
unsuccessful mutant rescue based on insufficient transfection efficiencies, experiments
should be repeated with newly prepared plasmid samples. Furthermore, growth
kinetics should be analysed again by using a lower virus load when inoculating cells,
as all tested viruses outgrew the dynamic range very fast and reached a plateau
already after 24 h. Additionally, to strengthen the drawn conclusions, a mammalian
two-hybrid system to probe protein interaction with CRM1, as used by Huang
et al. (2013) for NES1 or NES2, could be performed with mutants NEP-2xNES1,
NEP-2xNES2, and NEP-NES2-1, respectively. In this system, the reporter firefly
luciferase is used to probe protein interaction; here between NEP mutants and CRM1.
The reporter is only transcribed when two separated domains of a transcription
factor (i.e. DNA-binding, and transcription activator domain) reconstitute into the
native structure due to interaction of two proteins predicted to interact, each fused
to one of the two subdomains, respectively. Furthermore, the suggested experiment
should be additionally performed with a mutant in which NES2 is located in α-helix
N1, whereas in α-helix N2 mNES1 is located. If the hypothesis is correct, that one
NES located in α-helix N1 is sufficient for the function of NEP, but for precise
regulation NES1 should preferably be positioned in α-helix N1, a phenotype similar
to NEP-mNES2 and NEP-2xNES1 was to be observed.
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The described cooperativity of localization signals is a common mechanism in pro-
teins to ensure their subcellular localization in dependence of the present protein
context. Roberts et al. (1987) showed, that a NLS can function at a variety of
positions within proteins as long as it is not masked due to the protein structure or
dominated by another signal. Additionally, they demonstrated that partially defective
NLSs, and thus weakened in activity, can cooperate to promote translocation of a
protein into the nucleus. Cooperativity of localization signals was likewise shown
for viral proteins. The human cytomegalovirus protein UL84, the main initiator for
viral DNA synthesis, possesses a complex domain of 282AAs that functions as an
unconventional bi-cistronic NLS. Additionally, within this domain two conventional
CRM1-dependent NESs of equal export strength were found (Lischka et al., 2006).
The shuttling activity of this protein was shown to be important for virus growth
as it facilitates transport of at least one virus encoded transcript to the cytoplasm
(Gao et al., 2010). In african swine fever virus (ASFV) three NESs were found in
protein p37, a core shell protein; two N-terminal NESs were shown to be CRM1-
dependent, whereas the C-terminal NES mediates nuclear export independent of
CRM1. Both pathways are equal in strength once investigated separatly, and might
be important for different subcellular localization and function during the course
of infection (Eulálio et al., 2006). Another interesting mechanism is exploited by
Rev protein, the nuclear export protein of HIV-1. Early in infection HIV-1 RNA
transcripts are extensively spliced to promote translation of regulatory proteins such
as Rev. Later in infection, partially or fully unspliced transcripts are exported from
the nucleus using a Rev-CRM1-dependent mechanism. These transcripts then encode
the structural proteins building up the mature virus particles. Hence, through its
slow accumulation Rev not only regulates the timing, but also the magnitude of late
viral gene expression (Jain and Belasco, 2001). Regarding its nuclear export activity
it was shown, that (I) export is CRM1-dependent (Aligeti et al., 2014), (II) 6 to 14
Rev monomers cooperatively assemble on Rev-responsive elements (RRE), a specific
secondary structure of HIV-RNA-transcripts, to recruit at least two CRM1 proteins
thereby increasing binding affinity ∼500-fold (Behrens et al., 2017, Daugherty et al.,
2010), and (III) bias of Rev towards the nucleus is influenced by transient masking
of the NESs through self-association of Rev (Behrens et al., 2017).
In the present study, a similar regulation mechanism for IAV NEP was hypothe-
sized. As previously discussed, both NESs in NEP might have a cooperative and
position-dependent CRM1-related export activity. Interestingly, FCCS measurements
on NEP-mEGFP with NEP-mCherry2 resulted in positive cross-correlations in the
cytoplasm and nucleus of transfected A549 cells, indicating an oligomerization of NEP
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(see Fig. 3.19). Additionally, differences in the interacting fractions were observed for
nucleus (∼8%) and cytoplasm (∼16%). It was thus speculated (I) whether NEP is
able to form homo-oligomers, and (II) whether homo-oligomerization regulates the
export activity by stabilising a transient masking of both NESs as observed for HIV
Rev protein. Therefore, molecular brightness analysis was performed to investigate
the oligomerization in dependence of the subcellular localization of several NEP
mutants and to relate these results to the corresponding localization phenotypes to
gain further insights into the regulation mechanism of NEP. Molecular brightness
values for NEP wt were higher than that of EGFP monomers but lower than that of
EGFP homo-dimers. Besides, significant differences were observed in cytoplasm and
nucleus of transfected cells (see Fig. 3.23), similar to what was observed in FCCS.
However, only a fraction of NEP proteins oligomerize, thus a clear statement on the
homo-oligomer size that is present next to monomers can not be given. Alternatively,
brightness values could result from a homo-dimer/monomer, homo-trimer/monomer
or even homo-tetramer/monomer mixture (see Fig. 3.24b). The simplest approach
to distinguish these differences would be to analyse the chemical equilibrium, i.e.
reactant and products are present in concentrations that no longer have the tendency
to change. Hence, at high concentrations either a brightness of two for homo-dimers,
three for homo-trimers, or four for homo-tetramers would be expected. However,
when the obtained brightness values were plotted a as function of concentration no
such chemical equilibrium was observed, indicating that either higher concentra-
tions are needed, which is very unlikely as the obtained values were constant over
1.5-log10 scales, or the maximal achievable oligomer fraction is already reached at
concentrations as low as 10 nM, and thus indicating a rather high affinity. For that
reason, similar experiments could be performed with mutant NEP-mNES1 since
a significantly higher fraction of homo-dimers was observed for this mutant (see
Fig. 3.30). This way, the dynamic range to precisely determine a concentration
dependent chemical equilibrium increases, which possibly promotes interpretation of
data.
Lommer and Luo (2002) performed investigations on the structural plasticity of
NEP. They observed a heterogeneous, compact but at the same time very flexible
conformation with a highly dynamic structure for NEP in solution. The C-terminus
appeared to be relatively rigid, whereas the N-terminus is highly flexible and ex-
posed. Although they stated, that NEP in their hands appeared to be exclusively
monomeric, the investigated structure very likely only represents one organizational
arrangement. From their observations, they concluded, that the characteristics of
NEP are typical attributes connected with intrinsically disordered protein states, a
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highly flexible conformation state in between the native and denaturated form of a
protein (Lommer and Luo, 2002). These observations might explain why no chemical
equilibrium could be reached for NEP in this study as NEP might be present in
different conformations at the same time. Interestingly, Akarsu et al. (2003) were
able to crystallize a truncated NEP variant lacking the N-terminal domain and the
last five AAs of the C-terminal domain. Although they observed a small but not
further discussed dimer fraction even for full-length NEP, the truncated version
showed a strong tendency to form homo-dimers after cross-linking with EGS. They
concluded that the N-terminal domain may pack against the hydrophobic face in the
C-terminal part only in the full-length protein (Akarsu et al., 2003). However, it was
shown, that this closely packed structure might be subtype specific, as a mutation in
NEP, known to be important for adaption of avian Influenza virus to mammalian
hosts, likely results in a more open conformation, and thus leads to a different
regulation in polymerase activity (Reuther et al., 2014a). Additionally, Golovko
et al. (2017) observed a homo-dimer fraction of 10 - 30% from total protein input
for heterologously expressed and purified full-length NEP using GA cross-linking.
These values are in very good agreement with what was observed from molecular
brightness measurements in A549 cells, in which ∼20% homo-dimers were observed
in the cytoplasm and only ∼8% in the nucleus (see Fig. 3.24). The same group
predicted a model in which NEP forms homo-dimers along the C-terminal region
only when the protein shows a rather open conformation (Shtykova et al., 2017).
These observations, together with the results obtained in this study, emphasize the
existence of NEP homo-dimers rather than higher-order oligomers. Interestingly, for
NEP-mEGFP-C1 fusion constructs no oligomer fractions were observed. Although
only two experiments were performed, this highlights an influence of a fusion tag
on protein conformation and function. Presuming a flexible N-terminus of NEP, a
fluorescent protein tag fused to the N-terminal domain might lead to a deregulation
of conformational flexibility of this protein part.
Furthermore, when cells expressing NEP-mEGFP-N1 were co-infected with A/WSN,
NEP localization slightly changed towards a more homogeneous distribution (see
Fig. 3.22), i.e. NEP translocated partly into the nucleus, and thus might be used by
the virus to promote its infection cycle. This is further supported by the observa-
tion that NEP dimer-fractions decrease during co-infection, in which labelled and
unlabelled versions provided by the virus compete for an interaction partner. Hence,
independent of the function of dimerization, NEP wt appears functionally active
at least for one of its two major functions, i.e. nuclear export or polymerase regu-
lating activity (located in the C-terminus, last 3 AAs most important according to
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Reuther et al. (2014a)). Interestingly, when cells expressing NEP wt were additionally
treated with LMB the overall dimer fraction increased drastically, especially within
the nucleus. Further, the difference in dimer fractions between both compartments
strongly decreased, indicating that NEP dimers accumulate in the nucleus when a
CRM1-dependent pathway is not available. Hence, the ability of NEP to access the
CRM1-dependent pathway influences its oligomeric state. Based on these observations,
it was hypothesized, that the masking/unmasking of both NESs that was discussed
earlier to be a possible regulation mechanism for nuclear export of NEP, might be
influenced additionally by the oligomeric state of NEP. Assuming, that α-helices C1
and C2 are involved in the formation of homo-dimers (Akarsu et al., 2003, Shtykova
et al., 2017), one could hypothesize, that dimer formation stabilizes the compact
structure in which both NESs are masked by each other through back-folding of
NES1 to NES2. In this model, homo-dimers would form within the cytoplasm to
bias translocation of NEP into the nucleus by passive diffusion. Transient masking
of NESs would then prevent immediate export of NEP. Only in the nucleus NESs
would be unmasked through (I) monomerization and (II) opening of α-helices N1
(localization of NES1) and N2 (localization of NES2). This hypothesis was supported
by the observation that all NEP-NES mutants with intact structure (i.e. not ΔNES1
and ΔNES2) located similar to NEP wt only when the fraction of monomers in the
nucleus were as low as for NEP wt. This might be independent of the change in dimer
fraction within the cytoplasm. However, when a more homogeneous distribution
was observed, such as for NEP-mNES1, the fraction of homo-dimers in the nucleus
increased strongly (compare Fig. 3.29 and 3.30). Due to the fact, that homo-dimers,
although fused to EGFP, can freely diffuse through NPCs the observed homogeneous
distribution of NEP-mNES1 could be caused by deregulation of its nuclear export
activity through its inability to monomerize. Classical assays to investigate the
CRM1-dependent export activity encompass, for example: (I) fusion of NESs into
an export deficient HIV Rev mutant to probe complementation of its export defect
(Brunotte et al., 2014, Reuther et al., 2014a), (II) mammalian two-hybrid systems in
which interaction with CRM1 is investigated as described earlier in the discussion
(Huang et al., 2013), or (III) direct microinjection of recombinantly expressed proteins
into the nucleus followed by analysis of successful nuclear export (Kurisaki et al.,
2006). However, the described regulation mechanism is difficult to investigate with
most of these classical export assays since the structure of the protein is highly
involved in regulating its activity according to the proposed model. Furthermore,
it was described that the last three AAs of NEP are involved in regulating the
polymerase activity of IAVs (Mänz et al., 2012, Robb et al., 2009), and that Trp78
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is involved in M1 binding (Akarsu et al., 2003). Whether the C-terminal domain is
involved in regulating the export activity of NEP is not clear yet. Hence, a fluorescent
protein tag on the C-terminus as used in this study, might additionally influence
the regulation mechanism. Therefore, it would be interesting to repeat molecular
brightness measurements with an alternative fusion construct in which a fluorescent
protein is localized in between the N- and C-terminal domain of NEP. At least such
a construct (EGFP fused in between AAs 49 and 50) was shown to exhibit the
polymerase activity regulating function of NEP and is able to interact with M1 in a
co-immunoprecipitation assay (Brunotte et al., 2014). However, whether the position-
and structure-dependent regulation mechanism of NEP is restored in this mutant is
not clear. Furthermore, to probe intramolecular changes of the masking/unmasking
of NES1 and NES2 in dependence of the oligomeric state, a promising approach was
introduced by Reuther et al. (2014a). They used a split-luciferase complementation
system to show that the polymerase enhancing function of M16I-NEP mutant, that
is important for the adaption of avian Influenza viruses to mammalian cells, is based
on a more flexible open structure of NEP. At least the proposed masking/unmasking
mechanism of NES1 and NES2 could be investigated by fusing one reporter fragment
to the N-terminal domain of NEP, the second fragment between the N-terminal and
C-terminal domain and finally monitoring reconstitution of the reporter. However,
whether this can be performed in living cells to connect the observed results to
the subcellular localization of NEP (originally cells were lysed to perform reporter
detection) would need to be evaluated. However, a huge disadvantage of this method
is the overall size of ∼60 kDa of the luciferase reporter itself. In summary, it will be
very difficult to address all relevant open questions since NEP is only 14 kDa in size.
Hence, a fluorescent protein tag, independent of its position within the protein might
always influence at least partially the structure and/or function of NEP. Alternative
labelling methods to analyse the protein in living cells directly, such as SNAP- or
Halo-tags again suffer from the considerable size of the tags (∼20 kDa).
Furthermore, based on the conserved spacing of NES1 and the three serins (i.e.
phosphorylation sites) in IAV and IBV it was speculated, that phosphorylation
might regulate the interaction of NEP with CRM1 (Hutchinson et al., 2012). Taken
together with the conclusions drawn in this study, phosphorylation of serins could
regulate the masking and unmasking process of NEP. Due to the fact that Ser24 is
surface exposed and was shown to be predominantly phosphorylated during viral
infection (Hutchinson et al., 2012, Reuther et al., 2014b), two NEP mutants in
which Ser24 was substituted with Ala (’S24A’) or Glu (’S24E’), respectively, were
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analysed for their subcellular localization profile and oligomeric state. Whereas in
mutant S24A, i.e. mimicking constant dephosphorylation, an increase in homo-dimer
fractions was observed in the cytoplasm and nucleus, for mutant S24E which mimics
constant phosphorylation, a decrease in homo-dimer fractions in both compartments
was observed. This clearly highlights an influence of Ser24 post-translational modi-
fication on oligomerization of NEP. Interestingly, in mutant S24A the subcellular
distribution was not altered compared to NEP wt, although homo-dimer fractions
increased. This is in contrast with the conclusions drawn from NEP-NES mutants,
where an increase in homo-dimer fractions resulted in equal distribution of NEP
throughout cells. However, the cytoplasm to nucleus ratio (’CP/N’) of the obtained
homo-dimer fractions was closer to that observed for NEP wt (CP/N ratio NEP wt:
2.4; S24A: 1.9), whereas in NEP-NES mutants with homogeneous NEP distribution
equal homo-dimer fractions were observed in both compartments, i.e. CP/N ratios
were close to 1. It was thus concluded, that the ability of NEP to monomerize
in the nucleus, which is important for successful nuclear export according to the
proposed regulation mechanism, is as efficient as for NEP wt, and thus the mutant
is efficiently exported from the nucleus as shown by its subcellular localization
phenotype. Additionally, viral Ser24-mutants showed significantly slower growth
kinetics than wild-type A/WSN, although S24E mutant virus replicated slightly
worse than mutant S24A. The observed decreased replication ability of mutant S24E
was in agreement with a statement given in a talk by Dr. Hutchinson (2016-12-15,
Institute of Virology, FU Berlin); unfortunately his data have not been published
yet. Furthermore, viral mutants in which all three serins of NEP were exchanged
against Ala (’AAA’) or Asp (’DDD’, mimicking constant phosphorylation) did show
a significant increase in export activity for NEP-DDD but not NEP-AAA (Reuther
et al., 2014a), consistent with the presented data assuming a dependence of the
NEP export activity on its oligomeric state. Further, these mutants were shown to
influence the polymerase activity: in NEP-AAA an overall increased activity, but
decreased activity for NEP-DDD was observed (Reuther et al., 2014a). Altogether,
these results highlight an influence of phosphorylation at the conserved serine region
on both molecular functions of NEP.
Nuclear export of vRNPs was additionally shown to be dependent on activation of
the MAPK signalling pathway as a result of HA membrane accumulation late in
infection (Marjuki et al., 2006, Pleschka et al., 2001). This way, IAVs are able to
time vRNP export. Although it was demonstrated through U0126 inhibition, that
MEK kinase did not result in phosphorylation of NEP, MEK inhibition resulted in
decreased export activity of NEP (Pleschka et al., 2001). Therefore, two inhibitors,
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U0126 and H7, were used to test their influence on NEP dimerization and subcellular
localization, since phosphorylation influences the oligomeric state of NEP as shown
for mutants S24A and S24E. Surprisingly, homo-dimer fractions in both subcellular
compartments slightly decreased; although a phenotype more similar to mutant S24A
would have been expected in case MAPK signalling would directly target NEP, and
phosphorylation would lead to its monomerization, and would thus promote nuclear
export of vRNPs. Hence, MAPK signalling based phosphorylation might have a
different than expected effect on NEP. However, these results could explain why
Pleschka et al. (2001) did not observe an alteration of NEP subcellular localization
similar as seen in the present study, but an influence on NEP export activity in cells
treated with U0126. Nevertheless, phosphorylation of Ser24 might indeed trigger
export of vRNPs, by unmasking both NESs, that involves monomerization of NEP
and unmasking of NES2 by a charge induced conformational change of α-helix N1.
However, kinase inhibitors H7 and U0126 are very likely not directly involved in
this regulation step. Instead, the kinase CK2 was predicted to phosphorylate NEP
(Hutchinson et al., 2012). IAV infection results in increased CK2 activity, and in-
hibition of CK2 was shown to decrease budding efficiency of IAVs from MDCK II
cells (Hui and Nayak, 2002). Therefore, experiments should be performed with a
CK2 inhibitor, such as DRB (5,6-dichloro-1-β-d-ribofuranosylbenzimidazole), but
also in the presence of HA to rule out any influence of the MAPK signalling pathway.
Furthermore, timing of vRNP export should be analysed for mutant viruses S24A
and S24E, simply by indirect immunofluorescence staining of NP after infection of
A549 cells to probe localization of vRNPs.
Finally, in this study SPIM-FCS was applied to investigate the translocation dynamics
of NEP across the nuclear envelope in dependence of its oligomeric state. According
to the postulated model, free diffusion of especially dimers but also monomers of
NEP into the nucleus would be expected, while active transport out of the nucleus
would be expected only for monomeric NEP. To this aim, pCF analysis, which allows
analyses of dynamics across a diffusion barrier by correlating signals in two separate
pixels, was performed over the nuclear envelope as introduced by Cardarelli and
Gratton (2010). This approach was first tried using sFCS in confocal microscopy.
Unfortunately, SNRs for pCFs were very poor (data not shown), which is why SPIM-
FCS was tried, as it allows for multiplexed FCS. Through averaging of all pCFs
of equal distances in one image, it was aimed for a better SNR of pCFs. However,
even if the molecular brightness could be assessed for each pixel, similar to FCS
measurements only an oligomer distribution will be observed for each pixel. Hence,
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although differences in transport dynamics might be detected, no clear correlation
between dynamics and oligomeric state can be drawn. Therefore, to circumvent this
disadvantage, dynamics of NEP mutants with distinct monomeric or homo-dimeric
fractions should have been compared to NEP wt dynamics. Unfortunately, the SPIM
setup used in this study appeared to be very unstable, i.e. strong fluctuations in
intensity over time were observed for the whole image (see Fig. 4.4c in Appendix),
and are thus not caused by diffusing molecules. For some, only weakly disturbed
measurements, these dominant long-term fluctuations could be successfully corrected
(see Fig. 2.2 in Methods section). Additionally, fluctuation artefacts resulting from
moving vesicles in cells (see Fig. 4.4b in Appendix), or striping effects that result
in intensity differences throughout cells (see Fig. 4.4a in Appendix) were observed
(Krieger et al., 2015). In particular, striping effects can cause correlation artefacts of
spatially separated pixels in pCF analysis. Hence, samples showing these artefacts
could not be used for further analysis. Altogether, of all performed measurements
only a few were suitable for pCF analysis, mainly due to strong intensity instabilities.
Thus, only a proof-of-concept was possible.
First, similar average diffusion coefficients of NEP for both subcellular compartments
were observed for pFCS and SPIM-FCS measurements, indicating that both methods
yield similar results (see Fig. 3.32). Therefore, in a second step pCFs of different pixels
distance were calculated for NEP in individual compartments to verify pCF analysis
without a diffusion barrier such as the nuclear envelope (see Fig. 3.33 and 3.34). In
the used SPIM-FCS setup the PSF possessed a lateral extension of 1.1 μm, which
corresponds to 2.75 pixels in the resulting image. Hence, cross-excitation of pixels
with one or two pixels distance is expected. As a result, data and fit curves give rise to
a ’pseudo-correlation’ very similar to ACFs for short distances. In both compartments,
cytoplasm and nucleus, diffusion coefficients of ACFs resulted in higher Ds than
observed for pFCS or standard ACF analysis of SPIM-FCS measurements, whereas
Ds extracted from pCF(1) were very similar to previous results. In pFCS or the
standard SPIM-FCS data evaluation all obtained ACF data were fitted individually,
and thus only meaningful data contributed to results. In contrast to that, in pCF
analysis all data of equal distance were first averaged and subsequently a model was
fitted to the data. Hence, unusual dynamics can considerably influence the values
obtained by pCF analysis. Further, consistent with other studies, a decrease for
Ds with increasing distance was observed (Baum et al., 2014). This is very likely
attributed to an increasing proportion of proteins with reduced mobility due to a
heterogeneous cellular interior that leads to transient trapping of proteins such as
dense chromatin in the nucleus (Baum et al., 2014). Nevertheless, obtained Ds for
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intracompartment measurements are in good agreement with pFCS measurements.
Third, intercompartment pCFs were analysed for two controls, mEGFP-NLS and
mEGFP-NES, theoretically resulting in different transport dynamics across the
nuclear envelope (see Fig. 3.35). To avoid positive cross-correlation artefacts due
to spatial cross-excitation, a stripe of three pixels spanning the nuclear envelope
was excluded from pCF analysis performed over the nuclear envelope. Cardarelli
and Gratton (2010) observed peak values of 100 to 500ms for mEGFP-NLS passive
transition from the nucleus to the cytoplasm of cells, whereas active nuclear import
revealed average diffusion times of 1 to 40ms. Unfortunately, these differences in
transport activity were neither observed for mEGFP-NLS, nor mEGFP-NES. In
general, the obtained data for these constructs were very noisy, especially in the
compartment of low expression levels (i.e. cytoplasm for mEGFP-NLS or nucleus
for mEGFP-NES), and thus extracting information about peak values was difficult.
Although pixels could be binned to gain better statistics, this would come to the cost
of spatial resolution (Krieger et al., 2015). In conclusion, reproducing the data shown
by Cardarelli and Gratton (2010) was not possible using SPIM-FCS. Nevertheless,
intracompartment diffusion dynamics of NEP were compared to transport kinetics
across the nuclear envelope (see Fig. 3.36). Similar to mEGFP-NLS/NES no differ-
ences in transport dynamics for cytoplasm to nucleus or vice versa were observed,
although these measurements showed a higher SNR. Nevertheless, intercompartment
dynamics appeared slightly faster than intracompartment dynamics, which could
hint towards an active transport of NEP across the nuclear envelope. To better
address the discussed problems, STED microscopy could be combined with sFCS.
This way, resolution, especially near the nuclear envelope, could be significantly
improved. Hence, smaller distances closer to the nuclear envelope could be analysed,
and thus dynamics obtained from molecules transported across the nuclear envelop
might be less dominated by dynamics observed from surrounding intracompartment
dynamics. Nevertheless, whether SNRs would be sufficient to distinguish differences
in dynamics in such an experimental setup requires further exploration.
In summary, based on the discussed conclusions, combining for the first time the
oligomeric state of NEP in dependence of its subcellular localization with its localiza-
tion phenotype, a regulation mechanism was proposed in which the export of NEP is
regulated by transient masking and unmasking of its two NESs, which is supported
by monomerization of NEP within the nucleus of cells. According to this model, the
weak NES1 backfolds to the stronger NES2, thus transiently decreasing the export
activity of NEP. This masking is stabilized by homo-dimerization of NEP in the
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cytoplasm. This way, NEP is biased towards the nucleus, where it monomerizes and
thus can unmask its two NESs to gain access to the cellular export machinery. This
process is very likely promoted by phosphorylation, although the exact role of this
post-translational modification requires further investigations.
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Appendix
Figure 4.1: Consensus sequence of the primary structure of ICV NEP. The
consensus sequence of ICV NEP was generated using WebLogo3 (access: 2018-07-11). 176
available sequences of human and avian hosts have been collected from the Influenza
research database (https://www.fludb.org/, access: 2018-07-11). Two identified NESs have
been framed in red, according to Paragas et al. (2001). Colour code of AAs according to
chemical properties: polar AAs G,S,T,Y,C are green, neutral AAs Q,N are purple, basic
AAs K,R,H are blue, acidic AAs D,E are red, hydrophobic AAs A,V,L,I,P,W,F,M are
black.
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Figure 4.2: Consensus sequence of the primary structure of IDV NEP. The con-
sensus sequence of IDV NEP was generated using WebLogo3 (access: 2018-07-11). 3 available
sequences have been collected from the Influenza research database (https://www.fludb.org,
access: 2018-07-11). No NES has been mapped to NEP of IDV yet. Colour code of AAs
according to chemical properties: polar AAs G,S,T,Y,C are green, neutral AAs Q,N are pur-
ple, basic AAs K,R,H are blue, acidic AAs D,E are red, hydrophobic AAs A,V,L,I,P,W,F,M
are black.
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Coding sequence of A/WSN/1933 used in this study (5’-3’):
ATGGATCCAAACACTGTGTCAAGCTTTCAGGACATACTGATGAGGATGTCA
AAAATGCAGTTGGGGTCCTCATCGGAGGACTTGAATGGAATAATAACACAG
TTCGAGTCTCTGAAACTCTACAGAGATTCGCTTGGAGAAGCAGTAATGAGA
ATGGGAGACCTCCACTCACTCCAAAACAGAAACGGAAAATGGCGGGAACAA
TTAGGTCAGAAGTTTGAAGAAATAAGGTGGTTGATTGAAGAAGTGAGACAC
AGACTGAAGATAACAGAGAATAGTTTTGAGCAAATAACATTTATGCAAGCC
TTACAACTATTGCTTGAAGTGGAGCAAGAGATAAGAACTTTCTCGTTTCAG
CTTATTTAA
Corresponding amino acid sequence of A/WSN/1933 used in this study
(N to C-Terminus):
MDPNTVSSFQDILMRMSKMQLGSSSEDLNGIITQFESLKLYRDSLGEAVMRMG
DLHSLQNRNGKWREQLGQKFEEIRWLIEEVRHRLKITENSFEQITFMQALQLL
LEVEQEIRTFSFQLI*
Table 4.1: Overview of all oligonucleotides used for cloning. All used oligonu-
cleotides were purchased from Thermo Fisher Scientific Inc. with desalted purity. For
cloning of inserts into a target plasmid primer names contain information about insert,
restriction enzymes, and orientation: sense (for) or anti-sense (rev). Recognitions sites for
restriction enzymes are highlighted in bold, nts introduced to retain reading frames are
written in small letters, coding sequences are underlined, and mutations highlighted in red.
If not stated otherwise, all IAV proteins correspond to A/WSN. Term: Terminator/terminal,
Prom: Promoter.
Primer Sequence (5’-3’) Application
BGH Term. rev TAGAAGGCACAGTCGAGG
sequencing
CMV Prom. for CGCAAATGGGCGGTAGGCGTG
CRM1 (XhoI)
for
GAGACTCGAGgaATGACAATGTTAGC
AGACCATG
cloning into
mCherry2-C1
CRM1 (BamHI)
rev
GAGAGGATCCTTAATCACACATTTCT
TCTG
CRM1 for01
CTGTGTCAGTTTGTAATGGAAAATTC
TC
colony PCR,
sequencingCRM1 for02
GTGTTGGGCAATAGGCTCCATTAGTG
GAGCAATG
Continued on next page...
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Primer Sequence (5’-3’) Application
CRM1 for03
GATTATCAGAGAAATGTCCCAGCTGC
TAGAG
Homo-dimer
(BamHI) for
GAGAGGGATCCATGGTGAGCAAGGG
CGAGGAG
cloning of
homo-oligomers
with mEGFP-N1
or mCherry2-N1
Homo-dimer
(AgeI) rev
GAGAACCGGTctCTTGTACAGCTCGT
CCATGCC
Homo-trimer
(KpnI) for
GAGAGGTACCATGGTGAGCAAGGGC
GAGGAG
Homo-trimer
(BamHI)rev
GAGAGGATCCCgacggtctCTTGTACAG
CTCGTCCATGCC
Homo-tetramer
(EcoRI) for
GAGAGAATTCATGGTGAGCAAGGGC
GAGGAG
Homo-tetramer
(KpnI) rev
GAGAGGTACCgaccggtctCTTGTACAGC
TCGTCCATGCC
Hetero-dimer
(XhoI) for
GAGACTCGAGgaATGGTGAGCAAGGG
CGAGGAG
cloning of
hetero-dimers,
mEGFP into
mCherry(2)-C1
Hetero-dimer
(BamHI) rev
GAGAGGATCCTTACTTGTACAGCTCG
TCCATGCC
cMyc/ADAR
(NheI) for
GATCCGCTAGCGCTACCGGTCGCCAC
CATGGTGAGCAAGGGCGAGGAGCTGT
TC
cloning of
NLS/NES into
mEGFP-N1
cMyc-NLS
(XhoI) rev
GAGACTCGAGATCTGAGTTAGTCTAG
TTTAACGCGTTTGGCAGCAGGCTTGT
ACAGCTCGTCCATGCCGAG
ADAR1-NES
(XhoI) rev
GAGACTCGAGATCTGAGTTAGATACT
CAGTTCCTGGAAATGTGAGGAAAGCT
TGTACAGCTCGTCCATGCCGAG
M1 (KpnI) for
GTCGGGTACCATGAGTCTTCTAACC
GAGGTC cloning into
pCMV3
M1 (NotI) rev
GTGCGCGGCCGCTCACTTGAATCG
TTGCATCTGCAC
M1 (NdeI) for
GAGACATATGATGAGTCTTCTAACC
GAGGT
cloning into
pET15b
Continued on next page...
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Primer Sequence (5’-3’) Application
M1 (XhoI) rev
GTGCCTCGAGACTTCACTTGAATCG
TTGCATC
M1 (XhoI) for
GAGACTCGAGgtATGAGTCTTCTAAC
CGAGGTCGAAAC
cloning into
mCherry2-C1
M1 (BamHI) rev
GAGAGGATCCTCATTGAATCGTTGC
ATCTGCAC
M1 (NheI) for
GTGCGCTAGCATGAGTCTTCTAACC
GAGGTC
cloning into
mCherry2-N1
M1 (XhoI) rev
GTCGCTCGAGcttgCGTTGCATCTGC
ACC
NEP for ATGGATCCAAACACTGTGTCA amplification of
spliced NEP
from cDNA pool
NEP Intron for CAAGCTTTCAGGACATACTGA
NEP rev TTAAATAAGCTGAAACGAGAAAG
NEP (KpnI) for
GTCGGGTACCATGGATCCAAACACT
GTGTCAAG
cloning into
pCMV3
NEP (NotI) rev
GTGCGCGGCCGCTTATTAAATAAGC
TGAAACGAGAAAG
NEP (NdeI) for
GATACATATGATGGATCCAAACACTG
TGTC
cloning into
pET15b
NEP (XhoI) rev
GAGACTCGAGATCTTAAATAAGCTGA
AACGAGAAAG
NEP (XhoI) for
GATACTCGAGATGGATCCAAACACTG
TGTCAAG
cloning into
mCherry2-N1,
mEGFP-N1;
NEP (SmaI) rev
GAGACCCGGGtaaTAAGCTGAAACGA
GAAAGTTC
term. primer
2-step PCR
NEP-mNES1 rev
GATGAGGACCCTGCCTGGGCTTTTGA
TGCCCTC
internal primer
2-step PCR
NEP-mNES1 for
GAGGGCATCAAAAGCCCAGGCAGGGT
CCTCATC
NEP-ΔNES1 rev
CATTCAAGTCCTCCGATGAGGACCCGT
CCTGAAAGC
internal primer
2-step PCR
Continued on next page...
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Primer Sequence (5’-3’) Application
NEP-ΔNES1 for
CTTTCAGGACGGGTCCTCATCGGAGGA
CTTGAATG
NEP-2xNES1
rev
CTGTACAACTGCATTTTTGACATCCTC
ATCAGTATTCCATTCAAGTCCTCCGATG
internal primer
2-step PCR
NEP-2xNES1 for
GAATGGAATACTGATGAGGATGTCAA
AAATGCAGTTGTACAGAGATTCGCTT
GGAGAAGCAG
NEP-mNES2 rev
CAAGCGAATCTCTGTAGGCTTTTGCA
GACTCGAACTGTG
internal primer
2-step PCR
NEP-mNES2 for
GTTCGAGTCTGCAAAAGCCTACAGAG
ATTCGCTTGGAG
NEP-ΔNES2 rev
CAAGCGAATCTCTGTATCCATTCAAG
TCCTCCGATGAGG
internal primer
2-step PCR
NEP-ΔNES2 for
GACTTGAATGGATACAGAGATTCGCT
TGGAGAAGCAG
NEP-2xNES2
rev
GAATCTCTGTAGAGTTTCAGAGACTC
GAACTGTGTTATTATTCCATTCAAGTC
CTCCGATGAG
internal primer
2-step PCR;
template: No.
I23NEP-2xNES2 for
GAATAATAACACAGTTCGAGTCTCTG
AAACTCTACAGAGATTCGCTTGGAGA
AGCAGTAATG
NEP-NES2-1 rev
GAATCTCTGTAGAGTTTCAGAGACTC
GAACTGTGTTATTATTCCATTCAAGTC
CTCCGATGAG
internal primer
2-step PCR;
template: No.
I21NEP-NES2-1 for
GAATAATAACACAGTTCGAGTCTCTG
AAACTCTACAGAGATTCGCTTGGAGA
AGCAGTAATG
NEP-S24A rev CAAGTCCTCCGACGCGGACCCCAAC internal primer
2-step PCRNEP-S24A for GTTGGGGTCCGCGTCGGAGGACTTG
NEP-S24E rev CAAGTCCTCCGACTCGGACCCCAAC internal primer
2-step PCRNEP-S24E for GTTGGGGTCCGAGTCGGAGGACTTG
NS1(SAM)
(Esp3I) for
TATTCGTCTCAGGGAGCAAAAGCAG
GGTG
part A1 2-step
PCR NS1
Continued on next page...
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Primer Sequence (5’-3’) Application
NS1(SAM) rev
CTCATCAGTATGCCCGGGAAGAGAGG
GCAGTG
NS1(SAM)-2A
for
CACCACTGCCCTCTCTTCCCGGGCAT
ACTGATGAGGATG
part A2 2-step
PCR NS1
NS1(SAM)-2A
rev
CGGGCCCGGGTTTTCTTCCACATCGC
CCGCCTGTTTCAGCAGGCTAAAGTTGG
TCGCAACTTCTGACCTAATTGTTCCCG
CCATTTTCCGTTTCTG
NS1(SAM)-
2A-NEP_GFP
for
GCGACCAACTTTAGCCTGCTGAAACAG
GCGGGCGATGTGGAAGAAAACCCGGG
CCCGATGGATCCAAACACTGTGTCAAG
CTTTCAG
part B 2-step
PCR NS1-NEP
NS1(SAM)-2A-
NEP (Esp3I)
rev
ATATCGTCTCGTATTAGTAGAAACAAG
GGTGTTTTTTATTAttaAATAAGCTGAAA
CGAGAAAG
NS1(SAM)-2A-
NEP-mEGFP
(Esp3I) rev
ATATCGTCTCGTATTAGTAGAAACAAG
GGTGTTTTTTATTAttaCTTGTACAGCTC
GTCCATG
NP (KpnI) for
GAGAGGTACCATGGCGACCAAAGGCA
CCAAAC cloning into
pCMV3
NP (NotI) rev
GAGAGCGGCCGCTTAATTGTCGTAC
TCCTCTGC
NP (XhoI) for
GATCCTCGAGATGGCGACCAAAGGC
ACCAAAC
cloning into
mCherry2-N1,
mEGFP-N1NP (EcoRI) rev
GAGAGAATTCTATTGTCGTACTCCTC
TGCATTG
NP for CACGGTCTGCACTCATATTGA
colony PCR,
sequencing
PA (KpnI) for
GAGAGGTACCATGGAAGATTTTGTG
CGACAATGCTTC cloning into
pCMV3
PA (NotI) rev
GAGAGCGGCCGCCTATCTCAATGCA
TGTGTGAG
Continued on next page...
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Primer Sequence (5’-3’) Application
PA (XhoI) for
GATCCTCGAGATGGAAGATTTTGTG
CGACAATG
cloning into
mCherry2-N1,
mEGFP-N1
PA (BamHI) rev
GAGAGGATCCGTTCTCAATGCATGT
GTGAGGAAG
PA for01 CACGGTCTGCACTCATATTGA colony PCR,
sequencingPA for02 CACGGTCTGCACTCATATTGA
PB1 (KpnI) for
GAGAGGTACCATGGATGTCAATCCG
ACTTTACTT cloning into
pCMV3
PB1 (NotI) rev
GAGAGCGGCCGCACTCTATTTTTGC
CGTCTGAGCTCT
PB1 (XhoI) for
GAGACTCGAGATGGATGTCAATCCG
ACTTTAC
cloning into
mCherry2-N1,
mEGFP-N1PB1 (KpnI) rev
GAGAGGTACCgTTTTTTGCCGTCTG
AGCTCTTC
PB1 for01 CAGTTGGAGGCAATGAGAAGA colony PCR,
sequencingPB1 for02 AGAAACTGTGGGAGCAAACC
PB2 (KpnI) for
GAGAGGTACCATGGAAAGAATAAAA
GAACTAAG cloning into
pCMV3
PB2 (NotI) rev
GAGAGCGGCCGCCTAATTGATGGCC
ATCCGAATTC
PB2 (KpnI) for
GAGAGGTACCATGGAAAGAATAAAA
GAACTAAG
cloning into
mCherry2-C1,
mEGFP-C1PB2 (XbaI) rev
GAGATCTAGACTAATTGATGGCCAT
CCGAATTC
PB2-His (NheI)
for
GAGAGCTAGCGGCCATCATCATCATC
ATCACagcagcggcATGGTGAGCAAGGGC
GAGGAG
cloning into
mCherry2-C1
PB2-His
(BamHI) rev
GAGAGGATCCCTAATTGATGGCCATC
CGAATTCTTTTG
PB2 for01 GAGGCGAGGAATGATGATGT colony PCR,
sequencingPB2 for02 TGATGTGGGAGATTAATGGTCC
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Figure 4.3: Molecular brightness analysis of mEGFP, mCherry, and mCherry2
monomers and homo-dimers in different cell types. a) Box plots of the normal-
ized molecular brightness of mEGFP monomers (1xmEGFP, white) and homo-dimers
(2xmEGFP, grey) measured with N&B in the cytoplasm of HEK 293T, A549, CHO and
HeLa cells. Data were pooled from at least three independent experiments (1x/2x HEK:
n=47/48 cells, 1x/2x A549: n=38/33 cells, 1x/2x CHO: n=36/39 cells, 1x/2x HeLa: n=39/37
cells). b) Box plots of normalized molecular brightness of mCherry (light red) compared
to mCherry2 (dark red). Monomers (white) and homo-dimers (grey) were measured using
N&B in the cytoplasm of HEK 293T, A549, CHO and HeLa cells. Data were pooled from
at least three independent experiments (mCherry: 1x/2x HEK: n=50/53 cells, 1x/2x A549:
n=37/36 cells, 1x/2x CHO: n=44/41 cells, 1x/2x HeLa: n=35/36 cells; mCherry2: 1x/2x
HEK: n=49/54 cells, 1x/2x A549: n=38/34 cells, 1x/2x CHO: n=43/40 cells, 1x/2x HeLa:
n=38/40 cells).
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Figure 4.4: SPIM artefacts causing additional fluctuations. a) Striping artefacts
result in inhomogeneous intensity distributions throughout cells. b) Particles moving
around within the cell, or the surrounding buffer. Two tracks for vesicles moving within the
cytoplasm of an A549 cell are illustrated. c) System instabilities. NEP wt and mEGFP-NLS
were measured using two different diode lasers. In both cases no bleaching was observed
but reappearance of intensities; not only within the region of interest of a cell, but also in
the background.
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